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The Malaysian plant, Alstonia macrophylla Wall, was investigated for its alkaloidal 
content and the results are summarized in the Table below. A total of 90 alkaloids were 
isolated and characterized from the leaf and stem-bark of A. macrophylla. Of these, 30 
are new alkaloids. The leaf extract of A. macrophylla yielded a total of 13 new alkaloids, 
including a macroline indole 1, a macroline oxindole 16, eight akuammiline alkaloids 
(compounds 24, 25, 26, 27, 28, 29, 30, and 31), a sarpagine alkaloid 32, and two 
ajmaline alkaloids (compounds 33 and 34). The stem-bark extract of A. macrophylla 
gave a total of 19 new alkaloids. These include, in addition to the akuammiline and 
sarpagine alkaloids found in the leaf extract (24 and 32, respectively), compound 2, 3, 4, 
17, the linearly fused bisindole alkaloids, lumutinines A‒E (7175), the macroline-
macroline bisindoles, lumusidines AD (7780) and perhentidines A‒B (81and 82), 
and the macrolinepleiocarpamine bisindole alkaloids, villalstonidines B (86) and F 
(87). Perhentidines A‒B (81 and 82), perhentinine (83), villalstonine (88) and 
macrocarpamine (90), showed pronounced cytotoxicity toward KB cells (IC50 2.644.06 
g/mL), while lumutinines A‒E (71‒75), macralstonidine (76), lumusidines A-C 
(77‒79), anhydromacralstonine (85), and villalstonidine B (86) showed moderate 
cytotoxicity toward KB cells (IC50 4.3018.14 g/mL). Compounds 24, 25, 26, 29, 31, 
32, lumusidine D (80), and macralstonine (84) showed strong activity in circumventing 












Abstrak (Versi Bahasa Malaysia) 
 
Satu jenis tumbuhan dari Malaysia, Alstonia macrophylla telah dikaji dari segi 
kandungan alkaloidnya, keputusan yang diperoleh telah dirumuskan di dalam jadual 
seperti di bawah. Sebanyak 90 alkaloid telah diasingkan dan dicirikan dari daun dan 
kulit-batang A. macrophylla. Dari jumlah tersebut, 30 alkaloid merupakan alkaloid baru. 
Sebanyak 13 alkaloid baru telah diasingkan dari ekstrak daun, iaitu sebatian-sebatian 1, 
16, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, dan 34. Sebanyak 19 alkaloid baru telah 
dipisahkan dari ekstrak kulit-batang. Selain daripada dua alkaloid yang juga didapati 
dari ekstrak daun (24 dan 32), alkaloid-alkaloid baru ini termasuklah sebatian-sebatian 2, 
3, 4, 17, lumutinines A‒E (7175), lumusidines AD (7780), perhentidines A‒B (81 
dan 82), villalstonidines B (86), dan F (87). Perhentidines A‒B (81 dan 82), 
perhentinine (83), villalstonine (88) dan macrocarpamine (90), menunjukkan kesan 
sitotoksik yang kuat terhadap sel-sel KB (IC50 2.644.06 g/mL), manakala lumutinines 
A‒E (71‒75), macralstonidine (76), lumusidines A‒C (77‒79), anhydromacralstonine 
(85), dan villalstonidine B (86) menunjukkan kesan sitotoksik yang sederhana terhadap 
sel-sel KB (IC50 4.30 g/mL). Sebatian-sebatian 24, 25, 26, 29, 31, 32, 
lumusidine D (80), dan macralstonine (84) menunjukkan aktiviti yang kuat dalam 






























Table: Alkaloid Composition of Alstonia macrophylla 
Plant Plant Part Alkaloid 
A. macrophylla Leaves  Alstofolinine (1) [New] 
  Alstonerine (5) 
  Alstonerinal (6) 
  Alstophylline (7) 
  Alstophyllal (8) 
  Macrocarpine B (10) 
  Talcarpine (12) 
  N(4)-Methyl-N(4),21-secotalpinine (13) 
  Compound 16 (11-Methoxyalstonoxine A) [New] 
  Alstonoxine A (18) 
  Alstonoxine B (19) 
  Alstonisine (20) 
  Alstonal (21) 
  N(4)-Demethylalstophylline oxindole (22) 
  N(4)-Demethylalstophyllal oxindole (23) 
  Compound 24 (2(S)-Cathafoline) [New] 
  Compound 25 (2(S)-10-Methoxycathafoline) [New] 
  Compound 26 (2(R)-3-Hydroxycathafoline) [New] 
  Compound 27 (10-Demethoxyvincorine) [New] 
  Compound 28 (10-Demethoxyvincorine N(4)-oxide) [New] 
  Compound 29 (11-Methoxyvincorine) [New] 
  Compound 30 (Vincorine N(4)-oxide) [New] 
  Compound 31 (11-Demethoxyquaternine) [New] 
  Compound 32 (19,20-Z-Affinisine) [New] 
  Compound 33 (Vincamajine N(4)-oxide) [New] 
  Compound 34 (Vincamajine 17-O-veratrate N(4)-oxide) 
[New] 
  Cathafoline (35) 
  Cathafoline N(4)-oxide (36) 
  10-Methoxycathafoline (37) 
  Strictamine (38) 
  11-Methoxystrictamine (39) 
  11-Hydroxystrictamine (40) 
  Vincorine (41) 









Table, continued  
Plant Plant Part Alkaloid 
  Alstonamide (43) 
  Demethoxyalstonamide (44) 
  Alstomaline (45) 
  Quaternine (46) 
  Picrinine (47) 
  12-Demethoxytabernulosine (48)  
  Normacusine B (51) 
  Alstoumerine (52) 
  Quebrachidine (53) 
  Vincamajine (54) 
  Vincamajine 17-O-veratrate (55) 
  Sitsirikine (56) 
  16R,19E-Isositsirikine (57) 
  18,19-Dihydroisositsirikine (58) 
  Pleiocarpamine (59) 
  Fluorocarpamine (63) 
  Yohimbine (64) 
  Talpinine (65) 
  10,11-Dimethoxynareline (66) 
  11-Methoxyakuammicine (67) 
  11-Methoxyakuammicine N(4)-oxide (68) 
   
A. macrophylla Bark Compound 2 (20,21-Dihydroalstonerine) [New] 
  Compound 3 (N(1)-Demethylmacrocarpine B) [New] 
  Macrodasine H (4) [New] 
  Alstonerine (5) 
  Alstonerinal (6) 
  Alstophylline (7) 
  Alstophyllal (8) 
  Macrocarpine A (9) 
  Macrocarpine B (10) 
  Macrocarpine C (11) 
  Talcarpine (12) 
  N(4)-Methyl-N(4),21-secotalpinine (13) 
  Macrodasine A (14) 









Plant Plant Part Alkaloid 
  Compound 17 (11-Methoxyalstonoxine B) [New] 
  Alstonoxine B (19) 
  Compound 24 (2(S)-Cathafoline) [New] 
  Cathafoline (35) 
  Cathafoline N(4)-oxide (36) 
  Vincorine (41) 
  19,20-Z-Affinisine (32) [New] 
  Affinisine (49) 
  Affinisine oxindole (50) 
  Normacusine B (51) 
  Alstoumerine (52) 
  Vincamajine (54) 
  16R,19E-Isositsirikine (57) 
  Pleiocarpamine (59) 
  16-Hydroxypleiocarpamine (60) 
  Pleiomaltinine (61) 
  Picramicine (62) 
  Fluorocarpamine (63) 
  11-Methoxyakuammicine (67) 
  Antirhine (69) 
  Talpinine (65) 
  1,2,3,4-Tetrahydro-1-oxo--carboline (70) 
  Lumutinine A (71) [New] 
  Lumutinine B (72) [New] 
  Lumutinine C (73) [New] 
  Lumutinine D (74) [New] 
  Lumutinine E (75) [New] 
  Macralstonidine (76) 
  Lumisidine A (77) [New] 
  Lumisidine B (78) [New] 
  Lumisidine C (79) [New] 
  Lumisidine D (80) [New] 
  Perhentidine A (81) [New] 
  Perhentidine B (82) [New] 









Plant Plant Part Alkaloid 
  Macralstonine (84) 
  Anhydromacralstonine (85) 
  Villalstonidine B (86) [New] 
  Villalstonidine F (87) [New] 
  Villalstonine (88) 
  Villalstonine N(4)-oxide (89) 
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The exploration of natural products from plants, animals, insects, marine invertebrates, 
and microorganisms represents an active area of research in chemistry.
1-3
 Since the mid 
19
th
 century, serious efforts were made to isolate and purify the active compounds of 
herbs.
4
 A large variety of biologically active compounds have been obtained and their 
structures were determined, for example, morphine from opium, cocaine from coca 
leaves, and quinine from cinchona bark.
4
 Today, this field continues to grow as the 
pharmaceutical industry is constantly searching for new lead compounds for 
development into new drugs.
5-27
 The discovery of many therapeutic agents for cancer 
and infectious diseases (e.g., taxol,
28-32









) has provided an added impetus for natural product-
based drug discovery. Furthermore, natural products continue to provide subjects of 
investigation for the organic chemists in the areas of structure elucidation, biosynthesis, 
and biochemistry.
47-60
 They also present challenging targets for total synthesis leading 
to the remarkable progress seen in synthetic organic chemistry.
61-63
 The rich natural 
resources available in Malaysia provides opportunities for discovery of new bioactive 
compounds.
64
 In addition, from an organic chemistry viewpoint, there is also great 
potential for discovering novel molecular structures and for investigating novel 








The Malayan Alstonia macrophylla (Apocynaceae) was chosen for investigation in the 
present study with emphasis on the discovery and structure elucidation of new natural 












1.2 The Alkaloids  
 
Alkaloids are natural products which humankind has used in potions, medicines, teas, 
poultices and poisons for 4000 years.
65
 The term alkaloid was originally coined by 
Meissener in 1819 to cover plant derived substances that react like alkalis, in other 
words, basic compounds.
66
 This description was put forward at a time, when only very 
few plant bases were known, and those only in impure form. A new definition for 
alkaloids was presented by Hesse: alkaloids are nitrogen-containing organic substances 
of natural origin with a greater or lesser degree of basic character.
67
 As of 2001, a total 
of 26,900 known alkaloids has been isolated from various sources (plants, fungi, marine 
organisms, mammals, etc.).
68
 These can be subdivided into five main alkaloid classes, 





i. Heterocyclic alkaloids 
ii. Alkaloids with exocyclic N-atoms including aliphatic amines (e.g. 
capsaicine, ephedrine) 
iii. Putrescine, spermidine, and spermine alkaloids (e.g. paucine, lunarine, 
verbascenine) 
iv. Peptide alkaloids (e.g. integerrine, mucronine A) 

















Among the five classes, the heterocyclic alkaloids constitute the largest group and in 
common usage the term ‘alkaloids’ usually refers to the heterocyclic alkaloids. These 































































































































































































Indole alkaloids constitute one of the largest group of alkaloids and the total number of 
known indole alkaloids is ca. 1,500.
67
 This figure includes both those compounds that 
incorporate the actual indole chromophore and those containing its derivatives: namely 
indoline (dihydroindole), indolenine, hydroxyindolenine, -methylideneindoline, 
pseudoindoxyl, and oxindole as well as carbazole or - and -carbolines and their 
derivatives.
67
 Therefore, indole alkaloids are defined as natural products containing an 












1.3.2 Classification of the Indole Alkaloids 
 
For further subclassification of indole alkaloids, structural and biogenetic criteria are 
applied. The indole alkaloids can be divided into two main categories. The first 
constitutes the simple indole alkaloids, which do not present a structural uniformity, 






Scheme 1.1: The three major skeletal classes from loganin 
 
The second category of indole bases, which are known as the monoterpene indole 
alkaloids, contains two structural units, viz., tryptamine (or tryptophan) with the indole 
nucleus and a C9- or C10-monoterpene moiety derived from secologanin. The majority 
of the indole alkaloids from the plants belong to this category and can be further 








the secologanin unit (Scheme 1.1). The common precursor of all indole alkaloids is 
strictosidine, the condensation product of tryptamine and secologanin.
69-71
 Indole 
alkaloids can be grouped into ten main skeletal types based on their biogenesis, viz., 
corynanthean (C), vincosan (D), vallesiachotaman (V), strychnan (S), aspidospermatan 
(A), eburnan (E), plumeran (P), heynean (H), capuronan (K) and tacaman (T).
72-102
 The 




















1.3.3 The Corynanthean (C) Type Alkaloids 
 
The corynanthean alkaloids are the most extensive class of the indole alkaloids. 
1,2,72,77,78,83,104,105












Figure 1.1: Main skeletal subtypes of the corynanthean alkaloids found in Apocynaceae 
 









1.3.4 The Vallesiachotaman (V) Type Alkaloids 
 
The vallesiachotaman alkaloids are a small group of indole alkaloids and share a 
common precursor with the corynanthean alkaloids.
1,2,72,77,78,83,104,105
 Alkaloids of this 
group can be classified into two main subtypes, namely, antirhine, and angustine as 






Figure 1.2: Two main skeletal subtypes of the vallesiachotaman alkaloids 
 
















 are a relatively small group of indole alkaloids. 
Although they are fairly rich in skeletal variations, the occurrence in the Apocynaceae is 
quite limited and can be grouped into five subtypes, namely, vincoside, talbotine, 















Figure 1.3: Five skeletal subtypes of the vincosan alkaloids 
 
 
1.3.6 The Strychnan Type Alkaloids 
 
The strychnan alkaloids occur predominantly in the Strychnos species of the 
Loganiaceae family and show considerable variations in the skeletal framework. 
However, the majority of the alkaloids isolated from the Apocynaceae are of the 
akuammicine subtype, which is also the simplest skeletal subtype of this group (Figure 
1.4). The isostrychnine subtype is also found in the Apocynaceae, having only one 
representative to date. Although the structure variations of the strychnan alkaloids in the 
Apocynaceae are limited, the number of alkaloids in this group (mainly of the 














Figure 1.4: Main skeletal subtypes of the strychnan alkaloids found in the Apocynaceae 
            
    
1.3.7 The Aspidospermatan (A) Type Alkaloids 
 
Alkaloids of this group are distributed into six main subtypes based on the variations in 
the carbon skeleton as shown in Figure 1.5. The six main subtypes are stemmadenine, 
aspidospermatine, precondylocarpine, geissovelline, andraginine, and dichotine, with 

























1.3.8 The Eburnan (E) Type Alkaloids 
 
The eburnan alkaloids can be divided into five groups, viz., eburnamine, schizogamine, 
craspidospermine, cuanzine, and andrangine. Of these, the most populated is the 
eburnamine subtype. The structures of these five subtypes and the corresponding 
examples are given in Figure 1.6.
1,2,72,77,78,83,104,105











Figure 1.6: Main skeletal subtypes of the eburnan alkaloids 
 
 
1.3.9 The Plumeran (P) Type Alkaloids 
 
The plumeran alkaloids constitute the second largest group of the indole alkaloids after 
the corynanthean group and are characterized by a rich variation of the carbon skeleton. 
The alkaloids of the plumeran type are found exclusively from the subfamily 
Plumerioideae of the Apocynaceae which accounts for the name given to this group. 





































1.3.10 The Heynean (H) Type Alkaloids 
 
Based on new structure types found as well as from biogenetic considerations, Hesse 
has further divided the ibogan (J) group into two new main groups, namely, heynean (H) 
and capuronan (K). The heynean alkaloids can be further subdivided into four main 
structure subtype groups. The main subtypes of the heynean alkaloids and the 














1.3.11 The Capuranon (K) Type Alkaloids 
 
The capuranon alkaloids possess the class III rearranged secologanine skeleton. This 
group of alkaloids was subdivided from the ibogan group by Hesse. The main subtype 
of capuranon alkaloids are shown in the Figure 1.9.
1,2,72,77,78,83,104,105
   
 
 








1.3.12 The Tacaman Type Alkaloids 
 
The tacaman alkaloids possess the class III rearranged secologanine skeleton. This 
group of alkaloids was added by Verpoorte and Van Beek to account for the isolation of 
a few tacamines from Tecoma species.
 
To date the tacaman type alkaloids are limited to 






Figure 1.10: Main skeletal type of the tacaman alkaloids. 
 
 




The genus Alstonia belongs to the tribe Plumerieae, subfamily Plumerioideae of the 
family Apocynaceae. This genus consists of about 40 species distributed over the 
tropical parts of Central America, Africa and Asia, with the center of diversity in the 
Malesia region.
106-108
 Plants of this genus are usually found in wet ground, with some 
preferring peat swamp forests and others tolerating even open water. They are common 








Malesia, which includes Malaysia, Singapore, Indonesia, Brunei, Phllipines, and Papa 
New Guinea.
108
 They are listed as follows:  
  
i. A. actiophylla K. Schum 
ii. A. angustifolia Wall. ex A. DC. 
iii. A. angustiloba Miq. 
iv. A. beatricis Sidiyasa 
v. A. boonei De Wild. 
vi. A. breviloba Sidiyasa 
vii. A. iwahigensis Elmer 
viii. A. macrophylla Wall. ex G. Don 
ix. A. muelleriana Domin 
x. A. neriifolia D. Don 
xi. A. parvifolia Merr. 
xii. A. penangiana Sidiyasa 
xiii. A. pneumatophora Backer ex Den Berger  
xiv. A. rostrata C. E. C. Fisch 
xv. A. rubiginosa Sidiyasa 
xvi. A. scholaris R. Br. 
xvii. A. spatulata Blume 
xviii. A. spectabilis Sidiyasa 











However, only eight of the 19 species of Alstonia are found in Peninsular Malaysia, five 
species from the sect. Alstonia, and three from the sect. Monuraspermum (Table 1.1).
108
 
The morphological and physiological traits that reflect broadly the distinction between 
the two sect. within the genus Alstonia of the Peninsular Malaysia are given in Table 
1.2.
106,108
    
 
Table 1.1: The Alstonia species of the Peninsular Malaysia 
Sect. Alstonia Sect. Monuraspermum 
A. angustiloba A. angustifolia 
A. pneumatophora A. macrophylla 
A. rostrata A. penangiana 
A.scholaris  
A. spatulata  
 
Table 1.2: A comparison of the characteristic of the sect. Alstonia and the sect.   
Monuraspermum 
 Sect. Alstonia Sect. Monuraspermum 
1 Trees up to 60‒70 m high, and up to 200 
cm diameter 
Small or big trees, up to 40‒50 m high, and 
up to 100 cm in diameter 
2 With copious white latex from the trunk 
bark 
Without latex from the inner bark 
3 Leaves in whorls of 4‒8  Leaves in whorls of 3‒4 or decussate 
4 Lateral nerves numerous (40‒100 pairs), 
straight, 1‒5 mm apart 
Lateral nerves numerous (10‒20 pairs), 
4‒15 mm apart 
5 Leaves papillose below Leaves not papillose below 
6 Flowers mostly yellow Flowers white or cream 
7 Corolla lobes overlapping to left Corolla lobes overlapping to right 
8 Seeds obtuse at both ends Seeds acuminate at the upper end 
9 Seeds glabrous or very short-haired on 
margin 










Several species of Alstonia have been reported to be used in the treatment of malaria 
and dysentery throughout Southeast Asia.
109,110 
The use of plants of the genus Alstonia 
in traditional local medicine has been well documented.
111,112
 The traditional uses of 
Alstonia species are listed in Table 1.3. 
 
Table 1.3: Traditional Medicinal Uses of Alstonia Species
109-112 
Species Common names Country Traditional uses 
A. angustifolia 
Wall. ex A. DC. 
Pulai penipu paya 
(Malaysia) 
 
Malaysia  The leaves are heated and oiled, 
then applied to the spleen area 




Pulai (Malaysia) Malaysia  The leaves and the bark extract 
are used to treat fevers. 




Wall. ex G. Don. 




India  The leaves and stem bark are 
made into a drink to assuage 
stomachache and to counteract 
putrefaction of urine. 
    Externally it is used as a 
treatment for the skin. 
    The leaves are heated and oiled 
and applied to sprains and 
dislocated joints. 
    
  The 
Philippines 
 The bark is used to treat fever, 
fatigue, irregular menses, liver 
disease, dysentery, malaria, 
diabetes, and to expel worms 
from the intestines. 
 The leaves are heated, piled, 
and applied to sprains, bruises, 
and dislocated joints. 







Burma  The latex is used to heal ulcers. 
 popeal khe 
(Cambodia) 
 
Cambodia  The bark is used to promote 
menses and to treat chronic 
paludism with the enlargement 
of the spleen and liver 
discomfort.  
  India  The bark is used to promote 









Table 1.3, continued 
Species Common names Country Traditional uses 
  Indonesia  The plant is used to stop 
diarrhea, treat diabetes and heal 
hemorrhoids. 
 An infusion of the young leaves 
is drunk to treat beriberi. 
 The leaf tips roasted with 
coconut are used to treat 
stomatitis. 
    
 pulai (Malaysia) Malaysia  The plant is used to treat 
malaria.  
 The latex is used to assuage 
toothache.  
 A decoction of the bark is drunk 
to combat fever, invigorate the 
body, stimulate appetite, and 
treat yaws.  
    
 ditaa (Philipine) The 
Philippines 
 The plant is used internally to 
combat fever, stop dysentry, 
heal wounds, and treat epilepsy. 
  Vietnam  The bark is used to treat chronic 
malaria with enlarged spleen, 
while the leaves are used to 
promote milk secretion. 
    






 The latex is applied externally 
to sores and diseased skin. 
 The bark is used to lower fever 
and to expel worms from the 
intestines.  
    
A.spectabilis R. 
Br. 
(A. villosa Bl.) 
 The 
Moluccas 
 The bark is used to treat 
stomach and intestinal 
discomfort. 















1.4.2 Alkaloids of the Genus Alstonia  
 
Plants of the genus Alstonia are rich sources of alkaloids and are characterized by a 
preponderance of the macroline skeleton. In addition to indole alkaloids, bisindoles 
related to two macroline-related units (e.g. perhentinine (83) and macralstonine (84)), as 
well as the bisindoles composed of a unit of macroline and other skeletal type of indole 
alkaloid (e.g. macralstonidine (76) and villalstonine (88)) have been isolated from the 
Alstonia species.
64,113-115
 Macroline was proposed as the biomimetic precursor of many 
Alstonia alkaloids, however, it has not been isolated as a natural product to date.
116










1.4.3 Occurrence and Distribution of Alkaloids in the Genus Alstonia 
 
The occurrence of alkaloids in Alstonia as reported in the literature (up to 2012) is 
summarized in Table 1.4. 
 
Table 1.4: Alkaloids reported from Alstonia species. 
Species Plant part Alkaloids Ref. 
A. actinophylla Leaves Actinophyllic acid (363) 117 
(Australia)    
A .angustifolia Wall. Leaves 10-Methoxymacrocarpamine (422) 64,118 
(Peninsular Malaya)  10-Methoxymacrocarpamine N-oxide (423) 64,118 
  10-Methoxyvillalstonine (424) 64,118 
  10-Methoxyvillalstonine N-oxide (425) 64,118 
  11-Methoxyakuammicine (67) 64,118 
  19,20-Dehydro-10-methoxytalcarpine (111) 64,118 
  19,20-Dehydro-O-acetylyohimbine (337) 64,118 
  Affinisine (49) 64,118 
  Akuammicine (262) 64,118 
  Alstocraline (420) 64,118 
  Alstonerine (5) 64,118 
  Alstonisine (20) 64,118 
  Angusticraline (418) 64,118 
  Antirhine (69) 64,118 
  Cabucraline (137) 64,118 
  Cathafoline (35) 64,118 
  Fluorocarpamine (63) 64,118 
  Foliacraline (421) 64,118 
  16-Hydroxystrictamine (150) 64,118 
  Lochnerine (199) 64,118 
  N-desmethylquaternine (10,11-dimethoxy- 
picinine, volkensine, norquaternine) (170) 
64,118 
  Normacusine B (51) 64,118 
  Vincamajine (54) 64,118 
  Pleiocarpamine (59) 64,118 
  Tetrahydrocantleyine (93) 64,118 
  Yohimbine (64) 64,118 
  O-Acetylyohimbine (335) 64,118 









Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
 Stem-bark 11-Methoxyakuammicine (67) 64,118 
  Affinisine (49) 64,118 
  Alstonerine (5) 64,118 
  Alstonisine (20) 64,118 
  Alstopirocine (124)  119 
  Alstophylline (7) 64,118 
  Angustimaline (98)  64,120,121 
  Angustimaline A (99) 121 
  Angustimaline B (100) 121 
  Angustimaline C (101) 121 
  Angustimaline D (102) 121 
  Angustimaline E (103) 121 
  Fluorocarpamine (63) 64,118 
  Macralstonine (84) 64,118 
  Macrodasine A (14) 122-124 
  Macrodasine B (119) 123,124 
  Macrodasine C (120) 124 
  Macrodasine D (121) 124 
  Macrodasine E (122) 124 
  Macrodasine F (123) 124 
  Macrodasine G (15) 124 
  Bipleiophylline (441) 125 
  Perhentidine A (81) 126 
  Perhentidine C (414) 126 
  Perhentinine (83) 123,126 
  Anhydromacralstonine (85) 127 
  Lumutinine E (75) 127 
  Macrocarpamine (90) 127 
  Perhentisine A (415) 127 
  Perhentisine B (416) 127 
  Perhentisine C (417) 127 
  Villalstonidine A (426) 127 
  Villalstonidine B (86) 127 
  Villalstonidine C (428) 127 
  Villalstonidine D (429) 127 
  Villalstonidine E (430) 127 
  Pleiomalicine (254)  119 
  Pleiomaltinine (61)  119 
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  Villalstonine (88) 64,118 
  Villalstonine N-oxide (89) 64,118 
    





  Alstonerine (5) 64,128 
  Alstophylline (7) 64,128 
  Macralstonine (84) 64,128 
  Macrocarpamine (90) 64,128 
  Nor-C-fluorocurarine (292) 64,128 
  Pleiocarpamine (59) 64,128 
  Villalstonine (88) 64,128 
  Vincamajine (54) 64,128 
    
A. angustifolia Miq. Stem-bark 19-Epialstogustine (271) 129 
(Indonesia)  Akuammicine (262) 130 
  Akuammicine N-oxide (267) 130 
  Alstogustine (274) 129 
  Echitamine (161) 130 
  N(4)-Demethylalstogustine (276) 130 
  N(4)-Demethylalstogustine N-oxide (277) 130 
  N(4)-Demethylechitamine (158) 130 
  N(4)-Methylakuammidine (202) 130 
  N(4)--Methylantirhine (347) 130 
  Pseudoakuammigine (215) 130 
  Pseudoakuammigine N-oxide (216) 130 
  Tubotaiwine (304) 130 
    
A. angustifolia  Leaves 10-Methoxyaffinisine (198)  131 
var. latifolia K. and G.  10-Methoxycathafoline (37)  131 
(Peninsular Malaysia)  10-Methoxycathafoline N-oxide (135) 131 
  10-Methoxyvincamajine (218) 131 
  11-Hydroxystrictamine (40) 131 
  11-Methoxyakuammicine (67) 131 
  11-Methoxystrictamine (39) 131 
  16R,19E-Isositsirikine (57) 131 
  Affinisine (49) 131 
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  Alstofoline (126)  131,132 
  Alstolactone (118)  131 
  Alstolagumine (288) 131 
  Alstonal (21) 131,132 
  Alstonerinal (6)  131 
  Alstonerine (5) 131 
  Alstonisine (20) 131,132 
  Alstonoxine A (18)  131,132 
  Alstonoxine B (19)  131,132 
  Alstophylline (7) 131 
  Alstoumerine (52) 131 
  Alstovine (284) 131 
  Cathafoline (35) 131 
  Cathafoline N-oxide (36) 131 
  Isoalstonisine (125)  131,132 
  Lagumicine (290)  131 
  Lagumidine (291) 131 
  Lochnerine (199) 131 
  Macrogentine (133)  131,132 
  N(1)-Demethylalstonal (128)  131,132 
  N(1)-Demethylalstonisine (127)  131,132 
  N(4)-Demethylalstonerinal (113)  131 
  N(4)-Demethylalstonerine (112)  131 
  N(4)-Methyl-N(4),21-secotalpinine (13) 131 
  Nor-C-flourocurarine (292) 131 
  Normacusine B (51) 131 
  Quebrachidine (53) 131 
  Sitsirikine (56)  131 
  Strictamine (38) 131 
  Talcarpine (12) 131 
  Vincamajine (54) 131 
  Vincorine (41) 131 
    
 Stem-bark 10-Methoxyaffinisine (198) 133 
  10-Methoxycathafoline (37) 133 
  Alstonal (21) 133 
  Alstonerinal (66) 133 
  Alstonerine (5) 133 
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  Alstophylline (7) 133 
  Cathafoline (35) 133 
  Lochnerine (199) 133 
  Vincamajine (54) 133 
    
A. angustiloba Whole plant 15-Hydroxy-angustilobine A (381) 134 
(Indonesia)  4,6-Secoangustilobinal A (379) 134 
  6,7-Seco-19,20-epoxyangustilobine B 
(373) 
134 
  6,7-Seco-6-cynostemmadenine (375) 134 
  6,7-Secoangustilobine B (370) 134 
  Angustilobine A (382) 134 
  Angustilobine B (387) 134 
  Cantleyine (92) 135 
  Echitamidine (270) 136 
  Nor-6,7-secoangustilobine A (378) 134 
  O-Acetylvallesamine (384) 134 
  19,20-E-Vallesamine (383) 134 
  Venoterpine (91) 135 
    
A. angustiloba Leaves 16R,19E-Isositsirikine (57) 137 
Miq.  19,20-E-Vallesamine (383) 137,138 
(Peninsular Malaysia)  20(S)-Tubotaiwine (304) 137 
  6,7-Seco-19,20-epoxyangustilobine B 
(373) 
138 
  6,7-Secoangustilobine B (370) 137,138 
  Alstolucine B (256) 137 
  Andransinine (327) 137 
  Angustilobine A (382) 137 
  Angustilobine B (387) 137,138 
  Angustilobine C (392) 137 
  Angustilocine (372)  138 
  Angustilodine (397)  138 
  Condylocarpine (308) 137 
  Echitamidine (270) 138 
  Leuconoxine (365) 138 
  Losbanine (369) 138 
  O-Acetylvallesamine (384) 137 
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  Picrinine (47) 138 
  Scholaricine (269) 138 
  Vincamine (350) 137 
    
 Bark 17-O-Acetyl-N(4)-demethylechitamine (159) 137 
  20(S)-Tubotaiwine (304) 137 
  Ajmalicine (328) 138 
  Akuammicine (262) 138 
  Angustilobine B (387) 137,138 
  Cantleyine (92) 137,138 
  N(4)-Demethylechitamine (158) 137,138 
  Undulifoline (393) 137 
  Venoterpine (91) 137,138 
  Yunnannnesine (376) 137 
  Angustiphylline (432) 137 
  6,7-Seco-19,20-epoxyangustilobine B (373) 138 
  6,7-Secoangustilobine B (370) 137 
  19,20-E-Vallesamine (383) 137,138 
    
A. angustiloba  Leaves 6,7-Secoangustilobine B (370) 139 
(Peninsular   Alstilobanine A (399) 139 
Malaysia)  Alstilobanine B (395) 139 
  Alstilobanine C (394) 139 
  Alstilobanine D (371) 139 
  Alstilobanine E (398) 139 
  Alstonamic acid (389) 139 
  Undulifoline (393) 139 
    
A. boonei Stem bark Echitamidine (270) 140 
(Africa)  N(1)-Formylechitamidine (275) 140 
    
A. congensis Leaves 12-Methoxytubotaiwine (306) 141 
(Africa)  17-O-Acetyl-nor-echitamine (159) 141 
  6,7-Secoangustilobine A (380) 141 
  6,7-Secoangustilobine B (370) 141 
  Angustilobine A (382) 141 
    
 Stem bark 12-Methoxyakuammicine (264) 141 
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  Angustilobine A (382) 141 
  Angustilobine B (387) 141 
  Angustilobine B N-oxide (390) 141 
  Echitamidine (270) 141 
  Echitamine (161) 141 
    
 Root bark 12-Methoxyakuammicine (264) 141 
  12-Methoxy-N(4)-methylakuammicine (265) 141 
  17-O-Acetyl-nor-echitamine (159) 141 
  6,7-Secoangustilobine B (370) 141 
  Akuammicine (262) 141 
  Echitamidine (270) 141 
  Echitamine (161) 141 
  Nor-echitamine (158) 141 
  Tubotaiwine (304) 141 
    
A. constricta Stem bark 14-Ketoalstonidine (105) 142 
(Australia)  1-Carbomethoxycarboline (104) 142 
  Alstonidine (106) 142 
  Alstonilidine (107) 142 
  O-3',4',5'-Trimethoxybenzoylquebrachidine 
(220) 
142 
  Quebrachidine (53) 142 
  Vincamedine (234) 142 
    
 Root bark Alstonidine (106) 143 
  Alstonilidine (107) 143 
  O-3,4,5-Trimethoxybenzoylquebrachidine 
(220) 
143 
  O-3',4',5'-Trimethoxycinnamoylvincamajine 
(221) 
143 
  Reserpine (330) 143 
  Vincamajine (54) 143 
    
A. coriacea Stem bark 10-Methoxy-3-epi--yohimbine (332) 144 
(New Caledonia)  10-Methoxydeplancheine (211) 144 
  Cabucraline (137) 144 
  Corialstonine (401) 144 
  Desmethylquaternine (10,11-dimethoxy-
picrinine, volkensine, norquaternine) (170) 
144 
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  Vincamajine (54) 144 
    
A. deplanchei Leaves Pleiocorine (434) 145 
(New Caledonia)  Pleiocraline (437) 146 
  Vincorine (41) 145 
    
 Stem bark Deplancheine (212) 147 
    
A. glabriflora Bark Alstophylline (7) 148 
(New Guinea)  Macralstonine (84) 148 
  Pleiocarpamine (59) 148 
  Villalstonine (88) 148 
    
A. glaucescens Stem bark 17-O-Acetyl-N(4)-demethylechitamine (159) 149 
(Thailand)  20-Epi-19-echitamidine (273) 149 
  Echitamidine (270) 149 
  Echitamidine N-oxide (281) 149 
  Echitamine (161) 149 
  Echitaminic acid (162) 149 
  N(4)-Demethylechitamine (158) 149 
  N(4)-Demethylechitamine N-oxide (163) 149 
    
A. lanceolata Stem bark -Akuammigine (215) 150 






  10,11-Dimethoxy-1-methylpicraline (181) 150 
  10-Methoxycompactinervine (285) 150 
  Akuammicine (262) 150 
  Compactinervine (287) 150 
  Cathafoline (35) 150 
  Gentianine (94) 150 
  Lanceomigine (361) 150 
  Lanceomigine N-oxide (362) 150 
  Lochnericine (318) 150 
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A. lanceolifera Leaves 10-Methoxydeplancheine (24) 151 
(New Caledonia)  10,11-Dimethoxy-1-methyldeacetylpicraline 
benzoate (180) 
151 






    
 Stem bark 10,11-Dimethoxy-1-methyldeacetylpicraline-
3',4',5'-trimethoxybenzoate (177) 
152 
  10,11-Dimethoxy-1-methylpicraline (181) 152 
  10-Methoxycompactinervine (285) 152 
  10-Methoxy-nor-C-fluorocurarine (293) 152 
  10-Methoxyvincamajine (218) 152 
  11-Methoxyakuammicine (67) 152 
  11-Methoxycompactinervine (alstovine) (284) 152 
  Akuammiline (154) 152 
  Lochnericine (318) 152 
  N(1)-Methyl-10-methoxyakuammidine (210) 153 







  O-3',4',5'-Trimethoxycinnamoylvincamajine 
(221) 
153 
  Picraline (178) 152 
    






(New Caledonia)  12-Methoxy-19,20--epoxyakuammicine (289) 154 
  12-Methoxycompactinervine (286) 154 
    
 Bark 10,11-Dimethoxy-1-methyldeacetylpicraline 
(179) 
154 
  10,11-Dimethoxy-1-methylpicraline (181) 154 
  11-Methoxyakuammicine (67) 154 
  11-Methoxycompactinervine (alstovine) (284) 154 
  12-Methoxycompactinervine (286) 154 
  Akuammiline (154) 154 
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  Lochnericine (318) 154 
  Picraline (178) 154 
    





(New Caledonia)  12-Methoxycompactinervine (286) 154 
  Gentianine (94) 154 
    
A. macrophylla Bark Alstonal (21) 64,155 
(Sabah, Malaysia Borneo)  Alstonisine (20) 64,155 
  N(4)-Demethylalstophyllal oxindole (23) 64,155 
  N(4)-Demethylalstophylline oxindole (22) 64,155 
  Talcarpine (12) 64,155 
    
A. marcophylla Leaves 10-Hydroxystrictamine (147) 156 
(Sri Lanka)  16-Hydroxy-N(4)-demethylalstophylline 
oxindole (132) 
157 
  19-Hydroxyvincamajine (231) 158 
  Alstomacrocine (108) 156 
  Alstonamide (43) 159 
  Alstophylline (7) 158 
  Alstopicralamine (188) 160 
  Alstoumerine (52) 159 
  Cabucraline (137) 158 
  Demethoxyalstonamide (44) 159 
  Macroxine (134) 161 
  N(1)-Methyl-1,2-dihydrostrictamine (139) 157 
  N(4)-Demethylalstophylline oxindole (22) 162 
  Strictaminolamine (142) 163 
  Vincamajine (54) 158,160 
  Vincorine (41) 158 
    
 Bark Alstonerine (5) 158 
  Anhydromacralstonine (85) 158 
  Macralstonine (84) 158 
  Talcarpine (12) 158 
    
A. macrophylla Leaves 11-Methoxyakuammicine (67) 164 
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  Alstophylline (7) 164 
  Cathafoline (35) 164 
  Cathafoline N-oxide (36) 164 
  N(4)-Demethylalstophylline oxindole (22) 164 
  Vincamajine (54) 164 
  Vincamajine-17-O-veratrate (55) 164 
  Vincamajine-N(1)-tri-O-methylgallate (228) 164 
  Vincorine (41) 164 
    
 Stem Macralstonine (84)  165 
  Thungfaine (80) 165 
    
 Root  20-Epiantirhine (346) 166 
 bark Alstomacroline (431) 166 
  Alstomacrophylline (413) 166 
  Alstonerine (5) 166 
  Alstophylline (7) 166 
  Alstoumerine (52) 166 
  Macralstonine (84) 167 
  Macrocarpamine (90) 166 
  O-Methylmacralstonine (411) 167 
  Pleiocarpamine (59) 167 
  Talcarpine (12) 167 
  Villalstonine (88) 167 
  Villalstonine N-oxide (89) 166 
    
A. macrophylla  Leaves 10,11-Dimethoxy-N(1)-methylpicrinine 
(quaternine) (46) 
168 









  11-Methoxy-19,20-epoxyakuammicine 
(alstolagumine) (288) 
168 
  11-Methoxy-19-oxo-20-hydroxyakuammicine 
(lagumidine) (291) 
168 
  5,10,11-Trimethoxystrictamine (148) 168 
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  N(1)-Methylburnamine-17-O-benzoate (175) 168 
  Strictamine (38) 168 
    
 Root Affinisine (49) 169 
  Alstophylline (7) 169,170 
  Macralstonidine (76) 169,171 
  Macralstonine (84) 169,172 
  Macrocarpamine (90) 169 
  Macrosalhine (208) 169,173 
  N(1)-Methyl-2,16-dihydroakuammicine 
(299) 
169 
  O-Benzoylvincamajine (222) 169 
  Picralstonine (190) 169 
  Picrinine (47) 169 
  Pleiocarpamine (59) 169 
  Villalstonine (88) 169,174,175 
    
A. macrophylla  Affinisine (49) 176 
(India)  Picralstonine (190) 176 
  Picrinine (47) 176 
    
A. macrophylla Leaves 10,11-Dimethoxy-1-methyldeacetyl-
picraline-3',4',5'-trimethoxybenzoate (177) 
177 
(Terengganu,   10,11-Dimethoxynareline (66)  177 
Peninsular  16-Hydroxyalstonal (130)  177 
Malaysia)  16-Hydroxyalstonisine (129)  177 
  16-Hydroxy-N(4)-demethylalstophyllal 
oxindole (131)  
177 
  16-Hydroxy-N(4)-demethylalstophylline 
oxindole (132) 
177 
  6-Methoxy-4-methylquinoline (95) 177 
  6-Methoxy--methyl-4-quindine methanol 
(96) 
177 
  6-Oxoalstophyllal (115)  177 
  6-Oxoalstophylline (114)  177 
  Alstohentine (110)  177 
  Alstomaline (45)  177 
  Alstomicine (109)  177 
  Alstonal (21) 177 
  Alstonerinal (6)  177 
  Alstonerine (5) 177 
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  Alstonoxine B (19)  177 
  Alstophyllal (8)  177 
  Alstophylline (7) 177 
  Demethoxyalstonamide (44) 177 
  Macrocarpine A (9)  177 
  Macrocarpine B (10) 177 
  N(4)-Demethylalstophyllal oxindole (23) 177 
  N(4)-Demethylalstophylline oxindole (22) 177 
  N(4)-Methyl-N(4),21-secotalpinine (13) 177 
  Quaternine (46) 177 
  Talcarpine (12) 177 
  Vincoridine (157) 177 
  Vincorine (41) 177 
  Volkensine (170) 177 
    
 Stem  11-Methoxyakuammicine (67) 123 
 bark 16R,19E-Isositsirikine (57) 123 
  Alstonal (21) 123 
  Alstonisine (20) 123 
  Alstophyllal (8)  123 
  Alstophylline (7) 123 
  Angustimalal (97)  123 
  Fluorocarpamine (63) 123 
  Macrocarpine A (9)  123 
  Macrocarpine B (10)  123 
  Macrocarpine C (11)  123 
  Macrodasine A (14)  122,123 
  Macrodasine B (119)  123 
  N(1)-Demethylalstophyllal (117)  123 
  N(1)-Demethylalstophylline (116)  123 
  N(4)-Demethylalstophyllal oxindole (23) 123 
  N(4)-Demethylalstophylline oxindole (22)  123 
  N(4)-Methyl-N(4),21-secotalpinine (13) 123 
  Perhentinine (83) 123 
  Pleiocarpamine (59) 123 
  Talcarpine (12) 123 
  Villalstonine (88) 123 
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A. macrophylla Leaves Alstiphyllanine A (229) 178 
Wall. Ex G. Don  Alstiphyllanine B (182) 178 
(Indonesia)  Alstiphyllanine C (183) 178 
  Alstiphyllanine D (184) 178 




  19Z-Burnamine-17-O-3',4',5'-trimethoxy-benzoate 
(192) 
178 
    






  19Z-Burnamine-17-O-3',4',5'-trimethoxy-benzoate 
(192) 
179 
  Alstiphyllanine A (229) 179,180 
  Alstiphyllanine B (182) 179 
  Alstiphyllanine C (183) 179 
  Alstiphyllanine D (184) 179 
  Alstiphyllanine E (185)  179 
  Alstiphyllanine F (186)  179 
  Alstiphyllanine G (176) 179 
  Alstiphyllanine H (230) 179,180 
  Alstiphyllanine I (245) 180 
  Alstiphyllanine J (246) 180 
  Alstiphyllanine K (247) 180 
  Alstiphyllanine L (248) 180 
  Alstiphyllanine M (249) 180 
  Alstiphyllanine N (250) 180 
  Alstiphyllanine O (251) 180 
  Alstonal (21) 179 
  Alstonerine (5) 179 
  Burnamine (O-deacetylpicraline) (194) 179 
  Picralinal (189) 179 
  Picrinine (47) 179 
  Vincamajine (54) 179,180 
  Vincamajine-17-O-3',4',5'-trimethoxy-benzoate 
(226) 
179,180 
  Vincamajine-17-O-veratrate (55) 179,180 
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A. muelleriana Bark 11-Methoxyakuammicine (67) 181 
(Australia)  2,7-Dihydropleiocarpamine (253) 182 
  Alstonerine (5) 183,184 
  Alstonisidine (442) 184 
  Alstonisine (20) 184 
  Des-N'(1)-methylanhydromacralstonine (412) 182 
  Macralstonine (84) 185 
  Pleiocarpamine (59) 182 
  Quebrachidine (53) 182 
  Villalstonine (88) 184 
  Vinervinine (12-methoxyakuammicine) (264) 182 
    
A. odontophora Leaves 11-Methoxyakuammicine (67) 186 
(New Caledonia) and Antirhine (69) 186 
 stem N(1)-Demethylpleiocorine (433) 186 
  Pleiocarpamine (59) 186 
  Pleiocorine (434) 186 
  Pleiocraline (437) 186 
  Quebrachidine (53) 186 
  Vincamajine (54) 186 
    
A. plumosa Stem 10-Carboaldehydecabucraline (136) 187 
(New Caledonia) bark 11-Methoxycompactinervine (alstovine) (284) 187 
  2,7-Dihydroxypleiocarpamine (252) 187 
  Caberine (140) 187 
  Caberoline (213) 187 
  Cabucraline (137) 187 
  Cabucraline N-oxide (138) 187 
  Cathafoline (35) 187 
  Desoxycabufiline (435) 187 
  Fluorocarpamine (63) 187 
  Nordesoxycarbufiline (436) 187 
  Pleiocarpamine (59) 187 
  Pleiocorine (434) 187 
  Pleiocraline (437) 187 
  Quaternoline (raucubaine) (214) 187 
  Quaternoxine (141) 187 









Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
 Root 11-Methoxycompactinervine (alstovine) (284) 187 
  3,4-Seco-3,14-dehydrocabucraline (368) 187 
  Cabucraline (137) 187 
  Cabucraline N-oxide (138) 187 
  Fluorocarpamine (63) 187 
  Pleiocarpamine (59) 187 
  Plumocraline (438) 187 
    
A. pneumatophora Leaves Actinophyllic acid (363) 188 
(Peninsular   Akuammidine (200) 188 
Malaysia)  Alpneumine A (294) 188 
  Alpneumine B (295) 188 
  Alpneumine C (296) 188 
  Alpneumine D (297) 188 
  Alpneumine E (298) 188 
  Alpneumine F (364) 188 
  Alpneumine G (352) 188 
  Alpneumine H (396) 188 
  Alsmaphorazine A (301) 189 
  Alsmaphorazine B (302) 189 
  Alsmaphorazine C (402) 190 
  Alsmaphorazine D (403) 190 
  Alsmaphorazine E (404) 190 
  Alstilobanine B (395) 188 
  Apovincamine (353) 188 
  Echitamidine (270) 188 
  Scholarine (279) 188 
  Vincamine (350) 188 
    




(New Caledonia) plant Cathafoline (35) 191 
  Pseudoyohimbine (333) 191 
  Quaternatine (334) 191 
  Quaternidine (187) 191 
  Quaternoline (214) 191 
  Quaternoxine (141) 191 
  20(R)-Tubotaiwine (303) 191 
  Vincamajine (54) 191 
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A. rostrata  Leaves  Akuammidine (200) 192 
(China)  Alstrostine A (405)      193 
  Alstrostine B (406) 193 
  Alstrostine C (407)            192 
  Alstrostine D (408) 192 
  Alstrostine E (409) 192 
  Alstrostine F (410) 192 
  Deacetylakuammiline (156) 192  
  19,20-Dihydroakuammicine (283) 192 
  Echitamidine (270) 192 
  Isovallesiachotamine (345) 192 
  12-Methoxyechitamidine (Scholarine) (279) 192 
  N(4)-Demethylechitamine (115) 192 
  17-O-Acetyl-N(4)-demethylechitamine (159) 192 
  19-Oxo-12-methoxyechitamidine (259) 192 
  Tabersonine (203) 192 
  Undulifoline (109) 192 
  Vallesiachotamine (344) 192 
    
(= A. undulifolia) Stem  Akuammicine (262) 64,194 
(Peninsular  bark Cantleyine (92) 64,194 
Malaysia)  Echitamidine (270) 64,194 
  Echitamine (161) 64,194 
  20-Epi-19-echitamidine (273) 64,194 
  Norechitamine (N(4)-Demethylechitamine) (158) 64,194 
  Pleiocarpamine (59) 64,194 
  Tetrahydrocantleyine (93) 64,194 
  Undulifoline (393) 64,194 
    
A. scholaris Leaves Alschomine (168) 195 
(Thailand)  Isoalschomine (169) 195 
  Nareline (355) 195 
  Picrinine (47) 195 
  Scholaricine (269) 195 
  Tubotaiwine (304) 195 
  Vallesamine (383) 195 
    
 Stem-bark Echitamine (161) 196 
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  N(4)-Demethylechitamine (Norechitamine) (158) 196 
  Picrinine (47) 196 
  Tubotaiwine (304) 196 
    
 Root  Akuammicine (262) 196,197 
 bark Akuammicine N(4)-methiodide (266) 196,197 
  Akuammicine N(4)-Oxide (267) 196,197 
  Echitamidine (270) 196,197 
  Echitamine (161) 196,197 
  Hydroxy-19,20-dihydroakuammicine (273) 196,197 
  N(4)-Demethylechitamine (158) 196,197 
  Tubotaiwine (304) 196,197 
  -Akuammigine (215) 196,197 
    
A. scholaris Leaves 5-Epinareline ethyl ether (354) 64,198 
(Peninsular   Nareline ethyl ether (356) 64,198 
Malaysia)  Nareline methyl ether (357) 64,198 
  Picrinine (47) 64,198 
  Scholaricine (269) 64,198 
  Scholarine N-oxide (280) 64,198 
    
A. scholaris Leave Akuammidine (200) 199 
(India)  Echitamidine (270) 200 
  Echitamine (161) 200 
  Nareline (355) 199 
  Picralinal (189) 199 
  Picrinine (47) 199,200 
  Pseudoakuammigine (215) 199 
  Scholarine (279) 201 
    
 Fruit  Nareline (355) 202 
 pods N-Formylscholarine (300) 202 
  Picrinine (47) 202 
  Strictamine (deacetyldesformo akuammiline) (38) 202 
    
A. scholaris Leaves 19,20-E-Vallesamine (383) 203 
(The Phillipines)  20(S)-Tubotaiwine (304) 195,203,204 
  20(S)-Tubotaiwine N-oxide (305) 195,204 








Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
  Angustilobine B acid (389) 195,204 
  Angustilobine B N-oxide (390) 203 
  Lagunamine (19-hydroxytubotaiwine) (305) 195,204 
  Losbanine (6,7-seco-6-nor-angustilobine B) (369) 195,204 
  Manilamine (374) 203 
  N(4)-Methylangustilobine B (391) 203 
    
 Bark 6,7-Secoangustilobine B (370) 204 
  Acetylechitamine (160) 204 
  Echitamine (161) 204 
  Losbanine (6,7-seco-6-nor-angustilobine B) (369) 204 
  N(4)-Demethylechitamine (Norechitamine) (158) 204 
  20(S)-Tubotaiwine (304) 204 
  Tubotaiwine N-oxide (305) 204 
    
A. scholaris Leaves 19,20-E-Vallesamine (Vallesamine) (383) 195 
(Taiwan)  19-Epischolaricine (272) 195 
  6,7-Secoangustilobine B (370) 195 
  Alschomine (168) 195,205 
  Isoalschomine (169) 195,205 
  Nareline (355) 195,205 
  Picralinal (189) 195,205 
  Picrinine (47) 195,205 
    
A. scholaris Leaves 19,20-E-Vallesamine (Vallesamine) (383) 195 
(Indonesia)  19,20-E-Vallesamine N-oxide (385) 195 
  6,7-Seco-19,20-epoxyangustilobine B (373) 195 
  6,7-Secoangustilobine B (370) 195 
  Akuammidine (200) 195,206 
  Akuammidine-N-oxide (203) 206 
  Leuconolam (367) 195 
  N(1)-Methylburnamine (174) 195 
  N(4)-Methylscholaricine (278) 195 
  Picraline (178) 195 
  Scholaricine (269) 195 
  -Akuammigine (Pseudoakuammigine) (215) 195 
  -Akuammigine N-oxide (216) 195 









Table 1. continued… 
Species Plant part Alkaloids Ref. 
 Bark Akuammicine N-oxide (267) 207 
  Akuammiginone (217) 207 
  Echitamidine N-oxide (281) 207 
  Echitamidine-N-oxide 19-O--D-glucopyranoside 
(282) 
207 
  Echitaminic acid (162) 207 
  N(4)-Demethylalstogustine (276) 207 
  N(4)-Demethylalstogustine N-oxide (277) 207 
    
A. scholaris Leaves 19,20-E-Vallesamine (Vallesamine) (383) 208 
(Pakistan)  19,20-Z-Vallesamine (386) 208 
  Alstonamine (388) 209 
  Rhazimanine (348) 209 
    
A. scholaris Leaves 19,20-E-Alstoscholarine (358) 210 
(China)  19,20-E-Vallesamine (Vallesamine) (383) 211,212 
  19,20-Z-Alstoscholarine (359) 210 
  19-Epischolaricine (272) 212 
  5-Methoxystrictamine (151) 211,212 
  5-Oxo-17-deacetyl-1,2-dihydroakuammiline (143) 212 
  Akuammidine (200) 212 
  Leuconolam (367)  
  Methyl (2,16R,19E)-4,5-didehydro-1,2-dihydro-2-
hydroxy-16-(hydroxymethyl)-akuammilan-4-ium-
17-oate chloride (144) 
212 
  N(1)-Methoxymethylpicrinine (171) 211 
  N(1)-Methylburnamine (174) 212 
  N(4)-Demethylechitamine (Norechitamine) (158) 212 
  Picralinal (189) 211,212 
  Picrinine (47) 211,212 
  Rhazimanine (348) 212 
  Scholaricine (269) 211,212 
  Scholarisine A (360) 213 
    
 Bark 19,20-E-Vallesamine (Vallesamine) (383) 214 
  19-Epi-ajmalicine (329) 214 
  19-Epischolaricine (272) 214 
  19Z-16-Formyl-5-methoxystrictamine (146) 214 











Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
  3-Epi-dihydrocorymine (164) 214 
  5-Methoxystrictamine (151) 214 
  Akuammidine (200) 214 
  Echitamidine  (270) 214 
  Echitamine (161) 214 
  Leuconoxine (365) 214 
  N(4)-Demethylechitamine (Norechitamine) (158) 214 
  Nareline (355) 214 
  Picralinal (189) 214 
  Picrinine (47) 214 
  Scholarisine B (195) 214 
  Scholarisine C (165) 214 
  Scholarisine D (166) 214 
  Scholarisine E (167) 214 
  Scholarisine F (191) 214 
  Scholarisine G (366) 214 
    
A. spatulata Bl. Leaves ()-Alstolucine A (255)  215 
(Peninsular Malaysia)  ()-Alstolucine B (256)  215 
  ()-Alstolucine C (257)  215 
  ()-Alstolucine D (258)  215 
  ()-Alstolucine E (260)  215 
  ()-Alstolucine F (261)  215 
  16-Epivincamine (351) 215 
  16R, 19E-Isositsirikine (57) 215 
  20(R)-Tubotaiwine (303) 215 
  4,6-Secoangustilobinal A (379) 215 
  Akuammicine (262) 215 
  Alstolobine A (377) 215 
  N(4)-Demethyl-12-methoxyalstogustine (268) 215 
  Nor-6,7-secoangustilobine A (378)  215 
  Picrinine (47) 215 
  Undulifoline (393) 215 
  Vincaddiformine (309) 215 
  Vincamine (350) 215 
  Vinervine/12-Hydroxyakuammicine (263) 215 
    
 Stem (±)-Angustilobine B (387) 215 








Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
  19,20-E-Vallesamine (Vallesamine) (383) 215 
  20(R)-Tubotaiwine (303) 215 
  20(S)-Tubotaiwine (304) 215 
  Akuammicine (262) 215 
  Leuconoxine (365) 215 
  N(4)-Demethyl-12-methoxyalstogustine (268) 215 
  N(4)-Demethylechitamine (Norechitamine) (158) 215 
  Undulifoline (393) 215 
  Vinervine/12-Hydroxyakuammicine (263)  215 
    
A. spectabilis Bark Macralstonine (84) 148 
(New Guinea)  N(1)-Methylsarpagine (197) 148 
  Pleiocarpamine (59) 148 
  Quebrachidine (53) 148 
  Villalstonine (88) 148 
  Vincamajine (54) 148 
    
A. sphaerocapitata Leaves 10-Methoxyvincamedine (232) 216 
(New Caledonia)  10-Methoxyvincamedine N-oxide (233) 216 
  11-Methoxyakuammicine (67) 216 
  Akuammicine (262) 216 
  Caberoline (213) 216 
  Cabucraline (137) 216 
  Cathafoline (35) 216 
  Desoxycabufiline (435) 216 
  Quaternoline (214) 216 
  20(S)-Tubotaiwine (304) 216 
  Vincamedine (234) 216 
  Z-Isositsirikine (349) 216 
    
 Stem  10-Methoxyvincamedine (232) 216 
 bark 10-Methoxyvincamedine N-oxide (233) 216 
  11-Methoxyakuammicine (67) 216 
  Akuammicine (262) 216 
  Cabucraline (137) 216 
  Cathafoline (35) 216 
  Desoxycabufiline (435) 216 
  Nor-C-fluorocurarine (292) 216 








Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
  Undulatine (439) 217 
  Vincamedine (234) 216 
    
 Fruit 10-Methoxyvincamedine (232) 216 
  10-Methoxyvincamedine N-oxide (233) 216 
  11-Methoxyakuammicine (67) 216 
  Akuammicine (262) 216 
  Cabucraline (137) 216 
  Cathafoline (35) 216 
  Desoxycabufiline (435) 216 
  Quaternoxine (141) 216 
  Quebrachidine (53) 216 
  Vincamedine (234) 216 
  Vincoridine (157) 216 
    
A. undulata Leaves Cabucraline (137) 218 
(New Caledonia)  Cathafoline (35) 218 
  Deformylundulatine (440) 218 
  Pericyclivine (196) 218 
  Tetrahydroalstonine (331) 218 
  Vincorine (41) 218 
    
 Root  11-Methoxyakuammicine (67) 218 
 bark 11-Methoxyakuammicine N-oxide (68) 218 
  Alstonisidine (442) 218 
  Cabucraline (137) 218 
  Cabucraline N-oxide (138) 218 
  Deplancheine (212) 218 
  Desoxycabufiline (435) 218 
  Fluorocarpamine (63) 218 
  Gentiacraline (145) 218 
  Pleiocarpamine (59) 218 
  Plumocraline (438) 218 
  Tetrahydroalstonine (331) 218 
  Vincamedine (234) 218 
    
A. venenata Leaves  11-Methoxyechitovenedine (320) 219 
(India)  11-Methoxyechitoveniline (324) 219 








Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
  Alstolenine (155) 220 
  Deacetylakuammiline (156) 220 
  Echitoveniline (325) 219 
  Polyneuridine (206) 220 
  Raucaffrinoline (239) 220 
    
 Fruit ()-Minovincinine (319) 221 
  11-Methoxyechitovenedine (320) 219 
  11-Methoxyechitoveniline (324) 219 
  Echitoserpine (322)  222 
  Echitoserpidine (323)  223 
  Echitovenedine (321) 221 
  Echitoveniline (325) 219 
  Venoterpine (91) 224 
    
 Root  16-Epialstovenine (339) 225 
 bark 16-Epivenenatine (340) 225 
  5,22-Dioxokopsane (326) 225 
  Alstovenine (341) 225 
  Isovenenatine (338) 225 
  Venenatine (342) 225,226 
  Venoxidine (343) 225 
    















  19Z-16-Formyl-5-methoxystrictamine (146) 227 




  19Z-Picralinal (193) 227 
  5,10,11-Trimethoxystrictamine (148) 227 
  5,10-Dimethoxystrictamine (149) 227 










Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
  Quaternine (10,11-dimethoxy-N(1)-methyl-
picrinine) (46) 
227 
  Vincamajine (54) 227 
  Vincamajine-17-O-3',4',5'-trimethoxy-benzoate 
(226) 
227 
  Vincamajine-17-O-3',4',5'-trimethoxy-benzoate N-
oxide (227) 
227 
  Yohimbine-17-O-acetate (O-Acetyl-yohimbine) 
(335) 
227 
    
A. vitiensis var.  Stem 11-Methoxycompactinervine (alstovine) (284) 228 
novo ebudica  Cabucraline (137) 228 
monachino  Pleiocarpamine (59) 228 
(New Caledonia)  Quaternoxine (141) 228 
  Vincorine (41) 228 
    
A. yunnanensis Whole  ()-Echitoveniline (325)  229 
(Kunming, Yunnan plant 11-Methoxytabersonine (310) 229 
Province, People’s  19-Acetoxy-11-methoxytabersonine (311) 229 
Republic of China)  19-Epi-ajmalicine (329) 229 
  19Z-Burnamine-17-O-3',4',5'-trimethoxy-benzoate 
(192) 
229 
  Alloyohimbine (336) 229 
  Alstoyunines A (209) 229 
  Alstoyunines B (210) 229 
  Alstoyunines C (241) 229 
  Alstoyunines D (242) 229 
  Alstoyunines E (236) 229 
  Alstoyunines F (235) 229 
  Alstoyunines G (312) 229 
  Alstoyunines H (315) 229 
  Compactinervine (287) 229 
  Echitoserpidine (323)  229 
  Lochnerinine (314)  229 
  Perakine (243) 229 
  Picraline (178) 229 
  Picrinine (47) 229 
  Raucaffrinoline (239) 229 
  Tabersonine (317) 229 
  Vellosimine (204) 229 
  Vellosiminol (205) 229 








Table 1.4, continued… 
Species Plant part Alkaloids Ref. 
A. yunnanensis Whole plant 11-Hydroxy-6,7-epoxy-8-oxo-vincadifformine 
(313) 
230 
Chuxiong, Yunnan   14-chloro-15-hydroxyvincadifformine (316) 230 
Province, China  Perakine N(4)-oxide (244) 230 
  Raucaffrinoline N(4)-oxide (240) 230 
  Vinorine N(1), N(4)-dioxide (238) 230 
  11-Methoxy-6,7-epoxy-8-oxo-vincadifformine 
(Alstoyunine G) (312) 
230 































































































































































1.5 Objective of the Present Research 
 
The aim of the present research is to carry out a detailed investigation of the alkaloid 
composition of Alstonia macrophylla, collected near Lumut, Perak, on the western coast 
of Peninsular Malaysia. This study involes several aspects, such as characterization of 
the isolated alkaloids, the discovery of new alkaloids, and the screening and evaluation 















2 Results and Discussion 
 
2.1 Alkaloids from Alstonia macrophylla  
 
The Malaysian plant, Alstonia macrophylla Wall, was investigated for its alkaloidal 
content and the results are summarized in the Table below. A total of 90 alkaloids were 
isolated and characterized from the leaf and stem-bark of A. macrophylla. Of these, 30 
are new alkaloids. The leaf extract of A. macrophylla yielded a total of 13 new alkaloids, 
including a macroline indole 1, a macroline oxindole 16, eight akuammiline alkaloids 
(compounds 24, 25, 26, 27, 28, 29, 30, and 31), a sarpagine alkaloid 32, and two 
ajmaline alkaloids (33 and 34). The stem-bark extract of A. macrophylla gave a total of 
19 new alkaloids. These include, in addition to the akuammiline and sarpagine alkaloids 
found in the leaf extract (24 and 32, respectively), compound 2, 3, 4, 17, the linearly 
fused bisindole alkaloids, lumutinines A‒E (7175), the macroline-macroline bisindoles, 
lumusidines AD (7780) and perhentidines A‒B (81and 82), and the 



























































































Table 2.1: Alkaloid Composition of A. macrophylla 
Plant part Alkaloid Yield (g Kg
-1
) 
Leaves Alstofolinine (1) [New] 0.0009 
 Alstonerine (5) 0.2220 
 Alstonerinal (6) 0.2220 
 Alstophylline (7) 0.1746 
 Alstophyllal (8) 0.1746 
 Macrocarpine B (10) 0.0009 
 Talcarpine (12) 0.0607 
 N(4)-Methyl-N(4),21-secotalpinine (13) 0.0977 
 Compound 16 (11-Methoxyalstonoxine A) [New] 0.0079 
 Alstonoxine A (18) 0.0110 
 Alstonoxine B (19) 0.0024 
 Alstonisine (20) 0.0817 
 Alstonal (21) 0.0817 
 N(4)-Demethylalstophylline oxindole (22) 0.0575 
 N(4)-Demethylalstophyllal oxindole (23) 0.0674 
 Compound 24 (2(S)-Cathafoline) [New] 0.0047 
 Compound 25 (2(S)-10-Methoxycathafoline) [New] 0.0069 
 Compound 26 (2(R)-3-Hydroxycathafoline) [New] 0.0050 
 Compound 27 (10-Demethoxyvincorine) [New] 0.0010 
 Compound 28 (10-Demethoxyvincorine N(4)-oxide) [New] 0.0018 
 Compound 29 (11-Methoxyvincorine) [New] 0.0007 
 Compound 30 (Vincorine N(4)-oxide) [New] 0.0206 
 Compound 31 (11-Demethoxyquaternine) [New] 0.0132 
 Compound 32 (19,20-Z-Affinisine) [New] 0.0040 
 Compound 33 (Vincamajine N(4)-oxide) [New] 0.0002 
 Compound 34 (Vincamajine 17-O-veratrate N(4)-oxide) [New] 0.0019 
 Cathafoline (35) 0.0556 
 Cathafoline N(4)-oxide (36) 0.0625 
 10-Methoxycathafoline (37) 0.0048 
 Strictamine (38) 0.0149 
 11-Methoxystrictamine (39) 0.0404 
 11-Hydroxystrictamine (40) 0.0152 
 Vincorine (41) 0.0949 
 Norvincorine (42) 0.0186 








Table 2.1, continued 
Plant part Alkaloid Yield (g Kg
-1
) 
 Demethoxyalstonamide (44) 0.0139 
 Alstomaline (45) 0.0042 
 Quaternine (46) 0.3689 
 Picrinine (47) 0.0054 
 12-Demethoxytabernulosine (48) 0.0066 
 Normacusine B (51) 0.0027 
 Alstoumerine (52) 0.0243 
 Quebrachidine (53)  0.0503 
 Vincamajine (54) 0.1403 
 Vincamajine 17-O-veratrate (55) 0.0178 
 Sitsirikine (56) 0.0076 
 16R,19E-Isositsirikine (57) 0.0053 
 18,19-Dihydroisositsirikine (58) 0.0005 
 Pleiocarpamine (59) 0.0146 
 Fluorocarpamine (63) 0.0010 
 11-Methoxyakuammicine (67) 0.0777 
 11-Methoxyakuammicine N(4)-oxide (68) 0.0109 
 Yohimbine (64) 0.0007 
 Talpinine (65) 0.0010 
 10,11-Dimethoxynareline (66) 0.0013 
   
Stem-bark Compound 2 (20,21-Dihydroalstonerine) [New] 0.0002 
 Compound 3 (N(1)-Demethylmacrocarpine B) [New] 0.0035 
 Macrodasine H (4) [New] 0.0003 
 Alstonerine (5) 0.1278 
 Alstonerinal (6) 0.1278 
 Alstophylline (7) 0.2322 
 Alstophyllal (8) 0.2322 
 Macrocarpine A (9) 0.0042 
 Macrocarpine B (10) 0.0571 
 Macrocarpine C (11) 0.0037 
 Talcarpine (12) 0.0205 
 N(4)-Methyl-N(4),21-secotalpinine (13) 0.0163 
 Macrodasine A (14) 0.0064 









Table 2.1, continued 
Plant part Alkaloid Yield (g Kg
-1
) 
 Compound 17 (11-Methoxyalstonoxine B) [New] 0.0022 
 Alstonoxine B (19) 0.0006 
 Compound 24 (2(S)-Cathafoline) [New] 0.0001 
 Compound 32 (19,20-Z-Affinisine) [New] 0.0043 
 Cathafoline (35) 0.0013 
 Cathafoline N(4)-oxide (36) 0.0006 
 Vincorine (41) 0.0003 
 Affinisine (49)  0.0003 
 Affinisine oxindole (50) 0.0005 
 Normacusine B (51) 0.0040 
 Alstoumerine (52) 0.0027 
 Vincamajine (54) 0.0003 
 16R, 19E-Isositsirikine (57) 0.0202 
 Pleiocarpamine (59) 0.0283 
 16-Hydroxymethylpleiocarpamine (60) 0.0015 
 Pleiomaltinine (61) 0.0006 
 Picramicine (62) 0.0076 
 Fluorocarpamine (63) 0.0011 
 Talpinine (65) 0.0002 
 11-Methoxyakuammicine (67) 0.0014 
 Antirhine (69) 0.0009 
 1,2,3,4-Tetrahydro-1-oxo--carboline (70) 0.0001 
 Lumutinine A (71) [New] 0.0046 
 Lumutinine B (72) [New] 0.0025 
 Lumutinine C (73) [New] 0.0010 
 Lumutinine D (74) [New] 0.0047 
 Lumutinine E (75) [New] 0.0011 
 Macralstonidine (76) 0.0959 
 Lumusidine A (77) [New] 0.0073 
 Lumusidine B (78) [New] 0.0065 
 Lumusidine C (79) [New] 0.0007 
 Lumusidine D (80) [New] 0.0061 
 Perhentidine A (81) [New] 0.0126 
 Perhentidine B (82) [New] 0.0207 








Table 2.1, continued 
Plant part Alkaloid Yield (g Kg
-1
) 
 Macralstonine (84) 0.0336 
 Anhydromacralstonine (85) 0.0020 
 Villalstonidine B (86) [New] 0.0079 
 Villalstonidine F (87) [New] 0.0005 
 Villalstonine (88) 0.7126 
 Villalstonine N(4)-oxide (89) 0.0109 









2.1.1 Macroline Alkaloids 
 
2.1.1.1 Alstofolinine (1)  
 
Alstofolinine (1) was one of the minor alkaloids isolated from the leaf extract of A. 
macropylla. It was obtained as a light yellowish oil, with [α]D 104 (c 0.36, CHCl3). 
The UV spectrum showed two absorption bands (227 and 285 nm) characteristic of an 
indole chromophore. The IR spectrum showed a sharp band at 1769 cm
-1
 due to a 
lactone function. The EIMS of 1 showed a molecular ion at m/z 296, and high resolution 
measurements yielded the molecular formula C18H20N2O2 (DBE 10). Other notable 
fragment peaks observed at m/z 197, 182, 181, 170, and 144, are typical of macroline 
derivatives,
169,231
 while the mass fragment at m/z 281 can be attributed to loss of a CH3. 
The 
13
C NMR spectrum (Table 2.2) displayed a total of 18 carbon resonances, 
corresponding to two methyl, three methylene, eight methine and five quaternary 
carbons, in agreement with the molecular formula. The presence of the lactone 
functionality and an oxymethylene carbon, was supported by the observed carbon 
signals at δ 181.0 and δ 70.7, respectively. The 1H NMR spectrum (Figure 2.2; Table 
2.2) showed the presence of an unsubstituted indole moiety (δ 7.117.49), two methyl 
groups corresponding to N1-Me at δ 3.64 and N4-Me at δ 2.42, and two downfield 
signals at δ 4.42 (H-17, t, J = 8 Hz) and 4.52 (H-17, dd, J = 11, 8 Hz) due to the 
geminal hydrogens of an oxymethylene corresponding to C-17. 
The COSY and HSQC data disclosed partial structures that are characteristic of a 
macroline-type skeleton, such as NCHCH2 and NCHCH2CHCHCH2O, corresponding to 
the N-4‒C-5‒C-6 and N-4‒C-3‒C-14‒C-15‒C-16‒C-17-O fragments, respectively. The 
NMR data were suggestive of a macroline derivative, such as alstonerine (5),
133
 except 








E of 1. In addition, both the H-17 signals in 1 were shifted downfield to δH 4.42 and 
4.52, when compared to those in alstonerine (5) (δH 4.16 and 4.40) as well as other 
typical macroline-type compounds.
123,177
 Furthermore, the observed coupling constants 
for the H-17 resonances in the case of 1 differed significantly when compared to those 
in 5 (1: H-17, t, J = 8 Hz; H-17, dd, J = 11 and 8 Hz; 5: H-17, ddd, J = 11, 4, 2 Hz; 
H-17, t, J = 11 Hz) indicating changes in ring E of 1 compared to the ring E of normal 
macrolines as exemplified by alstonerine (5). The presence of a lactone functionality as 
a part of ring E is deduced from the observed three-bond correlations from H-14, H-
14, and H-17 to the lactone carbonyl C-18 in the HMBC spectrum (Figure 2.1). The 
NMR data at this point allowed the proposed structure 1 to be assembled. The relative 
configurations at the various stereogenic centers of 1 were established by 2D-NOESY 
which were similar to those in other macroline alkaloids. Alstofolinine (1) represents 
the first example of a macroline type alkaloid incorporating a -butyrolactone in ring E.  
 
 














C NMR Spectroscopic Data for Alstofolinine (1)
a
 
Position H C 
2  132.4 
3 3.91 br s 52.0 
5 3.06 d (6) 52.4 
6β 2.47 br d (16) 23.6 
6α 3.27 dd (16, 6) 
7  106.8 
8  127.3 
9 7.49 d (8) 119.0 
10 7.11 td (8, 1) 120.0 
11 7.22 td (8, 1) 122.3 
12 7.31 d (8) 109.8 
13  138.1 
14 2.10 m 29.5 
14 2.13 m  
15 2.17 m 34.1 
16 2.54 m 43.2 
17β 4.42 t (8) 70.7 
17α 4.52 dd (11, 8)  
18  181.0 
N(1)-Me 3.64 s 30.1 
N(4)-Me 2.42 s 42.2 


















2.1.1.2 Compound 2 (20,21-Dihydroalstonerine) 
 
Compound 2 was isolated in small amount as a light yellowish oil, with [α]D ‒31 (c 0.11, 
CHCl3). The IR spectrum showed a band at 1710 cm
-1
 due to a ketone function. The 
presence of a ketone function was confirmed by the observed resonance at  208.6 in 
the 
13
C NMR spectrum. The ESIMS of 2 showed a [M + H]
+
 ion at m/z 339, which 
analyzed for C21H26N2O2 + H. The UV spectrum showed absorption maxima at 228 and 





C NMR data (Table 2.3; Figure 2.4) showed the presence of an 
unsubstituted indole moiety (7.097.50, C 108.7120.9), two N-methyl signals (N4-
Me, CH2.29; N1-Me, C 3.61), a methyl ketone function (C 208.6; C 
28.4, H2.12), an oxymethylene, characteristic of C-17 in macroline type alkaloids (C 
68.6, 3.72 and 3.95), and another oxymethylene signal at C 64.3. The NMR signals, 
assigned with the aid of COSY and HSQC, indicated that 2 was a macroline-type 
alkaloid. The NMR data resembled that of alstonerine (5),
133
 which was also isolated 
from the extract of this plant, except for the absence of signals associated with the 
trisubstituted C-20C-21 double bond, such as the olefinic carbon signals at C-20 ( 
126.5) and C-21 (157.4), and the signal due to the vinylic H-21 in the 1H NMR 
spectrum (7.52). These signals have in 2 been replaced by a methine at C-20 (C 51.9, 
H 1.97, m) and a methylene at C-21 (C 64.3; H 3.86, dd, J = 12.5, 3 Hz, H 4.18, d, J 
= 12.5 Hz), consistent with saturation of the C20C21 double bond in 2. Less 
substantial changes were observed for the signals of carbons  to both of these carbons 
(C-20, C-21) in the 
13
C NMR spectrum. The configuration at C-20 can be deduced from 
the observed NOEs, viz., H-20/H-14, H-18, H-21 H-21/H-14, H-20, H-








therefore, the 20,21-dihydro derivative of alstonerine (5), which, while previously 
encountered as an intermediate compound in synthesis,
232
 is here encountered as an 
optically active natural product for the first time. Compound 2 was also independently 
































2 ‒  
3 3.97 m 53.6 
5 2.83 d (7) 54.8 
6 2.52 dd (16) 22.4 
6 3.24 dd (16, 7)  
7 ‒ 107.0 
8 ‒ 126.6 
9 7.50 d (8) 118.4 
10 7.09 td (8, 1) 118.9 
11 7.18 td (8, 1) 120.9 
12 7.27 d (8) 108.7 
13 ‒ 137.1 
14 1.42 dt (12, 3) 30.3 
14' 2.44 dd (12, 4)  
15 2.35 m 24.6 
16 2.12 m 39.3 
17 3.72 dd (11.5, 5) 68.6 
17 3.95 t (11.5)  
18 2.12 s 28.4 
19 ‒ 208.6 
20 1.97 m 51.9 
21 3.86 dd (12.5, 3) 64.3 
21 4.18 d (12.5)  
N(1)-Me 3.61 s 29.1 
N(4)-Me 2.29 s 41.8 



























2.1.1.3 Compound 3 [Macrocarpine D (N(1)-Demethylmacrocarpine B)] 
 
Compound 3 was obtained as a light yellowish oil, with []D  (c 0.89, CHCl3). It 
was isolated from the stem-bark extract of A. macrophylla as well as A. angustifolia.
233
 
The IR spectrum indicated the presence of hydroxyl and primary amine functions at 
3395 and 3292 cm
-1
, respectively, while the UV spectrum indicated an indole 
chromophore (max 231 and 286 nm). The ESIMS of 3 showed a [M + H]
+
 peak at m/z 
327, and HRESIMS measurements established the molecular formula as C20H26N2O2 + 




H NMR spectrum (Table 
2.4; Figure 2.6) of 3 showed the presence of four aromatic hydrogens due to an 
unsubstituted indole chromophore ( 7.11–7.49), a singlet at  2.34 due to N4-Me, a 
methyl doublet at  1.16 corresponding to 18-Me, an oxymethine at  3.50 ( 70.5), a 
pair of doublet-doublets at  3.34 and 3.50 (C 61.7) due to a hydroxymethyl group, two 
signals at  3.74 and 4.08 (C 67.7) due to an oxymethylene, and a low-field broad 
singlet at  7.89 due to an NH function. The 13C NMR spectrum (Table 2.4) gave a total 
of 20 carbon signals, comprising two methyl, four methylene, 10 methine, and four 
quaternary carbons. The spectrum was somewhat similar to that of macrocarpine B (10). 
Comparison of the NMR data of 3 with those of 10 revealed that these two compounds 
were similar in all respects, except for the replacement of the N1-Me group by an NH 
function. The relative configurations at the various stereogenic centers of 3, follow 
those in the macroline-type alkaloids. In common with compound 10, the orientation of 
H-19 and H-20 in 3, were deduced to be and , respectively from the observed NOEs 










 Figure 2.5: Selected NOEs of 3 
 




a CDCl3, 400 MHz and 100 MHz; assignments based on COSY, HMQC, HMBC, and NOESY 
Position H C 
2  132.2 
3 3.95 m 55.0 
5 2.94 d (7) 55.1 
6β 2.46 d (16) 22.5 
6α 3.27 dd (16, 7)  
7  107.7 
8  127.1 
9 7.49 d (7.5) 118.0 
10 7.11 t (7.5) 119.4 
11 7.15 t (7.5) 121.3 
12 7.32 d (7.5) 110.9 
13  135.5 
14 1.62 dt (13, 4) 26.1 
14 2.28 td (13, 4)  
15 2.01 m 27.1 
16 1.89 dt (12, 4) 43.6 
17β 3.74 dd (12, 5) 67.7 
17α 4.08 t (12)  
18 1.16 d (6) 20.3 
19 3.50 m 70.5 
20 1.50 m  46.9   
21a 3.34 dd (11, 8) 61.7 
21b 3.50 dd (11, 5)  
N(1)-H 7.89 br s 






















2.1.1.4 Macrodasine H (4) 
 
Compound 4 was obtained as a light yellowish oil, with [α]D 11 (c 0.14, CHCl3). The 
UV spectrum showed two absorption maxima at 233 and 288 nm, indicating the 
presence of an indole chromophore. The IR spectrum showed a broad band at 3423 cm
-1
 
due to a hydroxyl function. The ESIMS of 4 showed a [M + H]
+
 peak at m/z 439, and 
high-resolution measurements yielded the molecular formula C26H34N2O2 + H (DBE 
11). The 
13
C NMR spectrum (Table 2.5) showed a total of 26 carbon signals comprising 
three methyl, seven methylene, ten methine and six quaternary carbons, in agreement 
with the molecular formula. The observed carbon resonance at  70.1 was due to an 
oxymethine carbon, while the carbon resonances at  64.6 (C-17) and 64.0 (C-26) were 
due to two oxymethylene carbon atoms. In addition, two low-field quaternary carbon 
signals were observed at  108.6 and 105.1, each of which was attached to two oxygen 
atoms. The 
1
H NMR spectrum (Table 2.5; Figure 2.9) showed the presence of an 
unsubstituted indole moiety (δ 7.117.50), three methyl groups corresponding to N1-
Me, N4-Me, and 18-Me at δ 3.62, 2.33, and 1.62, respectively, and two sets of signals 
due to two oxymethylenes at δ 3.75, 4.05; and at δ 3.39, 3.84. 
The COSY spectrum disclosed some partial structures, which are characteristic of a 
macroline-type skeleton, such as NCHCH2, CHCH2, and NCHCH2CHCHCH2O, 
corresponding to the N-4‒C-5‒C-6, C-20‒C-21, and N-4‒C-3‒C-14‒C-15‒C-16‒C-17-
O fragments, respectively. An additional fragment, viz., OCHCH2CH2CH2O, was also 
indicated from the COSY spectrum which, taken with the other NMR data, indicated 
affinity to the macrodasine group of alkaloids reported recently.
124
 These macroline 
alkaloids incorporate additional fused spirocyclic tetrahydrofuran-tetrahydrofuran 
(macrodasines A, B, C, G (14, 119, 120, 15)) and tetrahydrofuran-tetrahydropyran 








from the COSY spectrum suggested that compound 4 belong to the latter group of 
macrodasine alkaloids (macrodasines D, E, and F (121–123)) characterized by 
incorporation of fused 5/6 (F/G) spirocyclic rings.
124
 This was further supported by the 
observed HMBC data viz., H-26b, H-24 to C-22, H-24 to C-26, H-25 to C-23, H-21 to 
C-15, C-23, etc. (Figure 2.7). The proposed structure is consistent with the full HMBC 
data. The structure of compound 4 is similar to that of macrodasine F (123), except for 
the absence of the OH substituent at C-25.      
The ring junction stereochemistries between rings C, D, E, and F were deduced to be 
similar to those of the macroline alkaloids as well as the macrodasines (A–G (14, 119–
123, 15)) from the NOE data. The reciprocal NOEs observed for H-23/H-21, H-25a 
and H-24a/H-26a suggested a chair conformation adopted by the tetrahydropyran ring G 
as shown in Figure 2.8, in which H-24a, H-25a, and H-26a are axially oriented. As in 
the case of macrodasine F, NOE was not observed between the C-26 hydrogens and 18-
Me, suggesting that the configuration of the spirocyclic C-22 is S (the C-26 hydrogens 
and 18-Me are directed away from each other; if C-22 is R, NOE would have been 





Figure 2.7: Selected HMBCs of 4 
 
 



















C NMR Spectroscopic Data for Macrodasine H (4)
a
 
Position H C 
2  132.7 
3 3.93 m 53.5 
5 2.96 d (7) 54.9 
6β 2.41 d (16) 22.6 
6α 3.26 dd (16, 7) 
7  106.7 
8  126.4 
9 7.50 d (8) 118.2 
10 7.11 t (8) 119 
11 7.20 t (8) 121.1 
12 7.30 d (8) 108.9 
13  137.0 
14 1.50 m 32.0 
14 2.41 m  
15 1.84 m 26.7 
16 2.09 m 37.0 
17β 3.75 dd (12, 5) 64.6 
17α 4.05 t (12)  
18 1.62 s 23.8 
19  105.1 
20 1.96 dd (12.5, 8) 44.1 
21 1.81 dd (12.5, 8) 32.2 
21 2.16 t (12.5)  
22  108.6 
23 (ax) 3.51 dd (10, 5) 70.1 
24 (ax) 1.37 m 27.9 
24' (eq) 2.05 m  
25 1.56 m 23.0 
25' 1.56 m  
26 (ax) 3.39 td (10, 4.5) 64.0 
26' (eq) 3.84 m  
N(1)-Me 3.62 s 30.1 
N(4)-Me 2.33 s 42.2 























2.1.1.5 Alstonerine (5), Alstonerinal (6), Alstophylline (7), Alstophyllal (8), 
Macrocarpine A (9), Macrocarpine B (10), Macrocarpine C (11), 
Talcarpine (12), N(4)-Methyl-N(4),21-secotalpinine (13), Macrodasine A 
(14), and Macrodasine G (15)  
 









 macrocarpine A 
(9),
123
 macrocarpine B (10),
123







 macrodasine A (16),
122-124
 and macrodasine G 
(15)
124
 were also isolated in this study. The 
1
H NMR spectra of these compounds are 
shown in Figures 2.10–2.18 and the NMR spectroscopic data are summarized in Tables 























H NMR Spectroscopic Data for Alstonerine (5), Alstonerinal (6), 
Alstophylline (7) and Alstophyllal (8)
a
 
H 5 6 7 8 
3 3.87 m 3.86 m 3.86 m 3.84 m 
5 3.07 br d (7) 3.07 br d (7) 3.09 d (7) 3.06 d (7) 
6a 2.49 d (16) 2.48 d (16) 2.48 d (16) 2.45 d (16) 
6b 3.32 dd (16, 7) 3.31 dd (16, 7) 3.30 dd (16, 7) 3.29 dd (16, 7) 
9 7.49 br d (8) 7.44 br d (8) 7.34 d (8) 7.34 d (8) 
10 7.08 td (8, 1) 7.08 td (8, 1) 6.76 dd (8, 1) 6.76 dd (8, 2) 
11 7.19 td (8, 1) 7.19 td (8, 1) ‒ ‒ 
12 7.31 br d (8) 7.31 br d (8) 6.81 d (1) 6.81 d (2) 
14a 1.81 td (12, 3) 1.79 td (12, 3) 1.80 td (12, 3) 1.77 td (12, 4) 
14b 2.12 ddd  
(12, 5, 3) 
2.12 ddd  
(12, 5, 3) 
2.11 m 2.14 m 
15 2.61 dt (12, 5) 2.61 dt (12, 5) 2.62 m 2.61 m 
16 1.89 m 1.89 m 1.90 m 1.89 m 
17a 4.16 ddd  
(11, 4, 2) 
4.18 ddd  
(11, 4, 2) 
4.18 ddd  
(11, 4, 2) 
4.19 ddd  
(11, 4, 2) 
17b 4.40 t (11) 4.46 t (11) 4.42 t (11) 4.46 t (11) 
18 2.07 s 2.15 s 2.09 s 2.17 s 
21 7.52 s 9.65 s 7.53 s 9.66 s 
N(1)-Me 3.64 s 3.63 s 3.60 s 3.60 s 
N(4)-Me 2.31 s 2.31 s 2.34 s 2.32 s 
11-OMe ‒ ‒ 3.89 s 3.89 s 










C NMR Spectroscopic Data for Alstonerine (5), Alstonerinal (6), 
Alstophylline (7), and Alstophyllal (8)
a 
C 5 6 7 8 
2 137.1 137.1 131.8 132.6 
3 54.6 54.6 53.6 53.9 
5 53.7 53.6 54.6 54.8 
6 22.8 22.3 22.3 25.0 
7 105.8 105.8 105.8 105.7 
8 126.5 126.5 121.0 121.0 
9 117.7 117.3 118.2 118.3 
10 120.7 121.0 108.1 108.3 
11 118.6 118.6 155.9 155.8 
12 108.6 108.6 93.2 93.4 
13 137.1 137.1 137.9 137.9 
14 38.5 38.5 31.8 32.3 
15 32.3 31.8 24.9 25.0 
16 41.7 41.7 38.4 38.5 
17 67.7 68.0 67.7 67.7 
18 22.7 16.5 16.5 22.9 
19 195.7 170.6 170.0 195.5 
20 126.5 126.5 121.0 121.0 
21 157.4 188.6 188.8 157.0 
N(1)-Me    29.1 
N(4)-Me 24.9 24.9 41.6 
11-OMe ‒ ‒ 55.8 56.1 










H NMR Spectroscopic Data for Macrocarpine A (9), Macrocarpine B (10), 
       and Macrocarpine C (11)
a 
H 9 10 11 
3 3.96 m 3.98 t (3) 3.97 t (4) 
5 2.87 d (7) 2.91 d (7) 2.91 d (7) 
6a 2.47 d (17) 2.43 d (17) 2.45 d (17) 
6b 3.25 dd (17, 7) 3.26 dd (17, 7) 3.27 dd (17, 7) 
9 7.49 br d (8) 7.49 br d (8) 7.49 dd (8, 1) 
10 7.10 td (8, 1) 7.10 td (8, 1) 7.09 td (8, 1) 
11 7.19 td (8, 1) 7.18 td (8, 1) 7.17 td (8, 1) 
12 7.29 br d (8) 7.29 br d (8) 7.27 dd (8, 1) 
14a 1.42 ddd (13, 5, 2) 1.54 ddd (12, 4, 3) 1.39 dt (13, 4) 
14b 2.50 td (13, 4) 2.29 m 2.26 td (13, 4) 
15 2.06 dt (13, 5) 1.97 dt (13, 4) 1.86 m 
16 2.15 dt (11, 5) 1.86 dt (11, 4) 1.86 m 
17a 3.79 dd (11, 5) 3.73 dd (11, 4) 3.74 dd (11, 4) 
17b 4.07 t (11) 4.06 t (11) 4.07 t (11) 
18 1.24 d (7) 1.15 d (6) 1.13 d (6) 
19 3.96 m 3.49 m 3.51 dq (10, 6) 
20 1.07 m 1.46 m 1.69 m 
21a 3.69 dd (11, 4) 3.31 dd (11, 8) 3.83 d (7) 
21b 3.81 dd (11, 6) 3.49 m 3.83 d (7) 
23 ‒ ‒ 1.68 s 
N(1)-Me 3.62 s 3.62 s 3.60 s 
N(4)-Me 2.31 s 2.30 s 2.34 s 










C NMR Spectroscopic Data for Macrocarpine A (9), Macrocarpine B (10), 
      and Macrocarpine C (11)
a
 
C 9 10 11 
2 133.2 133.2 133.0 
3 53.7 53.6 53.5 
5 54.6 55.1 54.9 
6 22.6 22.5 22.4 
7 106.6 106.7 106.7 
8 126.4 126.4 126.3 
9 118.1 117.9 117.9 
10 118.8 118.8 118.8 
11 120.8 120.7 120.8 
12 108.7 108.8 108.5 
13 136.9 137.0 136.9 
14 30.7 25.3 25.0 
15 28.6 26.7 27.1 
16 39.3 43.5 43.4 
17 68.9 67.6 67.5 
18 18.8 20.2 20.1 
19 71.2 70.5 70.3 
20 43.6 46.8 43.2 
21 63.1 61.6 62.9 
22 ‒ ‒ 170.8 
23 ‒ ‒ 20.3 
N(1)-Me 29.0 29.0 28.9 
N(4)-Me 41.7 41.7 41.6 
















Position 12  13 
 H C H C 
2  132.8  132.8 
3 3.98 m 53.5 3.93 m 53.1 
5 2.90 d (7) 54.5 2.96 d (7) 54.9 
6β 2.45 d (16) 22.5 2.49 d (16) 22.4 
6α 3.27 dd (16, 7)  3.30 dd (16, 7)  
7  106.6  106.6 
8  126.2  126.2 
9 7.49 br d (8) 118.1 7.52 br d (8) 117.9 
10 7.10 td (8, 1) 118.9 7.13 td (8, 1) 118.9 
11 7.19 td (8, 1) 121.0 7.21 td (8, 1) 121.0 
12 7.29 br d (8) 108.7 7.31 br d (8) 108.9 
13  137.2  137.0 
14 1.45 ddd (12, 4, 3) 30.1 1.28 m 26.7 
14 2.50 td (12, 4)  2.37 m  
15 2.20 m 27.0 2.37 m 26.1 
16 2.06 dt (11, 5) 39.4 1.93 m 42.5 
17 3.89 dd (12, 5) 68.8 3.75 dd (12, 5) 67.1 
17' 4.14 t (12)  4.06 t (12)  
18 1.30 d (7) 19.2 1.20 d (7) 20.2 
19 3.98 m 69.4 3.93 m 67.8 
20 1.79 br s 54.6 2.37 m 57.7 
21 9.95 d (3) 204.7 9.41 br s 203.0 
N(1)-Me 3.62 s 29.1 3.58 s 29.0 
N(4)-Me 2.32 s 41.8 2.31 s 41.6 



















Position 14   
 H C H C 
2  132.8 ‒ 132.5 
3 3.95 t (3) 53.3 3.95 m 53.3 
5 2.98 d (7) 54.8 3.50 d (7) 54.7 
6β 2.39 m 22.5 2.42 d (17) 22.5 
6α 3.27 dd (17, 7)   
7 ‒ 106.4 ‒ 106.5 
8 ‒ 126.4 ‒ 126.2 
9 7.50 d (8) 118.0 7.50 d (8) 118.0 
10 7.12 t (8) 118.9 7.12 t (8) 118.9 
11 7.21 td (8, 1) 121.0 7.21 t (8) 121.0 
12 7.31 d (8) 108.0 7.30 d (8) 108.8 
13 ‒ 136.9 ‒ 136.9 
14 1.55 ddd (13, 5, 3) 31.9 1.52 ddd (13, 5, 3) 31.9 
14 2.39 m  2.42 m 
15 1.85 m 26.5 1.81 m 27.0 
16 2.03 dt (12, 5) 36.9 2.16 dt (12, 5) 36.5 
17β 3.70 dd (12, 5) 64.3 3.87 dd (12, 5) 64.7 
17α 4.04 t (12)  4.09 t (12) 
18 1.59 s 24.2 1.59 s 23.6 
19 ‒ 105.5 ‒ 105.3 
20 2.01 dd (12, 8) 44.3 1.85 m 45.6 
21 1.85 m 34.7 2.00 dd (13, 8) 38.2 
21 2.39 m  2.32 t (13)  
22 ‒ 114.8 ‒ 112.0 
23 4.13 d (5) 77.7 3.95 m 75.7 
24a 1.85 m 33.0 1.87 m 34.2 
24b 2.39 m  2.08 ddd (13, 8, 5)  
25 4.42 m 79.2 4.32 m 77.0 
26a 3.43 dd (12, 3) 63.9 3.43 dd (12, 4) 64.6 
26b 3.77 dd (12, 2)  3.69 dd (12, 3)  
N(1)-Me 3.63 s 29.0 3.62 s 29.0 
N(4)-Me 2.33 s 41.6 2.35 s 41.6 


























































































































































































































































































































































2.1.2 Macroline Oxindole Alkaloids 
 
2.1.2.1 Compound 16 [Alstonoxine C (11-Methoxyalstonoxine A)] 
 
Compound 16 was isolated as a light yellowish oil, with [α]D 30 (c 0.39, CHCl3), and 
subsequently crystallized from CH2Cl2-hexane as colorless block crystals. The UV 
spectrum showed absorption maxima at 216, 255, and 285 nm indicative of an oxindole 





), NH (3295 cm
-1
) and hydroxyl (3395 cm
-1
) functions, while the 
carbon resonances at  183.0, 208.7, 65.9 confirm the presence of lactam, ketone, and 
oxymethylene groups, respectively. The ESIMS showed a [M + H]
+
 peak at m/z 359, 





C NMR spectroscopic data (Table 2.12; Figure 2.23) of 16 showed a close 
rememblance to those of 7(S)-alstonoxine A (18),
132,233
  except for the absence of an 
aromatic hydrogen signal at C-11, which was replaced in 16 by a 3H singlet at  3.84 of  
an aromatic methoxy substituent. The placement of the methoxy substituent at C-11 was 
further confirmed by the observed NOEs between OMe and H-10 as well as H-12. The 
configuration of the spirocyclic C-7 was assigned as S from the observed NOEs 
between H-9 and H-15 (Figure 2.19). In view of the availability of suitable crystals, an 
X-ray diffraction analysis was carried out which provided confirmation of the structure 
and relative configuration of 16 deduced from the spectroscopic data (Figure 2.20). The 
X-ray structure of 16 also provided additional support for the original assignment of the 
























2.1.2.2 Compound 17 [Alstonoxine D (11-Methoxyalstonoxine B)] 
 
Compound 17 was isolated as a light yellowish oil, with []D ‒16 (c 0.23, CHCl3). The 
UV and IR spectrum of 17 were similar to those of alstonoxine B (19),
132,233
 while the 
ESIMS showed a [M + H]
+





C NMR data (Table 2.12; Figure 2.24) of 17 were generally similar to 
those of alstonoxine B (19),
132,233
 except for the presence of an additional aromatic 
methoxy singlet at  3.83, and the absence of one aromatic-H signal. The placement of 
the methoxy substituent at C-11 was supported by the observed coupling behaviour of 
the aromatic hydrogens as well as from the observed three-bond correlations from H-9 
to C-11 and C-13, in the HMBC spectrum (Figure 2.21). This assignment was further 
supported by the observed NOEs between 11-OMe and H-10, H-12 (Figure 2.21). The 
configuration of the spirocenter C-7 was assigned as S from the observed NOEs 
between H-9 and H-15. The NMR data of 17 were however insufficient to establish the 
stereochemistry of C-19. Towards this end, alstonoxine C (16) was treated with 
NaBH4/MeOH, which gave a mixture of the epimeric alcohol products in approximately 
equal amounts, which were separated by preparative centrifugal TLC (SiO2, 1% 
MeOH/CHCl3, NH3-saturated). The NMR data revealed that the slower eluting 
compound corresponded to compound 17. With sufficient amounts of 17 obtained in 
this manner, the configuration at C-19 could be determined by Horeau’s procedure (see 
Experimental Section),
237,238
 which showed that the C-19 configuration in 17 is S (the 
faster eluting compound 6a therefore corresponded to the 19R epimer). The structure 
and relative configuration of alstonoxine B (19) was previously reported from Alstonia 
angustifolia var. latifolia, based on analysis of the NMR and MS data which at the time 
were insufficient to assign the configuration at C-19. Alstonoxine B (19) was also 








hexane solution in this instance, X-ray diffraction analysis was carried which 
established the relative configuration of C-19 in alstonoxine B (19) as S (Figure 2.22). 
The X-ray structure of 19 also provided additional support for the determination of the 
C-19 configuration of 17 as 19S, using Horeau’s procedure (vide supra), since the NMR 
data of 17 and 19 indicated that the non-aromatic portion of 6 was virtually identical to 
the non-aromatic portion of 19, and therefore the configuration of C-19 in 17 can be 






















C NMR Spectroscopic Data for Compound 16 (11-
Methoxyalstonoxine A) and Compound 17 (11-Methoxyalstonoxine B)
a
 
Position 16  17 
 H C H C 
2  183.0  183.1 
3 3.19 m 62.9 3.20 m 63.4 
5 3.86 m 61.7 3.90 m 61.8 
6β 2.08 d (14) 41.0 2.06 d (14) 40.8 
6α 2.39 dd (14, 8)  2.38 dd (14, 8) 
7 - 56.8 - 57.0 
8 - 120.8 - 121.1 
9 7.76 d (9) 125.8 7.39 d (8) 125.1 
10 6.70 dd (9, 2) 106.4 6.60 dd (8, 2) 106.6 
11 - 160.2 - 160.2 
12 6.45 d (2) 96.6 6.45 d (2) 96.5 
13 - 145.5 - 145.6 
14 1.69 m 33.1 1.72 m 34.2 
14 1.86 dd (13, 5)  1.82 m  
15 2.97 m 26.2 2.69 m 26.9 
16 1.69 m 41.6 1.72 m 40.7 
17 3.81 m 65.9 3.90 m 65.3 
17' 4.01 d (12)  4.00 dd (11, 1)  
18 2.20 s 31.0 1.29 d (6) 24.9 
19 - 208.7 3.90 m 65.5 
20 2.69 dd (18, 5) 47.1 1.53 m 42.5 
20' 2.80 dd (18, 8)  1.86 m  
N(1)-Me 3.16 s 26.4 3.17 s 26.4 
11-OMe 3.84 s 55.7 3.83 s 55.6 


















































































































2.1.2.3 Alstonoxine A (18), Alstonoxine B (19), Alstonisine (20), Alstonal (21), 
N(4)-Demethylalstophylline oxindole (22) and N(4)-Demethylalstophyllal 
oxindole (23) 
 












 and N(4)-demethylalstophyllal oxindole 
(23)
235
 were isolated in this study. The 
1
H NMR spectra of these compounds are shown 
in Figures 2.25–2.28, and the NMR spectroscopic data are summarized in Tables 




































Position 18  19  
 H C H C 
2 - 182.3 - 182.4 
3 3.25 m 63.1 3.25 m 63.5 
5 3.90 br d (8) 61.7 3.91 m 61.7 
6β 2.15 dd (13, 2) 40.7 2.13 dd (14, 1) 40.5 
6α 2.43 dd (13, 8)  2.41 dd (14, 8)  
7 - 57.2 - 57.4 
8 - 129.0 - 129.2 
9 7.84 br d (8) 125.0 7.52 br d (8) 124.3 
10 7.20 td (8, 1) 123.1 7.10 td (8, 1) 122.8 
11 7.32 td (8, 1) 128.1 7.31 td (8, 1) 128.1 
12 6.87 br d (8) 108.1 6.88 br d (8) 108.2 
13 - 144.1 - 144.2 
14 1.71 m 33.0 1.53 ddd (14, 9, 5) 42.3 
14 1.87 (14, 6, 2)  1.85 ddd (14, 9, 3)  
15 3.05 m 26.1 2.72 m 26.8 
16 1.71 m 41.4 1.77 m 40.7 
17 3.80 dd (12, 2) 65.8 3.91 m 65.2 
17' 4.02 dd (12, 1)  4.01 dd (11, 1)  
18 2.21 s 30.8 1.30 d (6) 24.7 
19 - 208.4 3.91 m 65.1 
20 2.72 dd (18, 6) 47.0 1.77 m 34.0 
20' 2.79 dd (18, 7)  1.77 m  
N(1)-Me 3.20 s 26.2 3.20 s 26.5 










H NMR Spectroscopic Data for Alstonisine (20), Alstonal (21), N(4)-




H 20 21 22 23 
3 3.18 br s 3.18 br s 3.16 br s 3.16 br s 
5 3.68 br d (7) 3.67 dd (7, 2) 3.68 m 3.68 m 
6 2.19 br d (13) 2.18 br d (13) 2.14 dd (13, 1) 2.13 dd (13, 1) 
 2.52 dd (13, 7) 2.51 dd (13, 2) 2.51 dd (13, 8) 2.50 dd (13, 8) 
9 8.25 br d (8) 8.24 br d (8) 8.17 d (8) 8.16 d (8) 
10 7.30 td (8, 1) 7.30 td (8, 1) 6.81 dd (8, 2) 6.80 dd (8, 2) 
11 7.33 td (8, 1) 7.34 td (8, 1) ‒ ‒ 
12 6.88 br d (8) 6.87 br d (8) 6.46 d (2) 6.46 d (2) 
14 1.55 ddd  
(14, 12, 3) 
1.54 ddd  
(14, 12, 3) 
1.57 m 1.57 m 
 2.25 ddd  
(14, 6, 3) 
2.29 ddd  
(14, 6, 3) 
2.26 m 2.26 m 
15 3.40 dt (12, 6) 3.36 dt (12, 6) 3.35 m 3.35 m 
16 1.96 m 1.97 m 1.96 m 1.96 m 
17 4.26 ddd  
(11, 4, 2) 
4.28 ddd  
(11, 4, 2) 
4.26 ddd  
(11, 4, 2) 
4.28 ddd  
(11, 4, 2) 
 4.45 t (11) 4.51 t (11) 4.47 t (11) 4.53 t (11) 
18 2.24 s 2.24 s 2.25 s 2.25 s 
21 7.62 s 9.86 s 7.63 s 9.85 s 
N(1)-Me 3.20 s 3.20 s 3.17 s 3.17 s 
11-OMe ‒ ‒ 3.85 s 3.86 s 











C NMR Spectroscopic Data for Alstonisine (20), Alstonal (21), N(4)-




C 20 21 22 23 
2 181.9 181.9 183.1 183.1 
3 63.4 63.4 63.8 63.8 
5 55.9 55.9 56.2 56.2 
6 41.5 41.5 42.1 42.1 
7 56.5 56.5 56.3 56.3 
8 128.7 128.7 121.2 121.2 
9 125.1 125.1 126.2 126.2 
10 122.8 122.8 106.3 106.4 
11 127.5 127.5 160.0 160.0 
12 107.5 107.5 96.9 96.9 
13 143.6 143.6 145.3 145.3 
14 30.6 30.3 31.2 31.2 
15 23.8 23.5 24.2 24.1 
16 36.5 36.5 37.0 37.0 
17 68.2 67.9 68.5 68.6 
18 24.5 16.2 25.0 16.6 
19 196.0 170.5 196.6 171.0 
20 121.3 117.7 122.0 118.4 
21 157.2 189.0 158.0 189.4 
N(1)-Me 25.8 25.8 26.3  26.3 
11-OMe ‒ ‒ 55.5  
















































































































































































































H NMR Spectrum (CDCl3, 400 MHz) of N(4)-Demethylalstophylline oxindole (22)  








2.1.3 Akuammiline, Sarpagine and Ajmaline Alkaloids 
 
 
2.1.3.1 Compound 24 (2(S)-Cathafoline) 
 
Compound 24 was isolated as a light yellowish oil, with []D ‒175 (c 0.22, CHCl3), and 
was subsequently crystallized from CH2Cl2-hexane as colorless block crystals. The UV 
spectrum showed absorption maxima at 208, 246, 308 nm, consistent with a 
dihydroindole chromophore.  The IR spectrum showed a sharp band at 1737 cm
-1
 due to 
an ester function, which was confirmed by the observed carbon shift of the carbonyl 
function at  172.8 in the 13C NMR spectrum. The ESIMS showed a [M + H]+ peak at 





C NMR data (Table 2.16; Figure 2.33) were generally similar to those of 
cathafoline (35),
146,241
 except for differences in the chemical shift of C-2, C-6, C-8, C-
14, and C-16, in the 
13





The relative configurations at the various stereogenic centers of 24 were similar to those 
of cathafoline (35), except for the configuration at C-2. The reciprocal NOEs observed 
for H-2/H-3, H-6, N1-Me, and H-6/H-2, H-5, H-6, H-9, allowed the relative 
configuration at C-2 to be assigned as S (H-2) (Figure 2.29). Since suitable crystals of 
3 were obtained from CH2Cl2–hexane, an X-ray diffraction analysis was carried out 
which confirmed the assignment of configuration of C-2 as S based on the NMR data 






























2.1.3.2 Compound 25 (2(S)-10-Methoxycathafoline)  
 
Compound 25 was obtained as a light yellowish oil, with []D 138 (c 0.47, CHCl3). 
The UV and IR spectrum were similar to those of compound 24. The ESIMS showed a 
[M + H]
+
 peak at m/z 369, which is 30 mass-units more than 24. The NMR data of 24 
and 25 (Table 2.16; Figure 2.34) were generally similar except for the presence of a 
methoxy group in 25. The substitution of the methoxy group at C-10 was deduced from 
the coupling behaviour of the aromatic hydrogens as well as from the observed three-
bond correlations (Figure 2.31) from H-12 and 10-OMe to C-10 in the HMBC spectrum. 
The placement of the methoxy substituent at C-10 was further confirmed by the 
reciprocal NOEs observed for H-9/10-OMe; H-11/10-OMe, H-12; and H-12/H-11, N1-
















2.1.3.3 Compound 26 (2(R)-3-Hydroxycathafoline) 
 
Compound 26 was isolated as a light yellowish oil, with []D ‒48 (c 0.24, CHCl3). The 
IR spectrum showed bands at 3395 and 1739 cm
-1 
due to OH and ester functionalities, 
respectively. The UV spectrum showed typical dihydroindole absorptions at 202, 252, 
and 295 nm. The ESIMS of 26 showed a [M + H]
+
 peak at m/z 355, which analyzed for 
C21H26N2O3 + H, differing from cathafoline (35) by addition of 16 mass units 





C NMR spectroscopic data (Table 2.17; Figure 2.35), which 
showed a close correspondence with those of 35 except for some notable differences. In 
13
C NMR spectrum, the chemical shif for C-3 signal was shifted down-field (from  
47.2 to 85.3) due to the attachement of an OH group. The various stereogenic centers 
were same to those of cathafoline (35) (the observed NOEs, viz. H-2/H-14a; and H-9/H-
16 (Figure 2.32)). The rigid architecture of the molecule restricts the configuration at C-
3 to R only. Compound 26 was previously encountered as an intermediate compound in 
synthesis,
242



















C NMR Spectroscopic Data for 2(S)-Cathafoline (24) and 2(S)-10-
Methoxycathafoline (25)
a 
Position 24  25  
 H C H C 
2 3.20 d (4)  3.21 d (4) 70.7 
3 3.86 d (4) 48.7 3.92 d (4) 48.9 
5 2.46 dd (14, 7) 46.5 2.55 dd (14, 7) 46.6 
5 3.33 td (14, 6)  3.43 td (14, 6)  
6 1.95 dd (14, 6) 28.7 2.02 dd (14, 6) 28.7 
6 3.23 m  3.28 td (14, 7)  
7 ‒ 42.9 ‒ 43.2 
8 ‒ 137.8 ‒ 139.4 
9 6.98 d (7) 123.3 6.72 d (2) 110.6 
10 6.64 t (7) 119.5 ‒ 153.8 
11 7.01 t (7) 127.5 6.66 dd (9, 2) 112.3 
12 6.51 d (7) 109.1 6.52 br d (9) 109.7 
13 ‒ 152.6 ‒ 146.8 
14a 1.98 dt (15, 4) 25.2 1.97 m 25.2 
14b 2.01 dd (15, 3)  2.13 dd (14, 3)  
15 3.27 br s 32.5 3.36 br s 32.6 
16 2.60 d (3) 49.6 2.71 d (4) 49.6 
18 1.34 dd (7, 2) 12.9 1.43 dd (7, 2) 13.0 
19 5.29 q (7) 119.5 5.38 br q (7) 119.9 
20 ‒ 138.1 ‒ 138.0 
21a 2.86 d (16) 56.2 2.96 br d (16) 56.3 
21b 3.84 d (16)  3.94 br d (16)  
N(1)-Me 2.56 s 34.0 2.61 s 34.9 
10-OMe ‒ ‒ 3.70 s 56.0 
CO2Me 3.41 s 51.0 3.52 s 51.1 
CO2Me ‒ 172.8 ‒ 172.9 


















Position H C 
2 2.89 s 
3 ‒ 85.3 
5 2.77 dd (13, 6.5) 51.5 
5 4.02 td (13, 5)  
6 1.32 dd (15, 5) 30.8 
6 2.87 m  
7 ‒ 46.3 
8 ‒ 140.0 
9 6.91 dd (8, 1) 120.9 
10 6.68 td (8, 1) 119.4 
11 7.09 td (8, 1) 127.3 
12 6.61 br d (8) 109.8 
13 ‒ 153.8 
14a 1.90 dd (14, 3) 42.3 
14b 2.20 dd (14, 3)  
15 3.61 m 36.5 
16 2.90 d (4) 52.0 
18 1.49 dd (7, 2) 13.6 
19 5.41 br q (7) 119.1 
20 ‒ 137.5 
21a 2.98 m 55.0 
21b 4.10 br d (17)  
N(1)-Me 2.95 s 51.7 
CO2Me ‒ 173.0 
CO2Me 3.78 s 37.6 







































































































































































































2.1.3.4 Compound 27 (10-Demethoxyvincorine) 
 
Compound 27 was isolated as a light yellowish oil, with []D ‒127 (c 0.48, CHCl3). The 
UV spectrum showed absorption bands (205, 256, and 308 nm) characteristic of a 
dihydroindole chromophore. The IR spectrum showed a band at 1736 cm
-1 
due to an 
ester carbonyl function. It was supported by the observed chemical shift of the carbonyl 
function at  173.8 in the 13C NMR spectrum. The ESIMS of 27 showed a 
pseudomolecular ion [M + H]
+
 at m/z 339, and high resolution measurements gave the 





C NMR spectroscopic data (Table 2.18, and Figure 2.38) 
showed the close resemblance to those of vincorine (41),
145,243-245
 except for the absence 
of the methoxy group (C-10) and the presence of an unsubstituted indole moeity. The 
relative configuration of C-16, and the geometry of the 19,20-double bond, were similar 














2.1.3.5 Compound 28 (10-Demethoxyvincorine N(4)-oxide) 
 
Compound 28 was obtained as a yellowish oil, with []D –62 (c 0.5, CHCl3). The UV 
spectrum (208, 247, and 299 nm) showed absorption maxima characteristic of an 
dihydroindole chromophore, while the IR spectrum showed the presence of an ester 
carbonyl (1734 cm
-1
) function. The ESIMS of 28 showed a [M + H]
+
 peak at m/z 355, 
which analyzed for C21H26N2O3 + H (16 mass units higher than that of 10-
demethoxyvincorine (27)). Compound 28 was readily identified as the N(4)-oxide of 
10-demthoxyvincorine from its NMR spectroscopic data (Table 2.18; Figure 2.39), in 
particular, the characteristic downfield shifts of the carbon resonances for C-2, C-5, and 
C-21, when compared with those of 10-demethoxyvincorine (27). 
 
 
2.1.3.6 Compound 29 (11-Methoxyvincorine) 
 
Compound 29 was obtained as a light yellowish oil, []D  (c 0.27, CHCl3). The UV 
spectrum showed absorption maxima at 208, 256 and 317 nm, characteristic of a 
dihydroxyindole chromophore, while the IR spectrum indicated the presence of ester 
carbonyl (1733 cm
-1
) function. The ESIMS of 29 showed a [M + H]
+
 peak at m/z 399, 
corresponding to the molecular formula C23H30N2O4 + H, differing from vincorine 
(41)
145,243-245




C NMR spectral data (Table 
2.19; Figure 2.40) are similar in all respects to those of 41, except for the aromatic 
region, which indicated the presence of a methoxy substituent at C-11 (which was also 















2.1.3.7 Compound 30 (Vincorine N(4)-oxide) 
 
Compound 30 was obtained as yellowish oil, with [D –84 (c 0.40, CHCl3). The UV 
spectrum (211, 250 and 323 nm) was characteristic of a dihydroindole chromophore, 
while the IR spectrum showed the presence of an ester (1734 cm
–1
) function. The 
ESIMS of 30 showed an MH
+
 at m/z 385, which analyzed for C22H28N2O3 + H (16 mass 
units higher than that of vincorine (41)).
145,243-245
 Compound 30 was readily identified as 
the N(4)-oxide of vincorine from its NMR spectroscopic data (Table 2.19; Figure 2.41), 
in particular the characteristic downfield shifts of the carbon resonances for C-2, C-5, 



















C NMR Spectroscopic Data for Compound 27 (10-
Demethoxyvincorine) and 28 (10-Demethoxyvincorine N(4)-oxide)
a 
Position 27 28 
 δH δC δH δC 
2 –  – 102.5
3 1.68 m () 20.8 1.73 m 17.5 
 2.32 m ()  2.90 m  
5 2.73 br t (11) () 55.0 3.42 dd (11, 9)  66.3 
 3.33 td (11, 9) ()  3.91 m   
6 1.97 ddd (14, 9, 1) () 41.0 2.06 dd (15, 9) 35.1 
 2.50 ddd (14, 11, 9) ()  2.81 m  
7 – 57.0 – 54.1 
8 – 137.0 – 135.5 
9 7.22 dd (7.5, 1) 123.5 7.11 d (8) 122.6 
10 6.58 td (7.5, 1) 116.9 6.69 td (8, 1) 119.4 
11 7.06 td (7.5, 1) 127.8 7.13 td (8, 1) 129.0 
12 6.27 br d (7.5) 105.3 6.47 d (8) 107.8 
13 – 149.0 – 149.7 
14 1.76 m 26.2 1.85 m  25.3 
 1.76 m  1.92 m   
15 3.61 m 34.8 3.65 m 33.8 
16 2.83 br s 50.6 2.80 br s 49.3 
18 1.59 dd (7, 2) 13.5 1.60 dd (7, 2) 13.7 
19 5.40 q (7) 122.4 5.73 q (7) 128.3 
20 – 138.9 – 132.0 
21a 3.00 br d (15) 58.3 3.91 br d (15) 74.0 
21b 3.81 m  4.20 m  
N(1)-Me 2.63 s 27.3 3.07 s 32.9 
CO2Me 3.79 s 51.5 3.79 s 52.1 
CO2Me – 173.8 – 172.6 












C NMR Spectroscopic Data for Compound 29 (11-
Methoxyvincorine) and 30 (Vincorine N(4)-oxide)
a 
Position 29 30 
 δH δC δH δC 
2 –  – 102.7
3 1.68 m ()  20.8 1.71 m  17.1 
 2.32 m ()  2.85 m  
5 2.75 br t (10.5) ()  55.2 3.35 br t (10) 66.1 
 3.38 m ()  3.94 m  
6 1.97 dd (14, 8) ()  41.4 2.06 dd (15, 9) 34.9 
 2.41 m ()   2.74 m  
7 – 57.4 – 54.3 
8 – 128.0 – 136.6 
9 7.02 s 111.9 6.76 d (2.5) 110.6 
10 ‒ 140.9 ‒ 153.6 
11 ‒ 150.1 6.67 dd (8.5, 2.5) 112.8 
12 5.96 s 92.3 6.37 br d (8.5) 107.9 
13 – 144.5 – 143.9 
14 1.77 m  26.6 1.83 m 25.2 
 1.77 m   1.91 m  
15 3.62 m 34.9 3.64 d (4) 33.8 
16 2.79 br s 51.5 2.77 br s 49.3 
18 1.60 dd (7, 2) 13.9 1.58 d (7) 13.6 
19 5.41 q (7) 123.1 5.69 q (7) 128.4 
20 – 139.0 – 131.9 
21a 3.02 br d (15) 58.6 3.85 br d (15) 73.7 
21b 3.84 m  4.18 br d (15)  
N(1)-Me 2.63 s 28.4 3.02 s 33.3 
CO2Me 3.80 s 51.9 3.77 s 52.1 
CO2Me – 174.0 ‒ 172.5 
10-OMe 3.78 s 58.2 3.69 s 56.1 
11-OMe 3.86 s 56.4 – – 






























































































































































































































































































































2.1.3.8 Compound 31 (11-Demethoxyquaternine) 
 
Compound 31 was obtained from the leaf extract of A. macrophylla as a light yellowish 
oil, []D 10 (c 0.21, CHCl3). The UV spectrum showed absorption maxima at 208, 241, 
307 nm, suggesting the presence of a dihydroindole chromophore. The IR spectrum 
showed a sharp band due to an ester function at 1736 cm
1
. The presence of an ester 
function was supported by the signal observed at δ 172.5 in the 13C NMR spectrum. The 
ESIMS showed a [M + H]
+
 peak at m/z 383, which analyzed for C22H26N2O4 + H, 





spectroscopic data (Table 2.20; Figure 2.43) showed the presence of a substituted indole 
ring (δ 6.54, br d (J = 9 Hz); 6.76, d (J = 2.5 Hz); 6.69, dd (J = 9, 2.5 Hz)), three 3H 
singlets at δH 3.70, 3.64, and 2.90, due to an aromatic methoxy (δC 56.0), a methyl ester 
(δC 172.5, and 51.7), and an N1-Me (δC 30.0) group, respectively, an isolated methine 
characteristic of H-5 (where the C-5 is adjacent to a nitrogen and an oxygen atom) as a 
doublet at δH 4.70 (d, J = 3 Hz, δC 87.2), and an ethylidene side chain at δH 5.39 (q, J = 
7 Hz; δC 120.6, C-19) and 1.48 (dd, J = 7, 2 Hz; δC 12.8, C-18). The NMR 
spectroscopic data revealed a similarity of quaternine (46)
168,246
 which also present in 
the same plant. The main departure noted from the NMR data was the absence of one of 
the aromatic methoxy group (two aromatic methoxy groups were presence in 
quaternine). The aromatic doublet at 6.54 was assigned to H-9 from its NOE with H-
6(Figure 2.42), while the placement of the remaining aromatic methoxy substituent at 
C-10 was confirmed by the observed NOEs for 10-OMe ( 3.70)/H-9 and H-11 ( 6.69). 
Another aromatic doublet at 6.76 was assigned to H-12 from the observed NOE 
between H-12 and N1-Me. These assignments were further supported by the observed 
three-bond correlations from H-9 to C-7, C-11, and C-13, H-11 to C-9 and C-13, and, 








of C-16 was same as in quaternine. It was assigned as R from the observed NOEs 
































Position H C 
2 ‒ 
3 3.72 m 49.7 
5 4.70 d (3) 87.2 
6 2.17 dd (14, 3) 40.5 
 3.37 br d (14)  
7 ‒ 50.8 
8 ‒ 136.5 
9 6.76 d (2.5) 112.1 
10 ‒ 154.3 
11 6.69 dd (9, 2.5) 112.6 
12 6.54 br d (9) 108.8 
13 ‒ 144.2 
14 1.79 br d (14) 25.9 
 2.11 dt (14, 4)  
15 3.27 br s 31.3 
16 2.41 d (4) 51.6 
18 1.48 dd (7, 2) 12.8 
19 5.39 q (7) 120.6 
20 ‒ 136.0 
21 3.06 br d (18) 46.4 
 3.75 m  
CO2Me 3.64 s 51.7 
CO2Me ‒ 172.5 
N(1)-Me 2.90 s 30.0 
10-OMe 3.70 s 56.0 

































































































2.1.3.9 Compound 32 (19,20-Z-Affinisine) 
 
Compound 32 was obtained as a light yellowish oil, []D  (c 0.45, CHCl3) from the 
leaf extract of A. macrophylla. The UV spectrum showed absorption maxima at 229, 
254, and 284, nm indicative of an indole chromophore. The IR spectrum showed a 
broad band at 3400 cm
1
 due to an OH function. The ESIMS of 32 showed a [M + H]
+
 
peak at m/z 309, which analyzed for C20H24N2O + H. The 
13
C NMR spectrum (Table 
2.21) showed a total of 20 resonances, comprising two methyl, four methylene, nine 
methine, and five quaternary carbon atoms, in agreement with the molecular formula. 
The 
1
H NMR (Table 2.21, Figure 2.45) showed the presence of an unsubstituted indole 
moiety, an N1-Me, and an ethylidene side chain. The COSY spectrum yielded 
fragments consistent with a sarpagine-type compound, viz. NCHCH2, NCH2, 
NCHCH2CH, CHCH2O, and C=CHCH3. With the help of HMBC data, the structure of 
32 was assembled, which revealed that it possesses the same structure as affinisine (49), 




C NMR data (Table 2.21) of 32 
are generally similar to those of 49 except for differences in the chemical shifts of C-15, 
C-17, C-19, C-20, and C-21 in the 
13
C NMR spectrum, and H-5, H-15, H-16, H-19 and 
H-21, in the 
1
H NMR spectrum. The configuration at C-16 can be deduced from the 
NOESY spectrum (Figure 2.44). The observed H-16/H-6, H-15, H-17 NOEs indicated 
that the configuration of C-16 is R. In addition, the reciprocal NOEs observed for H-
19/H-15 and H-21/H-18, established the geometry of the 19,20-double bond as Z. 





















 H C 
2 ‒ 
3 4.14 dd (10, 2) 49.2 
5 2.73 t (6) 54.9 
6 2.60 br d (15) 27.3 
6 3.03 dd (15, 5)  
7 ‒ 103.4 
8 ‒ 127.4 
9 7.41 d (8) 118.2 
10 7.08 td (8, 1) 118.9 
11 7.19 td (8, 1) 120.9 
12 7.29 d (8) 108.8 
13 ‒ 137.4 
14a 1.53 m 34.5 
14b 2.04 td (12, 2)  
15 2.23 br s 34.9 
16 1.62 m 44.1 
17 3.47 m 65.4 
 3.47 m  
18 1.57 d (7) 12.6 
19 5.28 q (7) 117.0 
20 ‒ 136.9 
21 3.63 m 53.9 
 3.63 m  
N(1)-Me 3.61 s 29.4 










































































2.1.3.10 Compound 33 (Vincamajine N(4)-oxide) 
 
Compound 33 was obtained as yellowish oil, with [D –29 (c 0.04, CHCl3). The UV 
spectrum (210, 231 and 282 nm) was characteristic of a dihydroindole chromophore, 
while the IR spectrum showed the presence of an ester and an OH (3400 and 1736 cm
–1
) 
functions. The ESIMS of 33 showed an [M + H]
+
 at m/z 383, which analyzed for 
C22H26N2O4 + H (16 mass units higher than that of vincamajine (54)).
143,144,164,247-249
 
Compound 33 was readily identified as the N4-oxide of vincamajine from its NMR 
spectroscopic data (Table 2.22; Figure 2.46), in particular the characteristic downfield 




2.1.3.11 Compound 34 (Vincamajine 17-O-veratrate N(4)-oxide) 
 
Compound 34 was obtained as yellowish oil, with [D –75 (c 0.94, CHCl3). The UV 
spectrum (209, 254 and 292 nm) was characteristic of a dihydroindole chromophore, 
while the IR spectrum showed the presence of an ester (1737 cm
–1
) function. The 
ESIMS of 34 showed an [M + H]
+
 at m/z 547, which analyzed for C31H34N2O7 + H (16 
mass units higher than that of vincamajine 17-O-veratrate (55)).
164
 Compound 34 was 
readily identified as the N4-oxide of vincamajine 17-O-veratrate from its NMR 
spectroscopic data (Table 2.22; Figure 2.47), in particular the characteristic downfield 
shifts of the carbon resonances for C-3, C-5, and C-21, when compared with those of 














C NMR Spectroscopic Data for Compound 33 (Vincamajine N(4)-
oxide) and 34 (Vincamajine 17-O-veratrate N(4)-oxide)
a
 
Position 33 34 
 H C H C 
2 3.86 d (5) 69.8 3.93 m 70.0 
3 3.76 m 69.8 3.93 m 69.7 
5 3.96 m 76.0 4.13 d (4) 75.9 
6a 2.53 m 30.3 2.62 m 31.6 
6b 2.78 br d (13)  3.00 br d (13)  
7 – 56.1 ‒ 55.5 
8 – 128.9 ‒ 127.1 
9 7.18 m 128.8 6.82 m 123.6 
10 6.80 t (8) 109.7 6.51 m 119.7 
11 7.16 m 124.6 7.07 m 129.0 
12 6.66 d (8) 119.6 6.63 br d (8) 109.8 
13 – 154.3 ‒ 153.9 
14a 1.82 td (10, 3) 22.2 1.96 m 22.1 
14b 2.55 m  2.81 dd (14, 5)  
15 3.56 m 29.5 3.61m 29.7 
16 – 60.6 ‒ 59.8 
17 4.13 s 74.0 5.76 br s 74.9 
18 1.60 dd (7, 1) 12.6 1.53 d (7) 12.6 
19 5.29  br q (7) 119.6 5.35 q (7) 120.4 
20 – 130.1 ‒ 129.5 
21a 3.72 m 70.8 3.87 m 71.0 
21b 3.96 m  4.25 br d (16)  
N(1)-Me 2.61 s 34.8 2.62 s 34.6 
CO2Me 3.70 s 52.3 3.38 s 52.5 
CO2Me – 170.8 ‒ 169.9 
1' – – ‒ 121.5 
2' – – 7.30 d (2) 111.9 
3' – – ‒ 148.8 
4' – – ‒ 153.4 
5' – – 6.84 m 110.4 
6' – – 7.49 dd (9, 2) 123.4 
3'-OMe – – 3.84b s 56.1 
4'-OMe – – 3.89b s 56.1 
–C=O – – ‒ 163.7 
a CDCl3, 400 MHz; assignments based on COSY, HMQC, and HMBC. 





































































































































































2.1.3.12 Cathafoline (35), Cathafoline N(4)-oxide (36), 10-Methoxycathafoline (37), 
Strictamine (38), 11-Methoxystrictamine (39), 11-Hydroxystrictamine (40), 
Vincorine (41), Norvincorine (42), Alstonamide (43), 
Demethoxyalstonamide (44), Alstomaline (45), Quaternine (46), Picrinine 
(47), and 12-Demethoxytabernulosine (48)  
 
The known akuammiline alkaloids which were isolated from A. macrophylla are 
cathafoline (35),
133,250




























 and 12-demethoxytabernulosine (48). The 
1
H NMR spectra of compounds 
3548 are shown in Figures 2.48–2.61. The 1H and 13C NMR spectroscopic data of 
compounds 3537, 3840, 4142, 4345, and 4648 are summarized in Tables 2.23–
2.24, 2.25–2.26, 2.27, 2.28–2.29, and 2.30‒2.31, respectively, while other data are given 




















H NMR Spectroscopic Data for Cathafoline (35), Cathafoline N(4)-oxide 
(36), and 10-Methoxycathafoline (37)
a
 
H 35 36 37 
2 2.50 s 2.88 s 2.44 s 
3 4.10 d (5) 4.64 d (5) 4.12 d (5) 
5 2.62 dd (14, 5) 3.36 dd (14, 6) 2.64 m 
 3.82 td (14, 5) 4.47 m 3.88 td (14, 5) 
6 1.41 dd (15, 5) 1.73 dd (16, 6) 1.45 dd (15, 5) 
 3.07 ddd (15, 14, 5) 3.21 ddd (16, 14, 6) 3.07 ddd (15, 14, 5) 
9 6.94 dd (8, 1) 6.69 br d (8) 6.61 d (1) 
10 6.69 td (8, 1) 6.75 td (8, 1) ‒ 
11 7.09 td (8, 1) 7.15 td (8, 1) 6.63 dd (8, 1) 
12 6.60 dd (8, 1) 6.66 br d (8) 6.53 d (8) 
14 1.59 dd (14, 3) 1.87 dd (14, 2) 1.61 dd (14, 3) 
 2.37 ddd (14, 5, 3) 2.82 m 2.37 ddd (14, 5, 3) 
15 3.59 br s 3.65 br s 3.60 br s 
16 2.96 d (3) 3.03 d (3) 2.94 d (3) 
18 1.50 dd (7, 3) 1.57 dd (7, 2) 1.50 dd (7, 3) 
19 5.38 br q (7) 5.62 br q (7) 5.41 br q (7) 
21a 2.90 d (16) 3.82 m 2.94 d (16) 
21b 3.91 br d (16) 4.45 br d (13) 3.95 br d (16) 
N(1)-Me 2.63 s 2.82 s 2.65 s 
CO2Me 3.79 s 3.82 s 3.77 s 
10-OMe ‒ ‒ 3.73 s 










C NMR Spectroscopic Data for Cathafoline (35), Cathafoline N(4)-oxide 
(36), and 10-Methoxycathafoline (37)
a
 
C 35 36 37 
2 79.3 78.6 79.3 
3 47.4 69.8 47.5 
5 50.8 66.8 50.3 
6 31.2 29.3 30.1 
7 43.1 41.2 43.0 
8 140.5 138.3 141.5 
9 121.0 121.2 109.3 
10 119.4 120.1 153.7 
11 127.2 128.0 110.9 
12 109.4 110.2 109.8 
13 153.2 151.3 147.2 
14 33.9 31.5 36.6 
15 34.4 32.3 34.9 
16 52.9 51.5 52.7 
18 13.0 13.3 13.0 
19 119.2 124.1 120.0 
20 139.3 129.8 138.0 
21 54.9 72.4 54.7 
N(1)-Me 34.0 34.3 34.2 
CO2Me 51.5 51.8 51.5 
CO2Me 172.9 171.9 172.6 
10-OMe ‒ ‒ 55.8 










H NMR Spectroscopic Data for Strictamine (38), 11-Methoxystrictamine 
(39), and 11-Hydroxystrictamine (40)
a
 
H 38 39 40 
3 4.77 d (5) 4.71 d (5) 4.68 d (5) 
5 2.63 td (14, 5) 2.60 td (14, 5) 2.58 td (14, 5) 
 2.78 dd (14, 6) 2.75 dd (14, 6) 2.72 dd (14, 6) 
6 2.02 dd (14, 5) 1.99 dd (14, 5) 1.98 dd (14, 5) 
 3.73 td (14, 6) 3.67 td (14, 6) 3.67 td (14, 6) 
9 7.43 br d (8) 7.31 d (8) 7.23 d (8) 
10 7.18 td (8, 1) 6.72 dd (8, 2) 6.64 dd (8, 2) 
11 7.35 td (8, 1) ‒ ‒ 
12 7.64 br d (8) 7.20 d (2) 7.14 d (2) 
14 1.78 dd (14, 3) 1.75 dd (14, 3) 1.74 dd (14, 3) 
 2.70 ddd (14, 5, 3) 2.69 ddd (14, 5, 3) 2.67 ddd (14, 5, 3) 
15 3.53 br s 3.52 br s 3.50 br s 
16 2.09 d (3) 2.07 d (3) 2.09 d (3) 
18 1.57 dd (7, 3) 1.55 dd (7, 2) 1.54 dd (7, 2) 
19 5.55 br q (7) 5.53 br q (7) 5.50 br q (7) 
21a 3.18 d (17) 3.17 d (17) 3.12 d (17) 
21b 4.11 br d (17) 4.07 br d (17) 4.04 br d (17) 
CO2Me 3.73 s 3.72 s 3.72 s 
11-OMe ‒ 3.79 s ‒ 











C NMR Spectroscopic Data for Strictamine (38), 11-Methoxystrictamine 
(39), and 11-Hydroxystrictamine (40)
a
  
C 38 39 40 
2 189.4 189.5 191.9 
3 55.0 55.1 54.6 
5 51.8 51.6 51.7 
6 32.5 32.0 33.4 
7 55.9 55.3 55.4 
8 145.9 138.0 137.0 
9 123.4 123.6 123.8 
10 125.7 111.7 113.0 
11 128.2 160.3 157.6 
12 121.0 107.0 108.4 
13 155.3 156.8 156.0 
14 35.6 35.5 35.9 
15 32.2 32.0 32.2 
16 55.1 55.5 55.7 
18 12.9 13.0 12.9 
19 120.8 121.5 120.2 
20 136.5 135.5 137.3 
21 53.4 53.4 53.3 
CO2Me 51.6 51.7 51.5 
CO2Me 171.4 171.4 171.5 
11-OMe ‒ 55.6 ‒ 


















Position 41 42 
 δH δC δH δC 
2 – 97.7 – 94.8
3 1.66 m 20.4 1.77 m 26.2 
 2.29 m  2.45 ddd (15, 11, 2)  
5 2.73 ddd (11, 9, 2) 55.0 2.80 ddd (12, 9, 1) 54.3 
 3.38 td (11, 9)  3.62 m  
6 1.99 ddd (14, 9, 2) 40.9 2.07 m 40.5 
 2.47 ddd (14, 11, 9)  2.56 ddd (14, 11, 9)  
7 – 57.2 – 57.5 
8 – 138.5 – 137.4 
9 6.95 d (2) 112.2 6.93 d (2) 112.4 
10 ‒ 152.0 ‒ 153.4 
11 6.63 dd (8, 2) 111.3 6.60 dd (8, 2) 111.8 
12 6.19 d (8) 105.0 6.48 d (8) 109.6 
13 – 143.7 – 141.4 
14 1.77 m 26.3 1.86 m 26.3 
 1.77 m  1.86 m  
15 3.60 d (4) 34.7 3.67 d (5) 35.2 
16 2.80 d (2) 50.7 2.85 br s 50.3 
18 1.59 dd (7, 2) 13.5 1.60 dd (7, 2) 13.6 
19 5.40 br q (7) 122.3 5.46 br q (7) 124.0 
20 – 139.0 – 137.9 
21a 3.00 br d (15) 58.3 3.04 br d (15) 57.6 
21b 3.80 br d (15)  3.93 br d (15)  
N(1)-Me 2.58 s 27.9   
CO2Me 3.79 s 51.6 3.80 s 51.7 
CO2Me – 173.6 3.73 s 173.3 
10-OMe 3.73 s 56.0  55.9 












H NMR Spectroscopic Data for Alstonamide (43), Demethoxyalstonamide 
(44), and Alstomaline (45)
a 
H 43 44 45 
3 1.86 m 1.83 m 1.28 ddd (16, 10, 8) 
 2.37 ddd (15, 11, 3) 2.37 ddd (16, 11, 2) 2.75 m 
5 2.78 t (11) 2.79 dd (12, 9) 2.75 m 
 3.19 td (11, 9) 3.21 ddd (12, 11, 8) 2.75 m 
6 2.07 m 2.02 m 1.87 m 
 2.44 ddd (14, 11, 9) 2.56 ddd (14, 11, 9) 2.52 ddd (14, 11, 8) 
9 7.07 s 7.01 d (3) 6.54 d (2) 
10 ‒ ‒ - 
11 ‒ 6.74 dd (9, 3) 6.60 dd (10, 2) 
12 7.80 s 8.01 d (9) 7.38 d (10) 
14 1.86 m 1.83 m 1.87 m 
 1.98 m 2.02 m 1.87 m 
15 3.74 br s 3.71 br d (5) 3.79 m 
16 2.83 br s 2.83 br s 2.75 m 
18 1.61 dd (7, 2) 1.60 dd (7, 2) 1.64 dd (7, 2) 
19 5.44 br q (7) 5.44 br q (7) 5.44 q (7) 
21a 3.01 br d (15) 3.01 d (16) 3.02 d (16) 
21b 3.91 br d (15) 3.91 br d (16)  4.02 d (16) 
N(1)-CHO 8.48 s 8.50 s ‒ 
CO2Me 3.89 s 3.82 s 3.79 s 
10-OMe 3.83 s 3.78 s ‒ 
11-OMe 3.84 s ‒ ‒ 











C NMR Spectroscopic Data for Alstonamide (43), Demethoxyalstonamide 
(44), and Alstomaline (45)
a
 
C 43 44 45 
2 94.8 94.7 104.3 
3 26.3 26.3 27.6 
5 54.3 54.3 53.6 
6 41.6 41.3 40.8 
7 58.4 58.4 56.9 
8 132.5 139.8 159.0 
9 108.2 112.0 123.0 
10 148.6 157.0 188.9 
11 146.1 110.0 135.6 
12 100.8 117.0 133.8 
13 129.3 132.3 164.1 
14 27.8 27.7 26.5 
15 35.2 35.4 35.6 
16 51.8 49.9 50.2 
18 13.5 13.5 13.8 
19 123.1 123.2 123.7 
20 138.5 138.9 138.7 
21 58.0 58.0 59.0 
N(1)-CHO 160.0 160.0 ‒ 
CO2Me 50.4 51.8 51.9 
CO2Me 173.3 173.0 172.5 
10-OMe 56.1 55.6 ‒ 
11-OMe 56.3 ‒ ‒ 










H NMR Spectroscopic Data for Quaternine (46), Picrinine (47), and 12-
Demethoxytabernulosine (48)
a
   
H 46 47 48 
3 3.75 m 3.75 m 3.55 d (5) 
5 4.82 d (2) 4.82 d (2) 4.82 d (3) 
6 2.20 dd (14, 2) 2.20 dd (14, 2) 2.25 dd (14, 3) 
 3.37 d (14) 3.37 d (14) 3.40 br d (14) 
9 6.78 s 7.14 br d (8) 6.75 br s 
10 ‒ 6.79 td (8, 1) ‒ 
11 ‒ 7.09 td (8, 1) 6.63 m 
12 6.31 s 6.76 br d (8) 6.63 m 
14 1.79 dd (14, 3) 1.86 dd (14, 3) 1.84 dd (14, 2) 
 2.14 ddd (14, 5, 3) 2.15 ddd (14, 5, 3) 2.12 dt (14, 5) 
15 3.28 br s 3.28 br d (3) 3.27 br s 
16 2.39 d (3) 2.44 d (3) 2.45 d (3) 
18 1.48 dd (7, 2) 1.49 dd (7, 3) 1.44 dd (7, 2) 
19 5.41 br q (7) 5.40 qt (7, 2) 5.39 q (7) 
21 3.10 d (18) 3.09 d (18) 3.08 br d (18) 
 3.79 m 3.76 m 3.75 m 
N(1)-Me 2.94 s ‒ ‒ 
N(1)-H ‒ 4.77 s 4.87 br s 
CO2Me 3.65 s 3.66 s 3.66 s 
10-OMe 3.87 s ‒ 3.70 s 
11-OMe 3.76 s ‒ ‒ 












C NMR Spectroscopic Data for Quaternine (46), Picrinine (47), and 12-
Demethoxytabernulosine (48)
a
   
C 46 47 48 
2 109.2 109.2  
3 49.7 49.7 52.1 
5 87.2 87.2 87.4 
6 40.3 40.3 40.6 
7 50.6 51.4 51.6 
8 125.9 135.1 136.6 
9 110.3 125.1 112.0 
10 144.2 120.8 154.5 
11 149.6 127.9 113.0 
12 94.6 110.6 111.0 
13 143.2 147.6 141.5 
14 25.8 26.0 26.1 
15 31.1 31.0 31.2 
16 52.0 52.0 51.8 
18 12.7 12.7 12.8 
19 120.5 120.4 120.4 
20 135.9 136.1 136.4 
21 46.3 46.3 46.4 
N(1)-Me 29.8 ‒ ‒ 
CO2Me 51.4 51.8 51.6 
CO2Me 172.5 172.4 172.6 
10-OMe 56.2 ‒ 55.9 
11-OMe 57.0 ‒ ‒ 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.3.13 Affinisine (49), Affinisine oxindole (50), Normacusine B (51), Alstoumerine 
(52), Quebrachidine (53), Vincamajine (54), and Vincamajine 17-O-
veratrate (55)  
 





 normacusine B (51),
254,257
 and alstoumerine (52),
159,166,258
 while three 










spectra of these compounds are shown in Figures 2.62–2.68, the NMR spectroscopic 

































C NMR Spectroscopic Data for Affinisine (49) and Affinisine 
oxindole (50) 
Position 49 50 
 δH δC δH δC 
2 ‒ 139.5  181.4
3 4.17 dd (10, 2) 49.5 3.36 dd (10, 2) 63.0 
5 2.73 m () 54.5 3.31 dd (6, 3) 59.3 
6 2.59 br d (15) () 27.1 1.81 d (13) 44.4 
 3.02 dd (15, 5) ()  2.79 dd (13, 6)  
7 ‒ 103.7 – 56.4 
8 ‒ 127.4 – 129.9 
9 7.40 d (7.5) 118.2 7.37 br d (8) 126.7 
10 7.07 t (7.5) 118.9 7.10 td (8, 1) 121.8 
11 7.18 t (7.5) 121.0 7.32 td (8, 1) 128.4 
12 7.28 d (7.5) 108.8 6.84 br d (8) 108.0 
13 – 137.4 – 144.5 
14a 1.57 m 32.9 1.57 ddd (14, 10, 2) 28.7 
14b 2.10 td (11, 1.4)  2.18 ddd (14, 4, 2)  
15 2.73 m 27.5 2.89 br s 26.3 
16 1.73 m 44.3 2.05 m 48.0 
17 3.42 m 65.0 3.63 m 65.5 
 3.45 m  3.63 m  
18 1.59 d (6.5) 12.9 1.61 dt (7, 2) 12.5 
19 5.34 q (6.5) 116.8 5.32 br q (7) 115.2 
20 – 135.7 – 135.9 
21 3.49 m 56.3 3.78 m 48.9 
 3.58 m  3.78 m  
N(1)-Me 3.60 s 29.4 3.21 s 26.6 
















C NMR Spectroscopic Data for Normacusine B (51) and 
Alstoumerine (52) 
Position 51 52 
 δH δC δH δC 
2 – 138.2 – 139.4
3 4.08 dd (10, 2) 50.4 3.88 dd (10, 2) 48.6 
5 2.75 m 54.3 3.03 t (6) 56.4 
6 2.61 dd (15, 1) 27.0 2.69 d (15) 29.6 
 3.03 dd (15, 5)  3.12 dd (15, 6)  
7 – 104.8 – 102.5 
8 – 127.7 – 127.2 
9 7.44 br d (8) 118.1 7.48 br d (8) 118.1 
10 7.08 td (8, 1) 119.3 7.10 td (8, 1) 118.9 
11 7.13 td (8, 1) 121.4 7.19 td (8, 1) 121.0 
12 7.29 br d (8) 110.9 7.28 br d (8) 108.7 
13 – 136.3 – 137.4 
14a 1.68 m 33.5 1.61 m 38.7 
14b 1.97 ddd (12, 10, 2)  1.88 ddd (12, 10, 2)  
15 2.75 m 27.7 2.78 br s 29.2 
16 1.79 tdd (8, 6, 2) 44.3 1.61 m 44.4 
17 3.51 m 65.0 3.46 dd (12, 5) 64.6 
 3.51 m  3.62 dd (12, 4)  
18 1.60 dt (7, 2) 12.7 1.36 d (7) 22.3 
19 5.33 br q (7) 116.6 4.52 d (7) 67.3 
20 – 136.0 – 136.4 
21 3.51 m 56.0 6.54 d (1) 149.3 
 3.51 m  –  
N(1)-H 8.07 br s – ‒ – 
N(1)-Me – – 3.58 s 25.4 


















H 53 54 55 
2 3.82 br s 3.23 d (5) 3.27 d (5) 
3 3.45 m 3.55 dd (10, 5) 3.60 dd (9, 5) 
5 3.54 d (5) 3.57 d (5) 3.69 d (5) 
6 1.73 d (12) 1.76 d (12) 1.88 d (11) 
 2.63 dd (12, 5) 2.58 dd (12, 5) 2.72 d (11) 
9 7.18 br d (8) 7.12 dd (8, 1) 6.87 br d (7) 
10 6.81 td (8, 1) 6.77 td (8, 1) 6.53 t (7) 
11 7.12 td (8, 1) 7.14 td (8, 1) 7.11 t (7) 
12 6.78 br d (8) 6.63 dd (8, 1) 6.67 br d (7) 
14 1.44 dd (14, 10) 1.49 dd (14, 10) 1.59 td (12, 4) 
 2.56 dd (14, 5) 2.42 dd (14, 5) 2.72 br d (12) 
15 3.45 m 3.46 d (5) 3.55 d (4) 
17 4.29 s 4.02 s 5.91 br s 
18 1.59 dt (7, 2) 1.57 br d (7) 1.55 d (7) 
19 5.26 br q (7) 5.26 br q (7) 5.29 br q (7) 
21 3.45 m 3.44 m 3.50 br s 
 3.45 m 3.44 m 3.50 br s 
N(1)-Me ‒ 2.61 s 2.68 s 
CO2Me 3.70 s 3.67 s 3.39 s 
2' – – 7.39 d (2) 
5' – – 6.88 br d (8) 
6' – – 7.55 dd (8, 2) 
3'-OMe – – 3.90 s 
4'-OMe – – 3.94 s 



















C 53 54 55 
2 68.5 74.4 74.9 
3 54.6 53.1 53.2 
5 61.6 61.6 61.6 
6 35.6 35.2 36.7 
7 57.8 57.0 56.3 
8 129.6 130.1 128.7 
9 124.8 128.2 123.5 
10 119.6 119.1 119.0 
11 128.2 124.4 128.5 
12 110.9 109.0 109.1 
13 151.7 154.4 154.2 
14 22.3 21.8 21.8 
15 30.3 30.0 30.2 
16 59.6 59.4 59.1 
17 74.3 74.5 75.9 
18 12.8 12.8 12.6 
19 116.4 116.5 116.8 
20 136.8 136.5 136.5 
21 55.3 55.2 55.5 
N(1)-Me ‒ 34.2 34.2 
CO2Me 51.6 51.5 51.6 
CO2Me 173.3 173.0 172.2 
1' – – 122.1 
2' – – 111.9 
3' – – 148.6 
4' – – 153.0 
5' – – 110.3 
6' – – 123.2 
3'-OMe – – 55.9 
4'-OMe – – 55.9 
–C=O – – 163.8 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.4 Corynantheine alkaloids 
 
2.1.4.1 Sitsirikine (56), 16(R),19(E)-Isositsirikine (57), 18,19-Dihydroisositsirikine 
(58), Pleiocarpamine (59), 16-Hydroxymethylpleiocarpamine (60), 
Pleiomaltinine (61), Picramicine (62), Fluorocarpamine (63), Yohimbine 
(64), Talpinine (65), and 10,11-Dimethoxynareline (66) 
 




























H NMR spectra of these compounds are shown 
in Figures 2.69–2.79. The 1H and 13C NMR data are summarized in Tables 2.36–2.42, 





















H NMR Spectroscopic Data for Sitsirikine (56), 16(R),19(E)-Isositsirikine 
(57) and 18,19-Dihydroisositsirikine (58)
a
 
H 56  57 58 
3 3.04 br d (12) 4.33 br s 2.98 m 
5 2.50 m 3.15 m 2.44 m 
 2.95 m 3.27 ddd (13, 6, 2) 2.98 m 
6 2.70 dd (14, 5) 2.67 dd (16, 6) 2.69 dd (14, 5) 
 2.95 m 2.99 m 2.98 m 
9 7.46 br d (8) 7.47 br d (8) 7.45 br d (8) 
10 7.08 td (8, 1) 7.10 td (8, 1) 7.07 td (8, 1) 
11 7.13 td (8, 1) 7.16 td (8, 1) 7.12 br t (8) 
12 7.28 br d (8) 7.39 br d (8) 7.27 br d (8) 
14 1.35 q (12) 2.24 m 1.36 m 
 2.19 dt (12, 3) 2.24 m 2.13 br d (12.5) 
15 1.66 br t (12) 3.15 m 1.56 m 
16 2.50 m 2.52 ddd (11, 8, 5) 2.98 m 
17 1.99 t (11) 3.54 m 3.69 dd (11, 6) 
 2.88 dd (11, 4) 3.54 m 3.96 dd (11, 7) 
18 5.17 dd (10, 2) 1.66 dd (7, 2) 0.90 t (8) 
 5.21 dd (17, 2)   
19 5.52 dt (17, 10) 5.65 br q (7) 1.15 m 
 ‒  1.68 m 
20 2.95 m ‒ 1.68 m 
21 3.71 dd (11, 6) 2.98 d (13) 1.78 t (11) 
 3.91 dd (11, 7) 3.54 m 2.98 m 
N(1)-H 8.36 br s 8.81 br s 8.42 br s 
CO2Me 3.62 s 3.81 s 3.61 s 
















C NMR Spectroscopic Data for Sitsirikine (56), 16(R),19(E)-Isositsirikine 
(57), and 18,19-Dihydroisositsirikine (58)
a
 
C 56 57 58 
2 134.3 133.8 134.5 
3 59.5 52.8 59.9 
5 52.6 51.3 53.1 
6 21.5 17.7 21.6 
7 107.8 107.7 108.0 
8 127.2 127.6 127.4 
9 118.1 118.0 118.2 
10 119.4 119.5 119.4 
11 121.4 121.6 121.4 
12 111.1 111.3 111.0 
13 136.1 136.2 136.2 
14 31.6 30.2 32.2 
15 40.1 32.6 40.5 
16 44.5 49.6 47.6 
17 60.7 62.1 62.1 
18 118.2 13.3 10.8 
19 138.3 123.7 23.2 
20 48.1 133.7 39.6 
21 61.6 52.5 60.2 
CO2Me 51.7 52.2 51.9 
CO2Me 174.7 175.4 174.4 












H NMR Spectroscopic Data for Pleiocarpamine (59), 16-
Hydroxymethylpleiocarpamine (60) and Pleiomaltinine (61)
a
 
H 59 60 61 
3 3.84 m 3.77 m 3.19 m 
5 2.28 m 2.26 ddd (13, 9, 7) 2.86 m (a) 
 3.35 ddd (13, 10, 3) 3.37 ddd (13, 10, 3) 3.15 m (b) 
6 2.66 ddd (16, 10, 6) 2.65 m 1.45 dt (14.4, 2) ()  
 3.14 ddd (16, 9, 3) 3.16 ddd (16, 9, 3) 2.32 td (14.4, 4) () 
9 7.53 m 7.55 m 7.08 br d (7.8) 
10 7.09 m 7.10 m 6.82 td (7.8, 1) 
11 7.09 m 7.10 m 7.06 td (7.8, 1) 
12 6.94 m 7.10 m 6.30 br d (7.8) 
14 2.19 ddd (13, 3, 2) 2.05 ddd (14, 4, 2) 1.74 dt (13, 3.6) () 
 2.49 ddd (13, 3, 2) 2.65 m 2.83 m () 
15 3.51 br s 3.77 m 3.37 q (3.6) 
16 5.21 d (4) ‒ 4.79 d (3.6) 
17 ‒ 4.24 d (12) ‒ 
 ‒ 4.54 d (12) ‒ 
18 1.47 dd (7, 2) 1.52 dd (7, 2) 1.59 dd (6.8, 2) 
19 5.30 qd (7, 2) 5.30 qd (7, 2) 5.42 qd (6.8, 2) 
21 1.73 br d (13) 1.87 dt (13, 2) 3.04 d (12.4) () 
 2.59 d (13) 2.65 m 4.27 dt (12.4, 2) () 
CO2Me 3.56 s 3.32 s 3.73 s 
5' ‒ ‒ 6.20 d (5.6) 
6' ‒ ‒ 7.53 d (5.6) 
7' ‒ ‒ 3.20 m 
 ‒ ‒ 3.20 m 














C NMR Spectroscopic Data for Pleiocarpamine (59), 16-
Hydroxymethylpleiocarpamine (60) and Pleiomaltinine (61)
a
 
C 59 60 61 
2 136.8 137.2 95.7 
3 50.5 50.5 50.3 
5 49.8 49.5 47.4 
6 20.6 20.6 31.6 
7 107.9 108.7 44.9 
8 128.5 128.8 134.1 
9 118.2 118.3 120.5 
10 119.8 120.2 119.8 
11 120.5 121.0 127.6 
12 112.2 112.1 110.6 
13 137.4 139.0 146.7 
14 28.4 25.4 27.2 
15 33.6 33.4 31.6 
16 61.1 68.5 57.3 
17 ‒ 66.0 ‒ 
18 12.4 12.6 12.2 
19 122.7 122.2 119.1 
20 133.1 134.6 134.9 
21 56.4 56.6 52.9 
CO2Me 51.8 51.5 51.8 
CO2Me 169.0 173.1 170.0 
2' ‒ ‒ 146.3 
3' ‒ ‒ 142.5 
4' ‒ ‒ 171.6 
5' ‒ ‒ 115.8 
6' ‒ ‒ 152.6 
7' ‒ ‒ 26.6 















C NMR Spectroscopic Data for Picramicine (62) and 
Fluorocarpamine (63)
a                                          
Position 62 63 
 H C H C 
2 ‒ n.d ‒ 76.0 
3 3.15 m 63.6 3.51 br s 61.8 
5 2.95 m 50.2 2.99 m 55.0 
 3.15 m  2.99 m  
6 1.41 ddt (14, 7, 2) 19.7 2.21 dd (12, 6) 39.0 
 1.88 m  2.99 m  
7 2.95 m 38.7 ‒ 205.2 
8 ‒ 134.9 ‒ 120.4 
9 7.14 br d (8) 123.3 7.62 d (8) 124.1 
10 6.71 td (8, 1) 118.6 6.90 t (8) 119.5 
11 7.01 td (8, 1) 126.9 7.51 t (8) 137.2 
12 6.16 br d (8) 108.3 6.70 d (8) 111.1 
13 ‒ 148.4 ‒ 163.6 
14 1.88 m  32.7 1.37 dt (13, 3) 24.9 
 2.05 dt (13, 3)  1.91 dt (13, 3)  
15 3.28 q (3) 32.1 3.64 br d (9) 30.5 
16 4.05 d (3) 60.9 4.56 d (9) 63.0 
18 1.57 dd (7, 2) 12.3 1.63 d (6) 12.3 
19 5.44 qd (7, 2) 120.1 5.50 br q (6) 121.0 
20 ‒ 134.9 ‒ 133.9 
21 3.03 d (12) 53.6 3.31 d (14) 53.4 
 4.37 dt (12, 2)  3.38 br d (14)  
CO2Me 3.71 s 51.8 3.72 s 51.8 
CO2Me ‒ 170.6 ‒ 172.5 














H 64 65 66 
3 3.27 br d (11) () 4.22 dd (10, 2.5) 4.59 t (3) 
5 2.58 td (11, 4) () 3.52 br t (5) 4.28 br s 
5 3.06 dd (11, 5) ()   
6 2.70 dd (15, 4) () 2.64 d (15.6) () 3.72 m 
6 2.98 m () 3.22 dd (15.6, 5) ()  
9 7.45 br d (7.6) 7.46 br d (7.5) 7.33 s 
10 7.06 br t (7.6) 7.08 td (7.5, 1) ‒ 
11 7.11 br t (7.6) 7.19 td (7.5, 1) ‒ 
12 7.29 br d (7.6) 7.28 br d (7.5) 7.27 s 
14 1.33 m () 1.33 ddd (12, 4, 2.5) () 2.07 dt (14, 3) 
14 2.04 m () 1.85 br t (12) () 2.33 dt (14, 3) 
15 2.01 m 1.89 br d (2) 3.35 q (3) 
16 2.31 br d (12) 1.24 m 2.26 d (3) 
17 4.22  br s () 3.45 dd (11, 1) () ‒ 
  3.68 d (11) () ‒ 
18 1.55 m 1.29 d (7) 1.70 d (7) 
 1.97 m   
19 1.40 m 4.05 q (7) 5.80 q (7) 
 1.55 m   
20 1.55 m 1.30 m ‒ 
21 2.19 t (11) 4.72 br d (2) 4.10 d (3) 
 2.91 br d (11)   
N(1)-H 8.17 br s ‒ ‒ 
N(1)-Me ‒ 3.57 s ‒ 
CO2Me 3.79 s ‒ 3.72 s 
10-OMe ‒ ‒ 3.90 s 
11-OMe ‒ ‒ 3.94 s 














C 64 65 66 
2 134.6 138.9 183.1 
3 60.0 40.1 62.4 
5 52.9 49.8 100.2 
6 21.7 26.2 55.9 
7 108.1 103.3 55.5 
8 127.4 127.2 131.2 
9 118.2 118.3 108.7 
10 119.4 118.9 147.4 
11 121.4 120.9 149.7 
12 110.9 108.7 104.3 
13 136.1 137.5 150.7 
14 34.2 31.9 35.1 
15 36.7 23.2 31.3 
16 52.1 35.2 53.9 
17 67.1 63.9 ‒ 
18 31.6 15.7 12.6 
19 23.4 72.5 122.7 
20 40.2 43.7 130.6 
21 61.3 87.9 65.5 
N(1)-Me ‒ 29.2 ‒ 
CO2Me 52.3 ‒ ‒ 
CO2Me  ‒ ‒ 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.5 Strychnan Alkaloids 
 
2.1.5.1 11-Methoxyakuammicine (67) and 11-Methoxyakuammicine N(4)-oxide 
(68) 
Two known strychnan alkaloids belonging to this group, viz., 11-methoxyakuammicine 
(67)
181,266
 and 11-methoxyakuammicine N(4)-oxide (68)
164
 were isolated in this study. 
The 
1
H NMR spectra of these compounds are shown in Figures 2.80 and 2.81, and the 










Position 67  68  
 H C H C 
2 ‒ 167.5 ‒ 164.7 
3 4.12 br s 61.8 4.29 br s 78.3 
5 3.06 dd (12, 6) 55.7 3.71 m 69.9 
 3.37 td (12, 6)  3.99 m  
6 1.87 dd (12, 6) 45.6 1.93 dd (14, 7) 41.7 
 2.53 td (12, 6)  2.47 td (14, 7)  
7 ‒ 56.5 ‒ 54.1 
8 ‒ 128.8 ‒ 126.8 
9 7.14 d (8) 121.2 7.41 d (8.5) 121.9 
10 6.43 dd (8, 2) 105.5 6.40 dd (8.5, 2) 106.0 
11 ‒ 160.3 ‒ 160.9 
12 6.43 d (2) 97.0 6.37 d (2) 97.5 
13 ‒ 144.5 ‒ 144.1 
14 1.34 dt (14, 3) 29.4 1.37 br d (14) 27.9 
 2.44 ddd (14, 3, 2)  2.75 br d (14)  
15 3.96 br s 30.5 3.97 br s 28.5 
16 ‒ 101.6 ‒ 102.0 
18 1.67 dt (7, 1) 13.0 1.58 d (6.8) 13.6 
19 5.42 br q (7) 122.4 5.55 br q (6.9) 127.1 
20 ‒ 137.4 ‒ 133.3 
21 3.03 d (14) 56.4 3.99 d (14.5) 74.0 
 3.98 br d (14)  4.19 d (14.5)  
N(1)-H 8.95 s ‒ 8.85 s ‒ 
CO2Me 3.81 s 51.1 3.75 s 51.4 
CO2Me ‒ 167.7 ‒ 167.2 
11-OMe 3.78 s 55.5 3.70 s 55.6 




















































































































































































































































































































































































































2.1.6 Miscellaneous Monoterpene Indole Alkaloids 
 
2.1.6.1 Antirhine (69) and 1,2,3,4-Tetrahydro-1-oxo--carboline (70) 
 
Two known monoterpene indole alkaloids isolated in this study are antirhine (69)
267
 and 
1,2,3,4-tetrahydro-1-oxo--carboline (70).268,269 The 1H NMR spectra of these 







































Position 69  70  
 H C H C 
2 ‒ 133.2 ‒ 126.3 
3 4.15 br s 54.2 ‒ 163.6 
5 3.03 m  51.5 3.71 td (7, 2.5) 42.2 
 3.21 m    
6 2.64 m 18.0 3.06 t (7) 20.9 
 3.03 m    
7 ‒ 107.0 ‒ 120.1 
8 ‒ 127.2 ‒ 125.3 
9 7.47 br d (7.5) 117.7 7.58 br d (8) 120.4 
10 7.09 td (7.5, 1) 119.0 7.13 td (8, 1.5) 120.3 
11 7.14 td (7.5, 1) 121.0 7.29 td (8, 1.5) 125.3 
12 7.33 br d (7.5) 110.9 7.48 br d (8) 112.8 
13 ‒ 135.8 ‒ 137.6 
14 1.90 m 31.2 ‒ ‒ 
 2.05 m    
15 1.54 m 31.1 ‒ ‒ 
16 1.47 m 28.6 ‒ ‒ 
 1.72 m    
17 2.62 m 46.6 ‒ ‒ 
 2.76 ddd (12, 9, 4)    
18 5.16 dd (17, 1.5) 117.7 ‒ ‒ 
 ‒    
19 5.22 dd (10, 1.5) 138.3 ‒ ‒ 
 5.60 ddd (17, 10, 9)    
20 2.24 m 49.6 ‒ ‒ 
21 3.59 dd (10.5, 7) 63.3 ‒ ‒ 
 3.74 dd (10.5, 4.5)    
N(1)H 8.03 br s ‒ 10.12 s ‒ 
N(4)H ‒ ‒ 6.37 s ‒ 




























































































































































































































































































































































































































2.1.7 Bisindole Alkaloids 
 
2.1.7.1 Linearly Fused Bisindole Alkaloids 
 
Four new linearly-fused bisindole alkaloids, lumutinines A–E (71–75),127,258 were 
isolated from the stem-bark extract of Alstonia macrophylla. Lumutinines A and B (71 
and 72) represent the first examples of linear, ring A/F-fused macroline-macroline type 
bisindoles, while lumutinines C‒E (73‒75) were constituted from the union of 
macroline and sarpagine moieties. 
 
 




 was obtained as a light yellowish oil with []25D +160 (c 0.4, 
CHCl3). The IR spectrum showed bands at 1617 and 1651 cm
-1
 due to the presence of 
an ,-unsaturated carbonyl group, while the UV spectrum showed absorption maxima 
at 210, 233, 254 (sh), and 283 nm, showing the presence of indole chromophores and an 
,-unsaturated carbonyl moiety. The ESIMS of 71 showed a [M + H]+ peak at m/z 673, 
which analyzed for C42H48N4O4 + H. The 
13
C NMR spectrum (Table 2.45) showed a 
total of 42 resonances, comprising six methyl, seven methylene, 16 methine, and 13 
quaternary carbon atoms, in agreement with the molecular formula. The observed 
quaternary carbon resonance at  196.4, and the olefinic carbon signals at 121.4 and 
158.1, are consistent with the presence of the ,-unsaturated carbonyl group, while the 
unusually low field resonance of the -carbon at 158.1 indicated oxygen substitution.  
The 
1
H NMR spectrum (Table 2.45; Figure 2.89) showed the presence of four aromatic 








singlets ( 6.76, 6.98) associated with another indole moiety substituted at C-10' and C-
11', a vinylic singlet at  7.58 associated with a trisubstituted double bond, a total of six 
methyl singlets, corresponding to two N1-Me ( 3.54, 3.55), two N4-Me ( 2.27, 2.29), 
one acetyl methyl ( 2.15, 18'-Me), and a methyl attached to a quaternary carbon ( 1.38, 
18-Me). Since only six aromatic hydrogens were observed and both indolic nitrogens 
are substituted, it can be inferred from the observation of the two H-9' and H-12' 
aromatic singlets, that the bisindole is branched from C-10' and C-11' of one monomeric 
unit. Furthermore, the observed NOE between the aromatic singlet at  6.76 and the N1-
Me' singlet at  3.54 allowed this aromatic singlet and the one at  6.98 and to be 
assigned to H-12' and H-9', respectively. The observation of the low field vinylic singlet 
at  7.58 (H-21') with the associated acetyl methyl singlet at  2.15, indicated this 
10',11'-branched monomer to be a type-B macroline.
118





NMR data with the help of 2-D COSY and HSQC experiments indicated that this type-
B macroline corresponded to a 10,11-substituted alstonerine,
133,158,164 
with C-11' 
carrying some form of oxygenation as deduced from the observed 
13
C NMR shift of this 
carbon at  150.3 and the observed correlation from H-9' to this carbon (C-11') in the 
HMBC spectrum. 
The other unit of the bisindole, after discounting the signals due to the substituted 
alstonerine half, corresponded to that of another macroline derivative with an 
unsubstituted indole moiety. The C-17 oxymethylene hydrogens were observed as a 
doublet of doublets at  3.69 and a triplet at  4.67, while the 18-methyl singlet was 
observed at  1.38. The C-19 resonance at  99.5 indicated attachment to two oxygen 
atoms while the methine H-20 was seen as a multiplet at  1.93. These features 
corresponded to a pentacyclic macroline alkaloid with a saturated ring E (for example, 








bond correlation from the 18-methyl hydrogens to C-20. The observed NOE between 
18-Me and H-20 requires a cis-orientation (Figure 2.84). In addition, an NOE was also 
observed between 18-Me and H-21, which in turn facilitated the assignment of the 
orientation of both 18-Me and H-20 as . Examination of models showed that had the 
orientation of 18-Me and H-20 been , NOE would have been impossible between 18-
Me and both the C-21 hydrogens. This mode of ring E/F fusion is also seen in the 
spirocyclic macrodasines
124
 and macralstonidine (76, vide infra).  
Of the two oxygens linked to C-19, one was also attached to C-17 (C-19OC-17 
connection) from the observed three-bond correlation from H-17 to C-19 in the HMBC 
spectrum, while the other was attached to the aromatic C-11', from its observed 
downfield shift at  150.3, which had been previously noted (vide supra). Connection 
from the ring E C-20 of the upper macroline unit to C-10' of the lower half was 
mediated via a methylene bridge (C-21), as shown by the observed H-21 to C-9' and C-
11' three-bond correlations in the HMBC spectrum, while that from C-19 to C-11' was 
via an oxygen atom. These observations revealed the mode of union of the two 
macroline halves, which from a biogenetic viewpoint (vide infra) can be considered as 
comprising a macroline (443) and an 11'-hydroxy- or 11'-methoxyalstonerine 
(alstophylline) (7). The structure is entirely consistent with the full HMBC as well as 


























2.1.7.1.2 Lumutinine B (72) 
 
The second bisindole, lumutinine B (72),
258
 was obtained as a light yellowish oil with 
[]25D 11 (c 0.5, CHCl3). As in the case of 71 the IR spectrum showed similar bands at 
1616 and 1651 cm
-1
, while the UV spectrum (210, 232, 255, and 285 nm) was also 
similar to that of 71. The ESIMS of 72 showed a [M + H]
+
 peak at m/z 673, which 




C NMR data (Table 2.46; Figure 2.90) showed the presence of similar 
functionalities as in 72, such as an unsubstituted indole moiety ( 7.09–7.49), another 
indole moiety substituted at C-11' and C-12' from the presence of a pair of AB doublets 
at  6.66 and 7.16, a vinylic singlet at  7.55 associated with a trisubstituted double 
bond, an ,-unsaturated carbonyl moiety (C 195.9, 121.3, and 157.9; H 2.12), and six 
methyl singlets, corresponding to two N1-Me, two N4-Me, one acetyl methyl, and a 
methyl attached to a quaternary carbon (18-Me). Thus, except for the aromatic AB 
doublets in place of the two aromatic singlets, and overall, small differences in the 
chemical shifts of the other signals, the NMR data bear a close resemblance to those of 
71, indicating the presence of the same two constituent units.  
The HMBC and NOE data, however, showed significant differences, indicating a 
different mode of union of the two halves (Figure 2.85). In the case of 72, a three-bond 
correlation from H-10' to the quaternary C-12' was observed in the HMBC spectrum. 
The observed NOE from the aromatic doublet at  7.16 to both the H-6' signals allowed 
this doublet to be assigned to H-9' and the other doublet at  6.66 to H-10'. This was in 
contrast to compound 71 where a three-bond correlation was observed from H-12'to the 
quaternary C-10'. In addition, in 72, three-bond correlations were observed from H-21 
and H-9' to C-11' ( 149.6, oxygenated) and C-13', indicating C-12' to be a branching 








correlations were observed from H-21 to C-11' (oxygenated) and C-9', indicating C-10' 
to be the branching point. These observations, therefore, indicated that in 72, the 
bisindole is branched at C-11' and C-12'. The branching from C-11' is mediated by a 
ketalic oxygen atom, while that from C-12' is mediated by a methylene (C-21). This 
difference in the mode of attachment of the two monomeric units was further supported 
by the NOE’s observed for N1-Me'/H-21 and N1-Me'/H-14 (Figure 2.85). Bisindoles 71 
and 72 are, therefore, regioisomers constituted from the union of similar macroline 
moieties, but differing in the mode of union of these moieties.  
 
 




















 was obtained as a light yellowish oil with []25D +84 (c 0.32, 
CHCl3). The IR spectrum showed an absorption band at 3360 cm
-1
 due to the presence 
of an OH group, while the UV spectrum showed absorption maxima at 208, 228, and 
284 nm, consistent with an indole chromophore. The ESIMS of 73 showed a [M + H]
+
 
peak at m/z 661, which analyzed for C41H48N4O4 + H. The 
13
C NMR spectrum (Table 
2.47) showed a total of 41 resonances, comprising five methyl, seven methylene, 17 
methine, and 12 quaternary carbon atoms, in agreement with the molecular formula. Of 
these, two were oxymethylenes ( 62.3, C-17; 64.5, C-17'), one an oxymethine ( 67.3, 
C-19'), and another, a quaternary carbon linked to two oxygen atoms ( 99.0, C-19). 
The olefinic carbon signals at 136.1 and 149.3 are consistent with the presence of 
trisubstituted double bond and the resonance at  136.1 is consistent with the presence 
of an N-substituted sp
2
 methine (C-21') with the corresponding hydrogen shift observed 
as a downfield singlet at  6.44.  
The 
1
H NMR spectrum (Table 2.47; Figure 2.91) showed the presence of four aromatic 
hydrogens ( 7.10–7.50) associated with an unsubstituted indole moiety, a pair of 
aromatic doublets ( 6.71, 7.01) associated with another indole moiety substituted at C-
9' and C-10', a vinylic singlet at  6.44 associated with a trisubstituted double bond, four 
methyl singlets, corresponding to two N1-Me, one N4-Me, and a methyl attached to a 
quaternary carbon (18-Me). In addition, a hydroxyethyl side chain was present from the 
characteristic signals at  1.34 (d, 3H) and 4.46 (q, 1H). The observed NOE (Figure 
2.86) between the aromatic doublet at  7.01 and the N1-Me' signal at  3.48 permitted 
the assignment of this signal to H-12'and the other aromatic doublet at  6.71 to H-11'. 








the aromatic ring is vicinally substituted, differs from 72 from the viewpoint of the 
actual site of aromatic substitution. In 72, the bisindole is branched at C-11' and C-12' 
with C-11' ( 149.6) being the site of oxygenation, whereas in 73, the bisindole is 
branched at C-9' and C-10' with C-10' ( 147.7) being the site of oxygenation. 
Examination of the NMR data showed that the monomeric unit corresponding to the 
upper half and incorporating the unsubstituted indole moiety, corresponded to the same 
macroline-derived moiety present in the previous two compounds. In the case of 73, 
therefore, the bisindole is branched at C-9' and C-10' of the lower monomeric unit, with 
C-9' connected to the upper ring E via a methylene bridge (C-21), and C-10' connected 
via an oxygen atom to C-19. This conclusion was supported by the HMBC data (Figure 
2.86), in particular, the observed three-bond correlations from H-21 to C-8' and to the 
oxygenated C-10', from H-11' to C-9', and from H-12' to C-10'. 
After discounting the upper macroline-derived half, the monomeric unit corresponding 
to the lower half was deduced from the NMR data to comprise an alkaloid of the 
sarpagine type, specifically, a 10-hydroxy- or 10-methoxyalstoumerine (444). 
Comparison of the NMR data with that reported for alstoumerine (52)
159,233
 showed a 
general agreement for the non-indole portion of the molecule, providing support for 
such a conclusion.  
In lumutinine C (73), the resonance due to H-16' was observed at  1.55, while the 
resonance due to the C-17' oxymethylene hydrogens were seen at  3.42 and 3.61. 
These values were similar to those in alstoumerine (52) and require H-16' to be directed 
towards the indole moiety (16R). In addition to the chemical shift considerations 
mentioned above, the 16R configuration of 73 was further confirmed by NOE 
experiments, which showed strong NOE between H-16 and H-6, requiring H-16 to be 








configuration C-19 as S followed those in alstoumerine (52), which was confirmed by 

























 was isolated as a light yellowish oil with []25D +209 (c 0.4, 
CHCl3). The IR spectrum showed an OH absorption band at 3370 cm
-1
 and the UV 
spectrum indicated the presence of an indole chromophore (209, 231, 290 nm). The 
ESIMS of 74 showed a [M + H]
+
 peak at m/z 645, which analyzed for C41H48N4O3 + H. 
The 
13
C NMR spectrum (Table 2.48) showed a total of 41 resonances (five methyl, 
eight methylene, 16 methine, and 12 quaternary carbon atoms). The 
1
H NMR spectrum 
(Table 2.48; Figure 2.92) showed signals associated with the same macroline-derived 
upper monomeric unit common to bisindoles 7173, such as those due to the four 
aromatic hydrogens of an unsubstituted indole moiety ( 7.10–7.49), three methyl 
singlets corresponding to N1-Me, N4-Me, and 18-Me (attached to a quaternary carbon), 
an oxymethylene due to the C-17 hydrogens, and another methylene due to the 
hydrogens of the C-21 methylene bridge. The remaining discernable signals included 
the two aromatic singlets ( 6.85, 6.91) associated with another indole moiety 
substituted at C-10' and C-11', a methyl singlet corresponding to N1-Me', a methyl 
doublet ( 1.63) and the associated vinylic quartet ( 5.40) due to an ethylidene side-
chain (H-19'/H-21' and H-18'/H-15' NOEs (Figure 2.87) indicated that the geometry of 
the 19', 20'-double bond is E), and an oxymethylene (C 64.8, H 3.48, 3.53) associated 
with a hydroxymethyl group. These features suggested the presence of another 
sarpagine unit. Examination of the NMR data and comparison with the literature, 
revealed this lower unit to be a 10-hydroxy(or 10-methoxy)affinisine (445).
131,133
 The 
observed shift of H-16' at  1.82 and the observed H-16'/H-6' NOE, are consistent with 
the assigned 16R configuration.  
The mode of union of the two units can be inferred from the NOE and HMBC data 








singlet at  6.85 and the N1-Me' singlet at  3.56 allowed this aromatic singlet to be 
assigned to H-12' and the other at  6.91 to be assigned to H-9'. The three-bond 
correlation from H-12' to the oxygenated carbon at  148.3 in the HMBC spectrum 
(Figure 2.87) facilitated the assignment of this quaternary aromatic signal to C-10'. The 
three-bond correlation from the C-21 methylene bridge hydrogens to C-10' and C-12' 
indicated direct attachment of C-21 to C-11'. These observations revealed the bridging 
of the affinisine moiety at C-11' to C-21 and at C-10', via an oxygen atom, to C-19. It 
transpires that the structure of lumutinine D (74) deduced from the NMR data 
corresponded to a regioisomer of the known bisindole, macralstonidine (76),
145,171
 
differing from 7 in the mode of union of the same constituent monomeric moieties, i.e., 
C-11' to C-21, C-10' to C-19–O in lumutinine D (74), c.f., C-9' to C-21, C-10' to C-19–












A plausible origin of these linearly-fused bisindoles (illustrated for lumutinine A (71), 
Scheme 2.1)
118
 derives from Michael addition of the electron-rich C-10' of 11'-
hydroxyalstonerine or alstophylline (7) onto macroline (443) to give the hydroxyketone 
446, which on subsequent ring closure via hemiketal formation, followed by 
ketalization, yields lumutinine A (71). The formation of lumutinine B (72) from attack 
of C-12' of 7, lumutinine C (73) from attack of C-9' of 444, and lumutinine D (74) from 
attack of C-11' of 445, follows a similar pathway. While the linear, ring A/F-fused 
macroline-sarpagine type bisindoles similar to 73 and 74 are known, this is the first 
report of linear, ring A/F-fused macroline-macroline type bisindoles (71 and 72).
103,115




























 was isolated as a light yellowish oil, []D 74 (c 0.14, CHCl3). 
The UV spectrum showed absorption maxima at 229 and 284 nm, indicating the 
presence of an indole chromophore, while the IR spectrum showed a broad band at 3380 
cm
-1
 due to NH and OH groups. The EI-mass spectrum showed a molecular ion at m/z 
630, which was also the base peak, with a peak due to loss of CH2OH observed at m/z 
599. HREIMS measurements gave the molecular formula C40H46N4O3 (DBE 20).  
The 
13
C NMR spectrum (Table 2.49) showed a total of 40 carbon signals, comprising 
four methyl, eight methylene, 16 methine, and 12 quaternary carbon atoms. 




C NMR spectroscopic data with the aid of COSY, HMQC, 
and HMBC data confirmed the presence of macroline and sarpagine units. Thus the 
1
H 
NMR spectrum (Table 2.49; Figure 2.93) of 75 showed the presence of an indolic NH 
( 7.95, sarpagine), an unsubstituted indole ring ( 7.117.51, macroline), another 
indole ring substituted at C-9' and C-10' ( 6.65,  6.97, sarpagine), a hydroxymethyl ( 
3.43, sarpagine), and three methyl singlets, corresponding to N1-Me, N4-Me, and Me-
18, associated with a macroline moiety ( 3.41, 2.27, and 1.37, respectively).  
The aromatic-H resonances of the sarpagine unit were observed as a pair of AB doublets 
at  6.65 and 6.97 (J = 8.6 Hz), due to a pair of ortho-coupled aromatic hydrogens, 
suggesting branching of the bisindole from C-9' and C-10' of the sarpagine half. The 
observed interaction between the indolic NH and the aromatic doublet at  6.97 in the 
NOESY spectrum (Figure 2.88) allowed assignment of this resonance to H-12' and the 
other doublet at  6.65 to H-11'. The oxygenated aromatic carbon resonance at  147.6 
was assigned to C-10' of the sarpagine unit, based on comparison of the aromatic carbon 
resonances with those of N1-methylsarpagine and 10-methoxyaffinisine.
131,133
 The 








two oxygen atoms. One of the oxygen atoms was also linked to C-17 of the macroline 
unit (C-19OC-17 connection), which was supported by the observed three-bond 
correlation from H-17 to C-19 in the HMBC spectrum (Figure 2.88), whereas the other 
was linked to C-10' of the sarpagine unit, which was consistent with the molecular 
formula as well as the carbon chemical shift of C-10' ( 147.6). Further proof of the C-
19OC-10' connection was provided by the observed interaction between H-11' and 
18-Me in the NOESY spectrum. The connection from C-9' of the sarpagine unit to C-21 
of the macroline unit, was inferred from the observed three-bond correlation from H-21 
to C-10' in the HMBC spectrum. This was further confirmed by the observed interaction 
between H-21 and H-6' in the NOESY spectrum (Figure 2.88). Examination of the 
NMR spectroscopic data (Table 2.49) of 75 revealed similarity of this compound with 
macralstonidine (76)
145,171
 (which has a similar mode of branching of the monomeric 
units), except for the signal of the N1'-Me group of the sarpagine unit which was absent 
in the NMR spectra of 75. Instead, an indolic NH was observed at  7.95 in the 1H 
NMR spectrum of 75. 
The relative configurations at the various stereogenic centers in the macroline and 
sarpagine moieties were established from the NOESY spectrum (Figure 2.88), which 
showed that these were similar to those in 76. The E/F ring junction stereochemistry 
was deduced to be cis from the observed interaction between H-20 and 18-Me (both -
oriented) in the NOESY spectrum. The signal due to H-16' of the sarpagine unit was 
unusually shielded ( 1.79), which is in agreement with the configuration at C-16', 
which places H-16' in the shielding zone of the indole moiety of the sarpagine unit (i.e., 
16'R).
133,254,270-272
 This was further confirmed by the observed NOE between H-16' and 
H-6'(Figure 2.88). Lumutinine E (75) therefore represents a new member of the 
linearly-fused macroline-sarpagine bisindoles, is assigned as the N1'-demethyl 




































C NMR Spectroscopic Data for Lumutinine A (71)
a
  
Position H C Position H C 
2 ‒ 133.7 2' ‒ 132.3 
3 3.90 m 53.8 3' 3.83 m 53.9 
5 3.00 d (7) 55.2 5' 3.07 d (6) 54.8 
6 2.48 m 22.8 6' 2.33 m 23.1 
 3.28 m   3.20 m  
7 ‒ 106.8 7' ‒ 104.9 
8 ‒ 126.5 8' ‒ 112.6 
9 7.50 d (7.5) 117.9 9' 6.98 s 116.5 
10 7.11 t (7.5) 118.8 10' ‒ 121.9 
11 7.18 t (7.5) 120.7 11' ‒ 150.3 
12 7.28 d (7.5) 108.9 12' 6.76 s 96.9 
13 ‒ 137.0 13' ‒ 137.2 
14 1.25 m 27.1 14' 1.84 m 32.5 
14 2.34 m  14 2.15 m  
15 1.87 m 30.3 15' 2.76 m 23.0 
16 2.00 m 43.5 16' 1.93 m 38.7 
17 4.67 t (12) 62.5 17' 4.19 dd (11.5, 3) 68.0 
17 3.69 dd (12, 4)  17 4.44 t (11.5)  
18 1.38 s 25.7 18' 2.15 s 25.2 
19 ‒ 99.5 19' ‒ 196.4 
20 1.93 m 37.5 20' ‒ 121.4 
21 2.43 m 28.9 21' 7.58 s 158.1 
21 3.24 m   ‒  
N(1)-Me 3.55 s 29.2b N(1)-Me' 3.54 s 29.6b 
N(4)-Me 2.29 s 41.8 N(4)-Me' 2.27 s 41.8 
a CDCl3, 400 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 













C NMR Spectroscopic Data for Lumutinine B (72)
a
 
Position H C Position H C 
2 ‒ 136.8b 2' ‒ 132.1 
3 3.93 d (8) 51.3 3' 3.81 m 53.9 
5 3.37 m 54.1 5' 3.06 d (7) 54.7 
6 2.35 m 21.6 6' 2.41 m 22.8 
 3.12 dd (16, 5)   3.22 dd (16.5, 7)  
7 ‒ 104.7 7' ‒ 106.3 
8 ‒ 127.5 8' ‒ 121.8 
9 7.49 br d (7.5) 118.1 9' 7.16 d (8) 116.7 
10 7.09 td (7.5, 1) 118.9 10' 6.66 d (8) 110.6 
11 7.17 m 120.8 11' ‒ 149.6 
12 7.28 br d (7.5) 108.9 12' ‒ 103.2 
13 ‒ 137.1b 13' ‒ 135.7 
14 2.52 m 31.0 14' 2.15 m  32.5 
14 1.78 m   ' 1.79 m  
15 1.78 m 28.3 15' 2.66 m 23.0 
16 1.75 m 37.3 16' 1.88 m 38.6 
17 4.22 dd (11, 3) 65.0 17' 4.41 t (11) 68.0 
17 3.75 m  17' 4.16 dd (11, 3)  
18 1.54 s 25.6 18' 2.12 s 25.3 
19 ‒ 99.4 19' ‒ 195.9 
20 2.68 m 38.0 20' ‒ 121.3 
21 3.33 m 24.2 21' 7.55 s 157.9 
21 3.54 m     
N(1)-Me 3.65 s 29.6 N(1)-Me' 3.86 s 32.5 
N(4)-Me 2.39 s 40.2 N(4)-Me' 2.29 s 41.9 
a CDCl3, 400 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 


















C NMR Spectroscopic Data for Lumutinine C (73)
a
 
Position H C Position H C 
2 ‒ 133.4 2' ‒ 139.3 
3 3.74 m 54.0 3' 3.82 m 48.7 
5 2.99 m 55.2 5' 2.87 m 56.4 
6 2.45 d (16) 22.8 6' 3.22 m 27.9 
 3.28 m  6 2.71 m  
7 ‒ 107.0 7' ‒ 102.1 
8 ‒ 126.4 8' ‒ 125.0 
9 7.50 d (7.5) 118.1 9' ‒ 111.4 
10 7.10 t (7.5) 119.0 10' ‒ 147.7 
11 7.17 t (7.5) 120.9 11' 6.71 d (9) 112.6 
12 7.25 d (7.5) 108.9 12' 7.01 d (9) 107.7 
13 ‒ 136.9 13' ‒ 132.4 
14 2.35 td (13, 3) 26.7 14' 1.89 m 38.6 
14 1.18 m  14' 1.66 m  
15 1.87 m 30.4 15' 2.82 m 29.2 
16 2.00 m 43.5 16' 1.55 m 45.0 
17 4.62 t (11.5)  62.3 17' 3.42 m 64.5 
17 3.67 dd (11.5, 4)   3.61 dd (12, 3)  
18 1.35 s 25.4 18' 1.34 d (6) 22.5 
19 ‒ 99.0 19' 4.46 q (6) 67.3 
20 1.97 m 37.2 20' ‒ 149.3 
21 3.25 m 26.8 21' 6.44 s 136.1 
21 2.75 m     
N(1)-Me 3.40 s 29.3 N(1)-Me' 3.48 s 29.4 
N(4)-Me 2.26 s 41.8    

















C NMR Spectroscopic Data for Lumutinine D (74)
a
 
Position H C Position H C 
2 ‒ 133.5b 2' ‒ 140.0 
3 3.70 m 53.8 3' 4.16 br d (9) 49.7 
5 2.97 m 55.2 5' 2.76 m 54.4 
6 2.43 d (17) 22.7 6' 2.57 d (15) 27.1 
6 3.25 m  6' 3.01 m  
7 ‒ 106.8 7' ‒ 102.8 
8 ‒ 126.5 8' ‒ 126.8 
9 7.49 d (7.5) 117.9 9' 6.91 s 105.1 
10 7.10 t (7.5) 118.9 10' ‒ 148.3 
11 7.18 t (7.5) 120.8 11' ‒ 114.9 
12 7.27 d (7.5) 108.9 12' 6.85 s 107.5 
13 ‒ 137.0 13' ‒ 133.5b 
14 1.10 d (13) 26.9 14'a 1.65 m 32.9 
14 2.28 m  14'b 2.05 m  
15 1.84 m 30.2 15' 2.82 m 27.5 
16 1.99 m 43.5 16' 1.82 m 44.4 
17 3.66 m 62.4 17'a 3.48 m 64.8 
17 4.63 t (11.5)  17'b 3.53 m  
18 1.39 s 25.6 18' 1.63 d (6.5) 12.9 
19 ‒ 99.3 19' 5.40 q (6.5) 117.0 
20 1.93 m 37.4 20' ‒ 135.7 
21 2.48 d (19) 29.5 21'a 3.59 m 56.3 
21 3.25 m  21'b 3.59 m  
N(1)-Me 3.47 s 29.3 N(1)-Me' 3.56 s 29.6 
N(4)-Me 2.24 s 41.8    
a CDCl3, 400 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 

















C NMR Spectroscopic Data for Lumutinine E (75)
a
 
Position H C Position H C 
2 ‒ 133.3 2' ‒ 138.5 
3 3.71 m 53.9 3' 4.01 br d (9.5) 50.4 
5 2.99 d (6.8) 55.1 5' 2.60 br t (5) 54.2 
6 2.45 d (16)  22.7 6' 2.64 d (15)  29.4 
6 3.27 dd (16, 6.8)  6' 3.13 dd (15, 5)  
7 ‒ 106.8 7' ‒ 104.4 
8 ‒ 126.3 8' ‒ 125.4 
9 7.51 d (7.5) 117.9 9' ‒ 111.1 
10 7.11 t (7.5) 118.8 10' ‒ 147.6 
11 7.17 t (7.5) 120.7 11' 6.65 d (8.6) 112.8 
12 7.26 d (7.5) 108.8 12' 6.97 d (8.6) 109.7 
13 ‒ 136.9 13' ‒ 131.1 
14 1.17 m  26.7 14'a 1.76 m 33.5 
14 2.34 td (13, 4)   14'b 1.96 m  
15 1.83 m 30.3 15' 2.82 m 27.7 
16 2.00 m 43.4 16' 1.79 m 44.2 
17 3.67 dd (11.5, 4)  62.2 17'a 3.43 m 64.8 
17 4.61 t (11.5)   17'b 3.43 m  
18 1.37 s 25.5 18' 1.63 br d (6.8) 12.8 
19 ‒ 98.8 19' 5.34 br q (6.8) 116.8 
20 1.94 m  36.9 20' ‒ 135.8 
21 2.73 d (18) 26.5 21'a 3.50 m 55.8 
21 3.20 dd (18, 8)  21'b 3.50 m  
N(1)-Me 3.41 s 29.0 N(1)-H' 7.95 s  
N(4)-Me 2.27 s 41.6    








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.7.1.6 Macralstonidine (76)  
 
Another known linearly fused bisindole was also isolated from the stem-bark extract of 




H NMR spectrum of compound 




C NMR data of compound 76 is 







C NMR Spectroscopic Data for Macralstonidine (76)
a
 
Position H C Position H C 
2 ‒ 133.3 2' ‒ 139.4 
3 3.75 m 53.9 3' 4.16 br d (10) 49.4 
5 3.00 d (7) 55.0 5' 2.64 d (5) 54.2 
6 2.45 br d (16) 22.6 6' 2.67 br d (15) 29.3 
 3.27 dd (16, 7)   3.17 dd (15, 5)  
7 ‒ 106.8 7' ‒ 103.1 
8 ‒ 126.3 8' ‒ 124.9 
9 7.51 br d (7.5) 117.8 9' ‒ 111.2 
10 7.11 td (7.5, 1) 118.7 10' ‒ 147.4 
11 7.18 td (7.5, 1) 120.6 11' 6.72 d (9) 112.3 
12 7.27 br d (7.5) 108.8 12' 7.04 d (9) 107.5 
13 ‒ 136.8 13' ‒ 132.3 
14 1.21 m  26.7 14' 1.74 m 32.8 
 2.33 td (13, 4)    2.10 m  
15 1.86 m 30.3 15' 2.87 m 27.4 
16 2.01 m 43.3 16' 1.79 m 44.1 
17 3.68 dd (11.5, 4)  62.2 17' 3.53 m 64.7 
 4.62 t (11.5)    3.53 m  
18 1.37 s 25.4 18' 1.65 d (6.8) 12.8 
19 ‒ 98.8 19' 5.41 q (6.8) 116.8 
20 1.96 m 36.9 20' ‒ 135.5 
21 2.77 br d (17.5)  26.5 21' 3.53 m 55.9 
 3.23 m    3.60 m  
N(1)-Me 3.45 s 29.3
b
 N(1)-Me' 3.57 s 29.0
b
 
N(4)-Me 2.28 s 41.6    
a






































































































































































































2.1.7.2 Macroline‒Macroline Bisindole Alkaloids 
 




 was isolated as a light yellowish oil, []D138 (c 0.24, CHCl3). 
The IR spectrum showed bands at 1618 and 1655 cm
-1
 due to the presence of an ,-
unsaturated carbonyl group, while the UV spectrum showed absorption maxima at 231 
and 285 nm, indicating the presence of an indole chromophore. The ESIMS of 77 
showed a [M + H]
+ 
peak at m/z 687, which analyzed for C43H50N4O4 + H. The 
13
C NMR 
spectrum (Table 2.51) showed a total of 43 resonances, comprising seven methyl, six 
methylene, 17 methine, and 13 quaternary carbon atoms. The observed quaternary 
carbon resonance at  195.2, and the olefinic carbon signals at 120.8 (quaternary 
carbon) and 157.3 (methine), are consistent with the presence of the ,-unsaturated 
carbonyl group, while the unusually low field resonance of the -carbon at 157.3 
indicated oxygen substitution. Another pair of olefinic signals associated with another 
trisubstituted double bond was observed at  120.5 (quaternary carbon) and 138.2 
(oxymethine), in addition to two oxymethylenes at  65.6 and 67.5. 
The 
1
H NMR spectrum (Table 2.51; Figure 2.102) showed the presence of four aromatic 
hydrogens ( 7.077.47) corresponding to an unsubstituted indole moiety, two aromatic 
singlets at  6.38 and 7.00, corresponding to another aromatic moiety substituted at C-
10' and C-11', two vinylic singlets associated with the two trisubstituted double bonds at 
 6.42 and 7.59, six methyl singlets, corresponding to two N1-Me ( 3.48, 3.32), two 
N4-Me ( 2.26, 2.26), one acetyl ( 2.12), and one aromatic methoxy group ( 3.39). In 
addition, a methyl doublet was observed at  1.26 which was coupled (J = 7.5 Hz) with 








the substitution of both indolic nitrogens, it can be inferred from the observation of the 
two H-9' and H-12' aromatic singlets, that the bisindole is branched from C-10' or C-11' 
of one of the monomeric units (lower unit). The observed reciprocal NOEs between the 
aromatic singlet at  7.00 and H-6', and between the aromatic singlet at  6.38 and the 
N1'-Me signal at  3.48, allowed the assignment of thesearomatic resonances to H-9' 
and H-12', respectively (Figure 2.95). The observed NOE between H-12' and the 
aromatic methoxy group at  3.39, allowed placement of the OMe substituent at the 
adjacent C-11', which in turn indicated C-10' as the branching point of the bisindole 
from this lower monomeric unit. These conclusions were also supported by the 
observed three-bond correlations from H-9' to C-7', C-11', and C-13', from 11'-OMe to 
C-11', and from H-12' to C-10' and C-8' (Figure 2.95). 
Examination of the NMR chemical shifts (Table 2.51) as well as the 2-D NMR data 
(COSY, HSQC, and HMBC), revealed that one unit of the bisindole (the lower half) 
corresponds to a 10-substituted alstophylline (7). Thus the COSY spectrum revealed the 
presence of NCHCH2 and NCHCH2CHCHCH2O partial structures, corresponding to the 
N-4'C-5'C-6' and N-4'C-3'C-14'C-15'C-16'C-17'O units,respectively,of the 
lower macroline (or alstophylline) half. The observed three-bond correlations from the 
vinylic H-21' ( 7.59) to C-15', C-17', and C-19' ( 195.2, acetyl carbonyl) accounted 
for the ring E of a typical type-B macroline moiety. The same alstophylline unit has 
been previously encountered as a constituent half in the Alstonia bisindoles, 
perhentinine (83)
123
 and perhentidines AC (81, 82, and 414).126   
The other unit (upper half) of the bisindole, after discounting the signals due to the 
alstophylline half, corresponded to another macroline derivative with an unsubstituted 
indole ring and a modified ring E. In addition to the signals due to the four contiguous 
aromatic hydrogens, and the typical macroline fragments corresponding to the N-4C-








oxygenated trisubstituted double bond, the NMR data indicated a residual fragment 
corresponding to a CH3CH (C-18C-19) unit. This two-carbon fragment is linked, via 
the methine C-19, to the quaternary carbon of the trisubstituted double bond (C-20,  
120.5) of the upper half moiety, as well as to the aromatic C-10' ( 126.2) of the lower 
half unit, as shown by the following three-bond correlations in the HMBC spectrum: H-
19 to C-21, C-15; H-21, H-15 to C-19; H-19 to C-9', C-11'; H-9' to C-19; Me-18 to C-20, 
C-10' (Figure 2.95). The lower alstophylline half is therefore linked to the upper 
macroline half via the C-19 methine of the CH3CH group. The origin of the upper 
macroline moiety is likely a hypothetical ring E-opened talcarpine derivative (vide 












The remaining issue concerns the configuration at C-19, and as the NMR data in this 
instance did not prove helpful, a solution of this problem by X-ray crystallographic 
analysis was indicated. Attempts to obtain suitable crystals however, were singularly 
unsuccessful and eventually conversion of lumusidine A (77) to its dimethyl diiodide 
salt 77a furnished suitable crystals, which on X-ray diffraction analysis yielded the 



























 was isolated as a light yellowish oil, []D59 (c 0.73, CHCl3). 
The IR spectrum showed bands at 3366, 1652 and 1615 cm
-1
 due to the presence of OH 
and,-unsaturated carbonyl groups, respectively, while the UV spectrum showed 
typical indole chromophore absorption maxima at 229 and 285 nm. The ESIMS of 78 
showed a [M + H]
+
 peak at m/z 705, which analyzed for C43H52N4O5 + H, differing 
from that of 77 by the addition of H2O. The presence of an OH function was supported 
by acetylation (Ac2O, pyridine), which yielded an O-acetyl derivative (78a) (Figure 
2.113). The 
13
C NMR spectrum (Table 2.53) showed a total of 43 resonances, 
comprising seven methyl, six methylene, 18 methine, and 12 quaternary carbon atoms. 




C NMR data and comparison with those of 77 (Table 2.51; 
Figure 2.103) showed that while the signals corresponding to the lower alstophylline 
half remained essentially unchanged, including the presence of the CH3CH fragment, 
noticeable changes have occurred in the signals corresponding to the upper macroline 
half, in particular with respect to the ring E signals. Thus comparison of the 
13
C NMR 
data showed that the resonances due to the olefinic carbons ( 120.5, C-20 and  138.2, 
C-21) in 77, were absent in the 
13
C NMR spectrum of 78. These signals have been 
replaced by signals at  44.9 (C-20) and 93.4 (C-21), the noticeable downfield shift of 
the C-21 methine carbon at  93.4, indicating substitution by two oxygen atoms 
(hemiacetal). Less substantial changes are observed for the signals of carbons  to both 
these carbons (C-20, C-21). These observations are consistent with the structure of 
lumusidine B as shown in 78, where H and OH have added across the C-20C-21 
double bond. The configuration at C-20 can be deduced from the NOESY spectrum. 
The observed H-20/H-15, H-16 NOEs indicated that the orientation of H-20 is . The 








consistent with an equatorial disposition of H-21 (H-21). As in the case of 77, it 
remained to establish the configuration at C-19. The NMR data in this case was also not 
helpful as the signals of both H-19 and H-20 were multiplets in lumusidine B (78) as 
well as in the O-acetyl derivative, 78a. As with 77, repeated attempts at crystallization 
proved fruitless, but eventually, suitable crystals were obtained upon conversion to the 
dimethyl diiodide salt 78b. X-ray diffraction analysis of this salt confirmed the 
structural assignments discussed above and established the absolute configuration of 
















Lumusidine A (77) is likely derived by dehydration of the hemiacetal, lumusidine B 
(78), which in turn can be considered as having originated from conjugate addition of 
alstophylline (7) via its nucleophilic C-10' onto a hypothetical ring E-opened talcarpine 
derivative 447, to give the hydroxy-aldehyde 448, which on subsequent ring closure 

















 was isolated as a light yellowish oil, []D16 (c 0.21, CHCl3). 
The IR spectrum showed bands at 1619 and 1653 cm
-1
 due to the presence of an ,-
unsaturated carbonyl group, while the UV spectrum showed typical indole chromophore 
absorption maxima at 231 and 283 nm. The ESIMS of 79 showed a [M + H]
+ 
peak at 
m/z 733, which analyzed for C45H56N4O5 + H. The 
13
C NMR spectrum (Table 2.54) 
showed a total of 45 resonances, comprising eight methyl, eight methylene, 16 methine, 




C NMR data and 
comparison with those of 77 and 78, showed the presence of signals corresponding to 
the same lower alstophylline half present in 77 and 78. These include, the two isolated 
aromatic singlets due to H-9' ( 6.86) and H-12' ( 6.06), four singlets due to N1'-Me ( 
3.32), N4'-Me ( 2.28), 11'-OMe ( 3.61), and COMe ( 2.08, C-18'), and signals due to 
a trisubstituted, oxygenated double bond corresponding to C-20'C-21' (C 121.5, 
157.5). The remaining signals corresponded to those of another macroline unit 
constituting the upper half such as, the four aromatic resonances corresponding to those 
of an unsubstituted indole moiety ( 6.95-7.34), three methyl singlets corresponding to 
N1-Me ( 3.34), N4-Me ( 2.25), and a methyl ( 1.36, C-18) attached to a quaternary 
carbon. In addition, signals due to an ethoxy group were observed at  1.30 and 3.58. 
This ethoxy group must be attached to the ring E quaternary C-19, as part of aketal 
functionality, consistent the observed downfield shift of this carbon at  101.6, 
indicating its attachment to two oxygen atoms. The COSY spectrum also showed the 
presence of another set of macroline fragments corresponding to the N-4C-5C-6 and 
N-4C-3C-14C-15C-16C-17O units. In addition, a CHCH2 fragment was 








and C-19, as indicated by the three-bond correlations from H-21 to C-15 and C-19 in 
the HMBC spectrum (Figure 2.98). The observed three-bond correlations from the 
methylene H-21 to the aromatic C-9' and C-11' of the lower half macroline moiety, 
indicated that the two macroline halves are connected via the C-21 methylene bridge. 
These observations allowed the structure of lumusidine C to be assembled as shown in 
79. Finally, the observed H-20/H-14 and H-20/H-18 NOEs (Figure 2.99) allowed the 
assignment of -orientation for H-20 and Me-18, which were also consistent with the 
other NOEs observed (Figure 2.99). In view of the use of ethanol during extraction, 
lumusidine C (79) is most likely an artifact derived from the precursor hemiketal 
alkaloid 449 (closed form of perhentinine) (which to date has not been encountered and 
which in turn is the closed form of perhentinine (83)).  
 
 
Figure 2.98: Selected HMBCs of 79 
 
 












 was isolated as a light yellowish oil, []D 161 (c 0.38, CHCl3). 
The IR spectrum showed bands at 1618 and 1654 cm
-1
 due to the presence of an ,-
unsaturated carbonyl group, while the UV spectrum showed typical indole chromophore 
absorption maxima at 233 and 283 nm. The ESIMS of 80 showed a [M + H]
+
 peak at 
m/z 687, which analyzed for C43H50N4O4 + H. The 
13
C NMR spectrum (Table 2.55) 
showed a total of 43 resonances, comprising seven methyl, seven methylene, 15 




C NMR data of 
80 (Table 2.55; Figure 2.106), indicated a number of similarities with those of 
lumusidine A (77). For instance most of the signals corresponding to the upper half 
macroline unit were observed with the exception of a vinyl-H at C-21 in place of a 
methyl group. Another difference is in the bridging of the two macroline halves, which 
in the case of 80 was similar to that in 79, i.e., via a C-21 methylene bridge. The NMR 
signals corresponding to the lower macroline unit were essentially similar to those in the 
previous bisindoles, 7779, indicating the presence of a similar alstophylline unit, but 
with one notable difference. In 80, the signals of the aromatic hydrogens of the lower 
alstophylline unit were seen as a pair of AB doublets, indicating that the aromatic ring is 
vicinally substituted. The observed reciprocal NOEs (Figure 2.100) between the 
aromatic doublet at  7.01 and the signal due to H-6' permitted the assignment of this 
signal to H-9' and the signal at  6.08 to H-10'. The observed reciprocal NOEs between 
the H-10' signal ( 6.08) and the aromatic methoxy signal at  2.92 confirmed its 
placement at C-11', which in turn indicated C-12' as the branching point of the bisindole 
from the lower alstophylline unit. In bisindole 80 therefore, branching is from C-12' of 
the lower alstophylline unit to the olefinic C-20 of the upper unit, the connection being 








observed three bond correlations in the HMBC spectrum (Figure 2.100), viz., from H-
21 to C-15, C-19, C-11', and C-13'. It transpired that lumusidine D corresponds to 
thungfaine, recently independently isolated from a Thai Alstonia.
165
 It’s likely origin is 
probably from conjugate addition of the electron-rich C-12' of alstophylline (7) onto 
macroline 443, followed by cyclization of the product hydroxyketone to the hemiketal 
450, and its subsequent dehydration (Scheme 2.3). It is also noteworthy that the 
hemiketal 450 is also the immediate precursor of one of the linearly fused macroline-
macroline bisindole, lumutinine B (72), via a subsequent ketalization.
258
 Since we were 
able to obtain suitable crystals of 80, X-ray diffraction was also carried out, which 









































C NMR Spectroscopic Data for Lumusidine A (77)
a
 
Position H C Position H C 
2 ‒ 133.0 2' ‒ 131.0 
3 3.76 m 53.5 3' 3.81 m 53.5 
5 3.01 d (7) 54.9 5' 3.06 d (7) 54.4 
6 2.43 br d (16) 22.3 6' 2.34 br d (17) 22.7 
6 3.19 m  6' 3.16 m  
7 ‒ 105.8 7' ‒ 105.0 
8 ‒ 126.2b 8' ‒ 119.9 
9 7.47 d (7.7) 118.1
c
 9' 7.00 s 115.5 
10 7.07 m 117.9
c
 10' ‒ 126.2b 
11 7.09 m 120.0 11' ‒ 153.5 
12 7.14 m 107.8 12' 6.38 s 91.1 
13 ‒ 136.5 13' ‒ 135.8 
14 1.57 m 35.6 14' 1.80 m 32.1 
14 1.86 m  14' 2.08 m  
15 1.86 m 25.0 15' 2.71 m 22.7 
16 1.86 m 39.8 16' 1.96 m 38.4 
17 3.92 br d (11) 65.6 17' 4.21 br d (11) 67.5 
17 4.29 t (11)  17' 4.44 t (11)  
18 1.26 d (7.5) 20.2 18' 2.12 s 24.7 
19 3.68 q (7.5) 33.1 19' ‒ 195.2 
20 ‒ 120.5 20' ‒ 120.8 
21 6.42 s 138.2 21' 7.59 s 157.3 
N(1)-Me 3.32 s 28.3 N(1)-Me' 3.48 s 28.7 
N(4)-Me 2.26 s 41.4 N(4)-Me' 2.26 s 41.4 
   11'-OMe 3.39 s 55.2 





















H 80 80a H 80 80a 
3 3.63 m 3.61 m 3' 3.98 m 3.97 m 
5 2.90 d (7) 2.86 d (7) 5' 3.11 m 3.17 m 
6 2.31 m 2.44 d (16) 6' 2.51 m 2.31 d (16) 
6 3.17 m 3.26 dd  
(16, 7) 
6' 3.13 m 3.13 m 
9 7.33 d (7) 7.38 d (7) 9' 7.01 s 6.91 s 
10 7.03 m 7.05 td (7, 1) 12' 5.63 s 5.61 s 
11 7.05 m 7.11 td (7, 1) 14' 1.79 m 1.82 td (13, 4) 
12 6.51 d (7) 6.58 d (7) 14' 2.11 m 2.15 m 
14 1.38 m 1.30 m 15' 2.48 m 2.53 m 
14 2.57 m 2.59 m 16' 1.87 m 1.90 m 
15 1.30 m 1.30 m 17' 4.17 dd  
(11.5, 3) 
4.18 dd  
(11.5, 3) 
16 1.84 m 1.90 m 17' 4.41 t (11.5) 4.42 t (11.5) 
17 3.48 dd  
(12, 4) 
3.88 dd  
(11.5, 4) 
18' 2.06 s 2.08 s 
17 4.47 t (12) 4.31 t (11.5) 21' 7.51 s 7.53 s 
18 1.18 d (6.8) 1.24 d (6.9) N(1)-Me' 3.44 s 3.45 s 
19 2.87 m 2.60 m N(4)-Me' 2.51 s 2.48 s 
20 2.46 m  2.29 m 11'-OMe 3.21 s 3.22 s 
21 5.39 d (3.2) 5.96 d (9)    
N(1)-Me 2.57 s 3.45 s    
N(4)-Me 2.29 s 2.23 s    
OCOMe ‒ 2.14 s    




















C 80 80a C 80 80a 
2 132.4 132.5 2' 131.1 131.2 
3 54.3 53.7 3' 54.1 54.1 
5 55.5 54.9 5' 54.9 54.8 
6 22.9 22.9 6' 22.8 22.8 
7 106.0 106.3 7' 105.1 105.2 
8 125.9 126.0 8' 120.2 120.1 
9 117.3 117.4 9' 119.6 120.0 
10 118.3 118.3 10' 124.8 126.0 
11 119.8 120.0 11' 154.4 153.6 
12 108.1 108.1 12' 91.8 91.5 
13 136.4 136.4 13' 136.5 136.4 
14 26.9 25.0 14' 32.4 32.3 
15 26.2 28.5 15' 23.0 27.4 
16 44.5 43.8 16' 38.6 38.5 
17 59.8 66.6 17' 67.9 67.8 
18 19.5 21.6 18' 25.1 25.0 
19 40.3 40.1 19' 195.6 195.5 
20 44.9 45.9 20' 121.2 121.1 
21 93.4 96.2 21' 157.6 157.5 
N(1)-Me 27.6 29.3 N(1)-Me' 29.4 29.3 
N(4)-Me 41.9 41.7 N(4)-Me' 41.8 41.7 
OCOMe ‒ 21.6 11'-OMe 54.7 54.3 
OCOMe ‒ 170.1    












C NMR Spectroscopic Data for Lumusidine C (79)
a
 
Position H C Position H C 
2 ‒ 133.0 2' ‒ 131.0 
3 3.77 m 54.3 3' 3.75 m 53.9 
5 2.92 d (7) 55.3 5' 2.98 d (7) 54.8 
6 2.26 m 22.6 6' 2.10 m 22.6 
6 3.14 dd (16, 7)  6' 3.14 dd (16, 7)  
7 ‒ 106.6 7' ‒ 104.9 
8 ‒ 126.6 8' ‒ 119.9 
9 7.34 d (7) 117.9 9' 6.86 s 118.1 
10 7.06 t (7) 118.4 10' ‒ 121.4 
11 7.02 t (7) 120.1 11' ‒ 154.0 
12 6.95 d (7) 108.2 12' 6.06 s 90.8 
13 ‒ 136.8 13' ‒ 136.1 
14 1.24 m 32.4 14' 1.75 td (13, 4) 32.6 
14 3.05 m  14' 2.05 m  
15 1.61 m 27.2 15' 2.50 m 22.9 
16 2.12 m 37.5 16' 1.84 m 38.3 
17 3.49 dd (11, 4) 62.0 17' 4.15 m 68.0 
17 4.18 m  17' 4.38 t (11)  
18 1.36 s 22.1 18' 2.08 s 25.2 
19 ‒ 101.6 19' ‒ 195.6 
20 1.67 dd (10.4, 4.5) 45.8 20' ‒ 121.5 
21a 2.60 dd (13.6, 10.4) 30.4 21' 7.55 s 157.5 
21b 2.83 dd (13.6, 4.5)     










OCH2CH3 3.58 m 55.3 11'-OMe 3.61 s 55.3 
 3.58 m     
OCH2CH3 1.30 t (7) 15.9    
a CDCl3, 400 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 















C NMR Spectroscopic Data for Lumusidine D (80)
a
 
Position H C Position H C 
2 ‒ 133.5 2' ‒ 132.6 
3 3.72 m 53.5 3' 3.80 m 53.9 
5 3.00 d (7) 55.3 5' 3.06 d (7) 54.6 
6 2.34 m 22.8 6' 2.34 m 22.9 
6 3.17 d (16)  6' 3.15 d (16)  
7 ‒ 105.3b 7' ‒ 105.4b 
8 ‒ 126.3 8' ‒ 121.8 
9 7.34 d (8) 117.6 9' 7.01 d (8.5) 115.7 
10 7.02 t (8) 118.3 10' 6.08 d (8.5) 104.9 
11 7.15 m 120.1 11' ‒ 153.7 
12 7.17 m 108.9 12' ‒ 110.3 
13 ‒ 136.8 13' ‒ 137.2 
14 0.85 d (13) 32.5 14' 1.76 m 32.3 
14 1.86 m  14' 1.99 d (13)  
15 1.61 m 25.9 15' 2.53 m 22.6 
16 1.89 m 40.8 16' 1.86 m 38.7 
17 3.95 dd (11, 3) 66.1 17' 4.17 dd (11, 3) 67.8 
17 4.42 t (11)  17' 4.42 t (11)  
18 1.82 s 16.8 18' 2.11 s 25.1 
19 ‒ 144.1 19' ‒ 195.4 
20 ‒ 108.3 20' ‒ 121.1 
21 3.65 m 25.5 21' 7.52 s 157.4 
 3.65 m  N(1)-Me' 3.72 s 31.4 
N(1)-Me 2.83 s 28.2 N(4)-Me' 2.33 s 42.0
c
 
N(4)-Me 2.24 s 41.6
c
 11'-OMe 2.92 s 55.7 
a CDCl3, 400 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 was obtained as a light yellowish oil with []25D 77 (c 0.40, 
CHCl3). The IR spectrum showed bands at 3400, 1702, 1648 and 1617 cm
-1
, due to the 
presence of OH, ketone carbonyl, and an ,-unsaturated carbonyl group, respectively, 
while the UV spectrum showed absorption maxima at 231 and 286 nm, consistent with 
the presence of indole chromophores. The ESIMS of 81 showed a [M + H]
+
 peak at m/z 
705, which analyzed for C43H52N4O5 + H. The 
13
C NMR spectrum (Table 2.57) showed 
a total of 43 resonances, comprising seven methyl, seven methylene, 16 methine, and 13 
quaternary carbon atoms, in agreement with the molecular formula. The quaternary 
carbon resonance at C212.9 is consistent with the presence of a ketone carbonyl, while 
the other quaternary carbon resonance at C 195.2 and the associated olefinic carbon 
signals atC 121.0 and 157.2, are consistent with the presence of an ,-unsaturated 
carbonyl group. The unusually low field resonance of the -carbon atC 157.2 indicated 
oxygen substitution. In addition, two oxymethylene carbons were observed at C 66.8 
and 67.6, the former due to a hydroxymethyl group as shown by acetylation, which 
yielded an acetate derivative (81a). 
The 
1
H NMR spectrum (Table 2.56; Figure 2.110) showed the presence of four aromatic 
hydrogens (H 7.16–7.56) associated with an unsubstituted indole moiety, a pair of AB 
doublets at H 6.75 and 7.22 associated with another indole moiety substituted at 
positions 11' and 12', a vinylic singlet at H 7.49 associated with a trisubstituted double 
bond, a total of seven methyl singlets, corresponding to two N1-Me (H 3.58, 3.69), two 
N4-Me (H 2.36, 2.37), two acetyl methyls (H 1.55, 2.06), and an aromatic methoxy 
substituent (H 3.83, 11'-OMe). Since only six aromatic hydrogens were observed and 








branched from one of the aromatic carbon atoms of one monomer, with the adjacent 
position occupied by the methoxy substituent. The aromatic doublet at H 7.22 was 
assigned to H-9' from its NOE with H-6', while the placement of the methoxy 
substituent at C-11' was confirmed by the observed NOE between H-10' (H 6.75) and 
11'-OMe (H 3.83). These assignments were further supported by the observed three-
bond correlations from H-9' to C-7' and C-13', and from H-9' and 11'-OMe to C-11' in 
the HMBC spectrum (Figure 2.107). These observations indicated position 12' as the 
site of branching of the bisindole from this monomeric unit. 
The remaining part of this macroline half can be assembled with the help of the 2-D 
NMR data. The COSY spectrum revealed a NCHCH2CHCHCH2O fragment, which 
corresponds to the N-4'–C-3'–C-14'–C-15'–C-16'–C-17'–O unit of the lower macroline 
half. The observed three-bond correlations from the vinylic H-21' (which is associated 
with the acetyl group forming the ,-unsaturated carbonyl chromophore) to C-17' and 
C-15' in the HMBC spectrum indicated that the lower macroline half corresponds to a 
type-B macroline
118
 (a 12'-substituted alstophylline (7))
118,158,164
 which was in agreement 
with the NMR data.   
The other unit of the bisindole, after discounting the signals due to the substituted 
alstophylline (7) half, corresponded to that of another macroline derivative with an 
unsubstituted indole moiety. The oxymethylene C-17 hydrogens were observed as two 
doublet of doublets at H 3.88 and 3.91 (C 66.8). This oxymethylene constitutes part of 
a primary alcohol function as shown by acetylation (H 4.15 and 4.53; C 63.7). The 18-
methyl (acetyl) singlet was observed at H 1.55 with the C-19 ketone carbonyl observed 
at C 212.9. An additional methine corresponding to C-20 was observed at C 55.5 (H 
3.26), which was linked to C-19 from the observed three-bond correlations from 18-Me 
to C-20. These features are suggestive of a seco-macroline (with an opened ring E) such 
as alstomicine (109),
177








showed the presence of an NCHCH2CH(CHCH2)CHCH2O partial structure. The 
branching of the bisindole from this upper seco-macroline unit must be from this 
methine C-20. Connection from C-20 of the upper macroline unit to C-12' of the lower 
half was mediated via a methylene bridge (C-21), as shown by the observed H-21 to C-
11', C-13', and C-19 three-bond correlations in the HMBC spectrum (Figure 2.107). The 
structure of perhentidine A (81) indicated that it is a regioisomer of the previously 





















 was isolated as a light yellowish oil with []25D 38 (c 0.52, 
CHCl3). The UV (234 and 286 nm) and IR (3392, 1707, 1653 and 1618 cm
-1
) spectra 
were similar to those of 81, suggesting the presence of similar functionalities. The 
ESIMS of 82 showed a [M + H]
+
 peak at m/z 705, which also analyzed for C43H52N4O5 
+ H, indicating that 82 and 81 are isomers.  




C NMR data (Tables 2.58 and 2.59; Figure 2.112) of 82 
indicated a general similarity with those of 81, showing the presence of an unsubstituted 
indole moiety (H 7.14-7.56), another indole moiety substituted at C-11' and C-12' (a 
pair of AB doublets at  6.76 and 7.20; NOE: H-9'/H-6', H-10'/11'-OMe), a vinylic 
singlet at H 7.48 associated with a trisubstituted double bond, an ,-unsaturated 
ketone moiety (C 195.6, 121.2, and 157.9; H 2.05), a ketone carbonyl (C 214.7), a 
hydroxylmethyl group (C 66.1; H 4.09 and 4.49; acetylation yielded an acetate 
derivative 82a), and seven methyl singlets, corresponding to two N1-Me, two N4-Me, 




C NMR data of 82 
are generally similar to those of 81 except for differences in the chemical shifts of C-15, 
C-18, C-19 and C-20 in the 
13
C NMR spectrum, and H-14, H-17, and H-20, in the 1H 
NMR spectrum. The NMR data therefore indicated that 82 was also a bisindole of the 
macroline-macroline type incorporating the same two constituent halves as in 81.  
The COSY and HSQC data of 82 disclosed the same partial fragments as in those of 81. 
In addition, the HMBC data of 82 (Figure 2.108), showed the same key three-bond 
correlations (H-21 to C-11', C-13' and C-19) as those of 81, indicating similar branching 
of the bisindole from C-12' of the lower macroline half to C-20 of the upper half, the C-








observations, it can be concluded that perhentidine B (82) is the C-20 epimer of 
perhentidine A (81). 
The remaining issue concerns the assignment of relative configuration of C-20 in 81 and 
82. Examination of the 
1
H NMR data of perhentidines A (81) and B (82) showed that 
the signals of H-20 in both compounds were observed as multiplets (Tables 2.56 and 
2.58; Figures 2.110 and 2.112). Furthermore the signal of one of the C-21 hydrogens in 
perhentidine A (81) and of both the C-21 hydrogens in perhentidine B (82), were also 
observed as multiplets. In the case of the acetate derivatives of both compounds (81a 
and 82a) however, the signals for H-20 and H-21 were clearly resolved (Tables 2.56 and 
2.58; Figures 2.111 and 2.113). The signal due to H-20 in perhentidine A acetate (81a) 
was seen as a triplet of doublets at H 2.99 with J = 10.7 and 3.8 Hz (i.e., J20-21a = J15-20 
= 10.7, J20-21b = 3.8 Hz). The signal of one of the hydrogens on C-21 was observed as a 
doublet of doublets at H 2.83 (J21a-21b = 14 Hz, J20-21a = 10.7 Hz). The large coupling 
constant of 10.7 Hz due to the coupling between H-20 and H-21a, suggested that the 
conformation adopted about the C-21C-20 bond was one that places the two vicinal 
hydrogens at C-21 and C-20 anti (trans-diaxial) to one another. The preferred anti 
conformation was likely due to the presence of three bulky groups, two on C-20, and 
one on C-21, which resulted in steric hindrance to free rotation about the C-20C-21 
bond. The observation that H-20 is trans-diaxial to H-21a, coupled with the observed 
NOE interactions between H-21a and H-15; H-20 and H-14, H-21b; H-21b and H-14; 
18-Me and H-17, H-20 (Figure 2.109) allowed the configuration at C-20 in the acetate 
derivative 81a, and therefore in perhentidine A (81) as well, to be assigned as 20S.  
In the case of perhentidine B acetate (82a), the signal due to H-20 was also seen as a 
triplet of doublets at H 3.23 with J = 11 and 5 Hz. The observed H-20H-21a coupling 
of 11 Hz, indicated a trans-diaxial disposition of the two hydrogens as before in the 








which allowed the assignment of the configuration at C-20, were different from those 
observed in 81a. Thus, in the case of perhentidine B acetate (82a), NOEs were observed 
between H-20 and H-14, H-21b; H-21a and H-15; H-21b and H-16, H-17; H-18 and H-
14, H-15, H-20 (Figure 2.109). These NOEs are consistent with the assignment of the 
C-20 configuration in 82a (and 82) as 20R.   
 



















H 81 81a H 81 81a 
3 4.14 m 4.03 m 3' 3.80 m 3.79 m 
5 3.48 d (7.6) 3.25 m 5' 3.05 d (7) 3.05 m 
6 2.57 d (17) 2.50 m 6' 2.40 m 2.40 d (16) 
6 3.29 m 3.25 m 6' 3.23 dd  
(17, 7) 
3.23 m 
9 7.56 d (7.5) 7.57 d (8) 9' 7.22 d (8.6) 7.23 d (8.5) 
10 7.16 t (7.5) 7.15 t (8) 10' 6.75 d (8.6) 6.76 d (8.5) 
11 7.26 m 7.23 t (8) 14' 1.75 td (12, 4) 1.74 m 
12 7.36 d (7.5) 7.34 d (8) 14' 2.01 m 1.98 m 
14 2.01 m 1.94 m 15' 2.50 m 2.48 m 
14 2.46 m 1.94 m 16' 1.84 m 1.84 m 
15 2.27 m 2.25 m 17' 4.14 m 4.13 dd  
(11.5, 3.5) 
16 1.66 m 1.94 m 17' 4.39 t (11) 4.39 t (11.5) 
17 3.88 dd  
(11, 2) 
4.15 dd  
(11, 3.5) 
18' 2.06 s 2.06 s 
17 3.91 dd 
(11, 2) 
4.53 dd  
(11, 9) 
21' 7.49 s 7.49 s 
18 1.55 s 1.59 s N(1')-Me 3.58 s 3.48 s 




 s 2.27 s 
21a 2.92 dd  
(13, 10.5) 
2.83 dd  
(14, 10.7) 
11'-OMe 3.83 s 3.85 
21b 3.26 m 3.17 dd  
(14, 3.8) 
   
N(1)-Me 3.69 s 3.66 s    
N(4)-Me 2.36
b
 s 2.35 s    
OCOMe  2.03 s    
a CDCl3, 400 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 
















C 81 81a C 81 81a 
2 132.8 133.6 2' 133.5 133.8 
3 53.2 53.5 3' 53.9 53.9 
5 59.5 54.6 5' 54.6 54.6 
6 22.1 21.7 6' 22.5 22.5 
7 106.1 107.0 7' 105.8 105.8 
8 126.4 126.7 8' 122.9 122.9 
9 118.4 118.4 9' 116.0 116.1 
10 118.9 118.8 10' 104.8 104.7 
11 121.0 120.7 11' 153.6 153.5 
12 108.8 108.8 12' 110.9 110.9 
13 137.1 137.0 13' 136.3 136.3 
14 32.2 30.3 14' 32.2 32.2
c
 
15 31.5 30.8 15' 22.7 22.7 
16 42.6 43.0 16' 38.4 38.4 
17 66.8 63.7 17' 67.6 67.7 
18 31.8 32.2
c
 18' 24.9 25.0 
19 212.9 212.8 19' 195.2 195.3 
20 55.5 54.8 20' 121.0 121.0 
21 26.0 26.2 21' 157.2 157.2 





 41.9 N(4)-Me' 41.9
b
 42.1 
OCOMe ‒ 21.2 11'-OMe 56.7 56.6 
OCOMe ‒ 171.3    
a CDCl3, 100 MHz; assignments based on COSY, HMQC, and HMBC. 














H 82 82a H 82 82a 
3 3.98 m 3.88 m 3' 3.72 m 3.72 m 
5 3.63 m 3.44 m 5' 3.01 m 3.01 m 
6 2.58 d (17) 2.52 m 6' 2.34 m 2.35 d (16) 
6 3.37 dd  
(17, 7) 
3.35 dd  
(17, 8) 
6' 3.20 m 3.18 dd (16, 7) 
9 7.56 d (8) 7.58 d (7.5) 9' 7.20 d (8.6) 7.19 d (8.5) 
10 7.14 m 7.14 t (7.5) 10' 6.76 d (8.6) 6.77 d (8.5) 
11 7.22 m 7.22 t (7.5) 14' 1.70 td  
(12.5, 3.5) 
1.71 td  
(12, 3.5) 
12 7.32 d (8) 7.31 d (7.5) 14' 1.99 m 1.99 m 
14 1.48 m 1.32 m 15' 2.51 m 2.50 m 
14 2.26 m 1.81 m 16' 1.82 m 1.82 m 
15 2.11 m 2.14 m 17' 4.12 m 4.12 dd (11, 3) 
16 1.88 m 2.21 m 17' 4.37 t (11) 4.37 t (11) 
17 4.09 m 4.63 m 18' 2.05 s 2.06 s 
17 4.49 d (12) 4.63 m 21' 7.48 s 7.50 s 
18 1.40 s 1.30 s N(1)-Me' 3.53 s 3.52 s 
20 3.55 m 3.23 td  
(11, 5) 
N(4)-Me' 2.24 s 2.24 s 
21a 3.05 m 3.04 m 11'-OMe 3.94 s 3.92 s 
21b 3.17 m 3.32 dd  
(14, 5) 
   
N(1)-Me 3.57 s 3.55 s    
N(4)-Me 2.36 s 2.28 s    
OCOMe ‒ 2.16 s    

















C 82 82a C 82 82a 
2 132.9 133.6 2' 133.7 133.6 
3 53.2 53.2 3' 53.9 53.8 
5 59.6 53.3 5' 54.7 54.6 
6 22.5 22.1 6' 22.77 22.7 
7 106.1 106.7 7' 105.3 105.2 
8 126.5 126.7 8' 123.3 123.2 
9 118.2 118.0 9' 115.9 115.8 
10 118.9 118.6 10' 104.3 104.5 
11 121.1 120.7 11' 153.9 153.8 
12 109.2 109.1 12' 110.2 110.0 
13 137.4 137.2 13' 136.2 136.1 
14 32.7 31.3 14' 32.1 32.0 
15 32.4 31.6 15' 22.85 22.8 
16 42.2 42.0 16' 38.6 38.5 
17 66.1 62.6 17' 67.8 67.7 
18 34.4 34.1 18' 25.1 25.0 
19 214.7 214.1 19' 195.6 195.5 
20 52.7 52.4 20' 121.2 121.1 
21 26.3 25.6 21' 157.5 157.4 
N(1)-Me 29.1 28.9 N(1)-Me' 32.5 32.4 
N(4)-Me 41.4 41.9 N(4)-Me' 41.8 41.7 
OCOMe ‒ 21.3 11'-OMe 56.7 56.6 
OCOMe ‒ 171.6    







































































































































































































































































































































































































































































































































































































































































































































































































































































































 was previously isolated by our group from the stem-bark of A. 
macrophylla which was collected from Terengganu. The structure of perhentinine (83) 
was established based on interpretation of the NMR (Tables 2.60 and 2.61; Figure 2.116) 
and MS data, which revealed a macroline-macroline type bisindole alkaloid, which was 
incorporating by a ring E-opened macroline (alstomicine) and a type-B macroline as the 
upper and lower units, respectively. The relative configurations at the various 
stereogenic centers were established by 2D NOESY experiments, except for the 
configuration of C-20, which was unable to obtained meaningful NOEs due to the 
overlapped of the key signals.  
Repeated attempts to obtain crystals of perhentinine were singularly unsuccessful. 
Eventually it was found that in the case of perhentinine (83), treatment with excess MeI 
gave suitable crystals for X-ray diffraction analysis (X-ray analysis by Y. Y. Low), 
which revealed formation of the dimethyl diiodide salt of the ring-E cyclized (hemiketal) 
product (83b) (Figure 2.114), from which the absolute configuration at C-20 of the 
precursor E-seco-compound, perhentinine, could be established as S. This was also in 
agreement with the results of analysis of the coupling constants (J20-21a = 11.0, J20-21b = 
3.5 Hz) and NOEs (H-21a/H-15; H-21b/H-14, H-20; 18-Me/H-17, H-20) of O-
acetylperhentinine (83a), carried out in a similar manner as described for perhentidines 
A and B (81 and 82) (vide supra). 
Since we have secured firm confirmation of the C-20 configuration of perhentinine by 
X-ray diffraction analysis of its cyclized or hemiketal derivative (in the form of its 
dimethyl diiodide salt, 83b), it would be advantageous if the X-ray structure of a 
corresponding 20R bisindole alkaloid was also available to serve as a model compound 








candidate. However, repeated attempts at crystallization (including treatment with MeI) 
proved fruitless. Another relevant bisindole candidate available from A. macrophylla, is 
macralstonine (84),
118,165,167
 which has been previously investigated by Hesse and 
Schmid.
172
 It has been observed that macralstonine exists as an equilibrium mixture of 
acyclic (ketone, 84a) and cyclized (hemiketal, 84) forms in CHCl3 solution.
172
 We have 
confirmed this by analysis of high-field NMR data (600 MHz) of macralstonine. Thus, 
in CDCl3 solution, the ratio of acyclic to cyclized form was 2.32:1, while in CD2Cl2, it 
was 1.14:1, and in THF-d8, it was virtually detected as the cyclized hemiketal form (84), 
albeit with poor solubility in this solvent. With the help of 2-D methods, the NMR data 
of the two forms could be distinguished (Tables 2.62 and 2.63; Figure 2.118). The E-
seco-macralstonine (84a) could be trapped by conversion to its O-acetyl derivative 
84b,
172
 in which case the NMR data of the pure O-acetyl-E-seco-macralstonine could be 
determined (Table 2.64). The relative configuration at C-20 in the O-methyl congener of 
macralstonine isolated from the Thai A. macrophylla was established as R based on its 
NOESY spectrum.
165,167
 In the case of macralstonine, however, NOE was not feasible 
due to the observation of H-20 and H-21 as multiplets. In the case of the O-acetyl-E-
seco-macralstonine derivative 84b, H-20 was clearly seen as a triplet of doublets (J20-21a 
= 11.0, J20-21b = 4.0 Hz) and this, coupled with the observed NOEs (H-21a/H-15, H-9'; 
H-21b/H-16, H-17, H-9'), allowed assignment of the C-20 configuration as R. In the 
event, macralstonine crystallized wholly as the cyclized hemiketal form (84) from 
CH2Cl2-MeOH solution.
 
X-ray analysis (X-ray analysis by Y. Y. Low) was therefore 



























Figure 2.115: X-ray crystal structure of 84. [Flack parameter: x = 0.1(0.4); 

















H 83 83a H 83 83a 
3 4.09 dd (4, 2) 4.00 m 3' 3.79 t (3) 3.80 br s 
5 3.46 d (7) 3.26 m 5' 2.99 d (7) 3.02 d (7) 
6 2.54 m 2.44 d (17) 6' 2.28 m 2.54 m 
6 3.32 m 3.14 dd (17, 7) 6' 3.08 m 3.14 dd  
(16.5, 7) 
9 7.52 d (8) 7.54 br d (7.5) 9' 6.90 s 6.87 s 
10 7.13 td (8, 1) 7.13 td (7.5, 1) 12' 6.69 s 6.69 s 
11 7.22 td (8, 1) 7.22 td (7.5, 1) 14' 1.75 td (12, 3) 1.75 m 
12 7.32 d (8) 7.32 br d (7.5) 14' 2.04 m 2.06 m 
14 1.98 m 1.86 m 15' 2.54 m 2.53 dt (11.5, 6) 
14 2.41 m 1.86 m 16' 1.84 dt (11, 4) 1.88 m 
15 2.14 m 2.14 m 17' 4.13 ddd   
(11, 4, 1) 
4.14 dd (11, 2) 
16 1.57 m 1.88 m 17' 4.37 t (11) 4.41 t (11) 
17a 3.95 dd (11, 3)  4.28 dd (11, 3.5) 18' 2.05 s 2.07 s 
17b 4.01 dd (11, 2) 4.58 t (11) 21' 7.51 s 7.51 s 
18 1.72 s  1.71 s N(1)-Me' 3.55 s 3.57 s 
20 3.32 m  3.08 td (11, 3.5) N(4)-Me' 2.25 s 2.30 s 
21a 2.41 m 2.31 m 11'-OMe 3.87 s 3.88 s 
21b 3.08 m 2.97 dd  
(13.5, 3.5) 
   
N(1)-Me 3.65 s 3.64 s    
 N(4)-Me 2.34 s 2.28 s    
OCOMe - 2.06 s    






















2 132.9 133.8 2' 131.1 131.5 
3 53.1 53.5 3' 53.7 53.8 
5 59.2 54.2 5' 54.7 54.7 
6 22.6 21.8 6' 22.0 22.8 
7 105.9 106.8 7' 105.4 105.6 
8 126.3 126.6 8' 120.1 119.2 
9 118.2 118.3 9' 118.7 119.4 
10 119.0 118.7 10' 119.1 118.7 
11 120.9 120.7 11' 153.6 153.7 
12 108.7 108.8 12' 91.3 91.4 
13 137.0 137.0 13' 136.5 136.7 
14 32.3 30.3 14' 32.4 32.4 
15 31.5 31.3 15' 22.8 22.9 
16 43.1 43.6 16' 38.3 38.4 
17 66.5 63.5 17' 67.7 67.8 
18 31.1 31.7 18' 24.9 25.4 
19 213.2 213.1 19' 195.4 195.6 
20 54.5 54.1 20' 120.8 121.1 
21 32.0 33.2 21' 157.4 157.7 
N(1)-Me 29.0 29.2 N(1)-Me' 28.9 29.0 
N(4)-Me 41.7 42.1 N(4)-Me' 41.2 41.9 
OCOMe – 21.1 11'-OMe 55.5 55.6 
OCOMe – 171.4    
a CDCl3; 




















H 84 84a H 84 84a 
3 3.95 m 4.00 m 3' 3.75 m 3.79 m 
5 2.93 d (d) 3.59 m 5' 3.00 m 3.00 m 
6 2.13 m 2.56 br d (17) 6' 2.33 m 2.35 m 
 2.63 dd  
(17, 10) 
3.35 dd  
(17, 7.5) 
 3.00 m 3.17 dd  
(16.5, 7) 
9 7.33 (7.5) 7.51 d (7.5) 9' 6.74 s 6.90 s 
10 7.00 m 7.12 t (7.5) 10' – – 
11 7.09 m 7.21 t (7.5) 11' – – 
12 7.09 m 7.30 d (7.5) 12' 6.40 s 6.69 s 
14 1.87 m 1.44 br d (12) 14' 1.76 m 1.77 m 
 2.86 td  
(13, 3.5) 
2.35 m  2.01 m 2.01 m 
15 1.77 m 2.01 m 15' 2.60 m 2.60 m 
16 1.77 m 1.90 m 16' 1.87 m 1.87 m 
17 3.49 m 4.12 dd  
(12, 3) 
17' 4.19 dd (11, 3) 4.14 dd (12, 3) 
 4.52 t (11.5) 4.43 d (12)  4.38 m 4.38 t (12) 
18 1.51 s 1.68 s 18' 2.07 s 2.09 s 
20 1.91 m 3.39 td  
(11, 4) 
20' – – 
21 2.43 m 2.39 m 21' 7.52 s 7.53 s 
 3.06 dd  
(14, 3.5) 
3.00 m  – – 
N(1)-Me 3.47 s 3.56 s N(1)-Me' 3.50 s 3.59 s 
N(4)-Me 2.28 s 2.38 s N(4)-Me' 2.13 s 2.24 s 
   11'-OMe 3.92 s 3.65 s 
a CDCl3, 600 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 
b Since only partial low-
field 1H NMR data of macralstonine (84) were previously available (ref. 172) and the high-field NMR 
data (refs 118, 165, 167) require revision for some of the original assignments, the full 13C and 1H NMR 


















C 84 84a C 84 84a 
2 133.3 132.6 2' 131.2 131.5 
3 54.0 53.1 3' 53.76 53.8
b
 





6 22.7 22.4 6' 22.5 22.8 
7 106.5 105.9 7' 105.1 105.6 
8 126.45 126.36 8' 119.7 119.1 
9 117.9 118.0 9' 118.8 119.5 





 121.0 11' 153.9 153.8 
12 108.5 109.0 12' 91.4 91.2 
13 136.8 137.2 13' 136.1 136.6 
14 26.9 33.0 14' 32.4 32.47
c
 





16 44.0 42.1 16' 38.5 38.4 
17 61.4 66.2 17' 67.87 67.85 
18 29.5 33.9 18' 25.0 25.1 










 21' 157.4 157.7 
N(1)-Me 29.07 29.14 N(1)-Me' 28.7 29.04 
N(4)-Me 41.69 41.4 N(4)-Me' 41.77 41.74 
   11'-OMe 55.3 55.6 
a CDCl3, 150 MHz; assignments based on COSY, HMQC, HMBC, and NOESY. 
b,d ‒g  Peaks are 
















Position H C Position H C 
2 – 133.4 2' – 131.3 
3 3.90 m 53.2 3' 3.81 m  53.9 
5 3.43 d (6) 53.6 5' 3.03 m 54.7 
6 2.49 d (17) 22.1 6' 2.39 m 22.9 
6 3.33 dd (17, 7)  6' 3.17 m  
7 – 106.6 7' – 105.5 
8 – 126.5 8' – 120.1 
9 7.53 d (7.5) 118.0 9' 6.90 s 119.4 
10 7.12 td (7.5, 1) 118.7 10' – 119.0 
11 7.19 td (7.5, 1) 120.8 11' – 153.9 
12 7.29 d (7.5) 109.0 12' 6.69 s 91.3 
13 – 137.2 13' – 136.7 
14a 1.28 d (12) 31.5 14'a 1.78 m  32.4 
14b 1.89 m  14'b 2.07 m   
15 2.03 m 31.5 15' 2.59 m 22.8 
16 2.23 m 41.9 16' 1.89 m 38.4 
17 4.59 m 62.6 17' 4.14 d (11) 67.8 
17 4.59 m  17' 4.39 t (11)  
18 1.59 s 32.7 18' 2.09 s 25.1 
19 – 213.9 19' – 195.7 
20 3.06 td (11, 4) 53.9 20' – 121.1 
21a 2.37 m 31.8 21' 7.54 s 157.6 
21b 3.15 m  N(1)-Me' 3.57 s 29.0 
N(1)-Me 3.55 s 29.1 N(4)-Me' 2.26 s 41.9 
N(4)-Me 2.31 s 42.1 11-OMe' 3.91 s 55.5 
OCOMe 2.15 s 21.3    
OCOMe – 171.4    
a CDCl3, 400 and 100 MHz, respectively; assignments based on COSY, HMQC, and HMBC. 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.7.2.8 Anhydromacralstonine (85) 
 
Another known macroline-macroline bisindole was also isolated from the stem-bark 




H NMR spectrum of 




C NMR data of compound 







C NMR Spectroscopic Data for Anhydromacralstonine (85)
a
 
Position H C Position H C 
2  133.4 2'  131.0 
3 3.85 m 53.9
b
 3' 3.85 m 54.0
b
 
5 3.10 d (6.7) 55.5 5' 3.04 d (7) 54.8 
6 2.49 d (17) 23.0 6' 2.19 d (17) 22.8 
6 3.24 dd (17, 6.7)  6' 2.88 dd (17, 7)  
7  106.2 7'  105.5 
8  126.7 8'  119.9 
9 7.43 br d (7.7) 118.1 9' 6.87 s 117.4 
10 7. 05 br t (7.7) 118.7 10'  121.5 
11 7.16 br t (7.7) 120.6 11'  154.1 
12 7.20 br d (7.7) 108.7 12' 6.52 s 91.3 
13  137.0 13'  136.2 
14a 1.77 m 33.0 14'a 1.77 m 32.5 
14b 1.94 m  14'b 2.05 m  
15 2.01 m 27.7 15' 2.58 dt (12, 6) 23.0 
16 2.05 m 40.9 16' 1.90 m 38.6 
17 3.97 dd (11, 2) 66.4 17' 4.19 dd (11, 3) 67.9 
17 4.45 t (11)  17' 4.37 t (11)  
18 1.82 s 17.0 18' 2.08 s 25.2 
19  146.1 19'  195.6 
20  107.9 20' 7.55 s 121.2 
21a 3.19 m 30.9 21'  157.6 
21b 3.19 m 29.0 N(1)-Me' 3.53 s 29.2 
N(1)-Me 3.43 s 41.8
c
 N(4)-Me' 2.32 s 41.9
c
 
N(4)-Me 2.27 s  11'-OMe 3.63 s 55.5 
a CDCl3, 400 and 100 MHz, respectively; assignments based on COSY, HMQC, and HMBC. 





























































































































































































































































2.1.7.3 Macroline-pleiocarpamine Bisindole Alkaloids  
 
2.1.7.3.1 Villalstonidine B (86) 
 
Villalstonidine B (86) was isolated as a colorless oil, []D + 98 (c 0.45, CHCl3). The 
UV spectrum showed absorption maxima at 230, 246 (shoulder), and 287 nm, showing 
the presence of superimposition of indole and indolic chromophores, while The IR 
spectrum showed the presence of OH (3388 cm
-1
) and ester carbonyl (1747 cm
-1
) 
functions. The ESIMS of 86 showed a [M + H]
+
 peak at m/z 691, which analysed for 
C42H50N4O5 + H.  
The 
13
C NMR spectrum (Table 2.67) showed a total of 42 carbon signals, comprising 
five methyl, nine methylene, 16 methine, and 12 quaternary carbon atoms. The observed 
quaternary carbon resonances at  172.5 and 51.8, are due to the presence of an ester 
carbonyl group, while two downfield carbon signals at 136.0 (quaternary carbon) and 
119.0 (methine) indicating the presence of the trisubstituted olefinic carbons. In 
addition, other two carbon signals were observed at δ 99.2 and 92.1, which are due to 
two quaternary carbons. The former is linked to two oxygen atoms, while the latter is 
linked to a nitrogen (N1') and an oxygen atom. Other signals observed include a 
quaternary carbon resonance at (C 67.1) due to the attachment of a nitrogen atom (N1'), 
and two oxymethylene carbon signals at C 65.8 (H 3.94, and 3.70), and 64.5 (H 4.34, 
and 4.16), where the latter one was associated with a primary alcohol function. The 
1
H 
NMR spectrum (Table 2.66; Figure 2.125) of 86 showed signals due to eight aromatic 
hydrogens, corresponding to two unsubstituted indole moieties ( 7.476.20), four 
methyl singlets corresponding to N1-Me ( 3.55), N4-Me ( 2.24), Me-18 ( 1.29), and 
CO2Me' ( 3.51), an ethylidene (a methine quartet at  5.28 and a methyl doublets of 








The COSY spectrum also disclosed partial structures, which are characteristic of a 
macroline skeleton, such as NCHCH2, NCHCH2CHCHCH2O, and CHCH2, 
corresponding to the C-5C-6, C-3C-14C-15C-16C-17, and C-20C-21 
fragments, respectively. The second moiety constituting the bisindole was deduced to be 
a 2,7-substituted pleiocarpamine derivative, similar to the pleiocarpamine half of 
villalstonine (88),
118,175





C NMR data of 86 showed that the signals due to the H-16' 
signal in 88 were absent in 86 and have been replaced by a hydroxymethyl function (δC 
67.1; δH 4.34 and 4.16). The presence of the hydroxymethyl function at C-16' was 
confirmed by the observed three-bond correlations from H-17'a, H-17'b to C-15' and 
CO2Me, in the HMBC spectrum (Figure 2.121). Examination of the NMR spectroscopic 
data indicated that in common with villalstonine (88), branching from the 
pleiocarpamine moiety in 86 was from C-2' and C-7'. The connection from C-2' to C-19 
of the macroline unit is mediated by an oxygen atom. This was consistent with the 
resonances of C-2' and C-19 which were observed at δ 99.2 and 92.1, respectively. The 
branching from C-7' of the pleiocarpamine moiety to the macroline unit via a methylene 
(C-21), was shown by the three-bond correlations from H-21 to C-15, C-19, C-2' and C-
8'; and from H-6' to C-21, C-2'; in the HMBC spectrum (Figure 2.121). This was also 
consistent with the NOEs seen for H-21a/H-20, H-9', H-6'a (Figure 2.122). The 
observed reciprocal NOEs H-17'/H-15'; H-12'/CO2Me' established the relative 
configuration of C-16' as R. The NMR data from 2D-NOESY also confirmed the 
various stereogenic centers in 86 which were same as those in villalstonine (88). Thus, 





























2.1.7.3.2 Villalstonidine F (87) 
 
Villalstonidine F (87) was obtained as a light yellowish oil, []D
 40 (c 0.10, CHCl3). 
The IR spectrum showed the presence of NH (3400 cm
-1
) and ester carbonyl (1753 cm
-1
) 
functions, while the UV spectrum (230, 251, 288, and 294 nm) can be considered as the 
result of superimposition of indole and indoline chromophores. The ESIMS of 87 
showed a [M + H]
+
 peak at m/z 647, which analyzed for C40H46N4O4 + H. The 
13
C NMR 
spectrum (Table 2.67) showed a total of 40 resonances, comprising four methyl, eight 




C NMR data of 
87 (Tables 2.66 and 2.67; Figure 2.126), indicated the presence of a pentacyclic 
macroline moiety (upper unit) with a saturated E ring incorporating a methyl-substituted 
ketalic carbon (C-19) and an adjacent methine. The usual fragments corresponding to a 
macroline indole were present, such as those corresponding to the NC-5C-6, NC-
3C-14C-15C-16C-17O, and C-15C-20C-21 partial structures, in addition to 
the presence of four aromatic hydrogens ( 7.15-7.55) of an unsubstituted indole moiety. 
Other groups present include an indolic NH ( 7.84), an N4-Me ( 2.31), an 
oxymethylene corresponding to C-17 (C 65.7), and an isolated methyl ( 1.23, C-18) 
attached to a quaternary carbon, which is linked to two oxygen atoms (C 98.7, C-19). 
The signals due to the other (lower) monomeric unit indicated the presence of another 
unsubstituted indole moiety ( 6.14-6.98), a methyl ester group ( 3.67; C 171.2, 51.9), 
and an ethylidene side chain ( 1.55, 5.38). In addition, a downfield resonance due to a 
quaternary carbon was observed at C 92.0, indicating a quaternary carbon linked to a 
nitrogen (N-1') and an oxygen atom (C-2'). The 
1
H NMR spectrum also showed a 
characteristic methine doublet at δ 4.43 (J 3.6 Hz, δC 57.8), reminiscent of the H-16 
signal of pleiocarpamine (δ 5.21, J = 4 Hz; δC 61.6)
167













. As with other bisindoles, incorporating a 
pleiocarpamine unit, branching of the bisindole is from C-7' and C-2' of the 
pleiocarpamine half to C-20 and C-19 respectively, of the upper macroline half. The 
connection between C-7' and C-20 is mediated by a methylene bridge (C-21), while that 
between C-2' and C-19 is via an oxygen. These conclusions are supported by the NMR, 
HMBC (Figure 2.123) and NOE (Figure 2.124) data. Villalstonidine F (87) is therefore 

























Position 86 87 Position 86 87 
3 3.80 m 3.77 m 3' 3.70 m 3.77 m 
5 2.85 d (7) 2.90 m 5' 2.58 dd (14, 4) 2.69 m 
6 2.40 d (16) 2.44 d (17) 5' 3.06 td (14, 2) 3.14 m 
6 3.23 dd  
(16, 7) 
3.28 dd  
(17, 6.5) 
6'a 1.06 br d (14) 1.16 m 
9 7.47 br d (8) 7.53 d (8) 6'b 1.83 td (14, 4) 2.00 m 
10 7.07 td (8, 1) 7.16 t (8) 9' 6.82 br d (7.5) 6.85 d (7.5) 
11 7.16 td (8, 1) 7.18 t (8) 10' 6.63 br t (7.5) 6.69 t (7.5) 
12 7.26 br d (8) 7.35 d (8) 11' 6.91 td (7.5, 1) 6.98 t (7.5) 
14 1.38 ddd 
(13, 5, 2) 
1.47 m 12' 6.20 br d (7.5) 6.14 d (7.5) 
14 2.36 m 2.35 m 14'a 1.55 m 1.73 m 
15 1.58 m 1.60 m 14'b 2.81 m 2.69 br d (13) 
16 2.04 dt  
(12, 5) 
2.06 m 15' 3.22 m 3.21 m 
17 3.70 m 3.71 m 16' – 4.43 d (3.6) 
17 3.94 t (12) 3.97 t (11) 17'a 4.16 dd (12, 6) ‒ 
18 1.29 s 1.23 s 17'b 4.34 dd (12, 7) ‒ 
19 ‒ 1.16 m 18' 1.51 dd (7, 2) 1.55 d (7) 
20 1.19 m 1.55 m 19' 5.28 br q (7) 5.38 q (6.6) 
21a 1.55 m 2.35 m 21'a 2.80 d (13) 2.97 br d (12)  
21b 2.38 m 2.35 m 21'b 4.00 br d (13) 4.22 br d (12)  
N(1)-Me 3.55 s ‒ 17'-OH 3.70 m ‒ 
N(4)-Me 2.24 s 2.31 s CO2Me' 3.51 s 3.67 s 
N(1)-H ‒ 7.84 s    

















Position 86 87 Position 86 87 
2 132.8 131.8 2' 92.1 92.0 
3 53.3 54.8 3' 51.4 51.9 
5 54.3 54.5 5' 47.1 47.4 
6 22.8 23.0 6' 32.0 31.3 
7 106.6 107.7 7' 44.6 44.1 
8 126.4 127.1 8' 134.8 135.7 
9 118.1 118.2 9' 120.7 120.9 
10 118.8 119.5 10' 118.4 118.7 
11 120.9 121.5 11' 126.3 126.7 
12 108.7 110.9 12' 111.1 109.5 
13 137.0 135.7 13' 145.6 146.9 
14 32.5 33.2 14' 25.5 27.3 
15 31.8 32.1 15' 33.8 32.3 
16 37.7 38.0 16' 67.1 57.8 
17 65.8 65.7 17 64.5 ‒ 
18 26.6 26.6 18' 12.4 12.4 
19 99.2 98.7 19' 119.0 119.5 
20 36.5 36.8 20' 136.0 135.7 
21 28.6 28.6 21' 51.9 53.0 
N(1)-Me 29.0 – CO2Me' 51.8 51.9 
N(4)-Me 41.8 41.7 CO2Me' 172.5 171.2 
































































































































































































































































































































































































































































































































2.1.7.3.3 Villalstonine (88), Villalstonine N(4)-oxide (89), and Macrocarpamine (90)  
 
Other known macroline-pleiocarpamine bisindole alkaloids, which were isolated in the 
present study are villalstonine (88),
118,123,128,148,169,174,175,184
 villalstonine N(4)-oxide 
(89),
118,166




H NMR spectra of these three 
compounds are shown in Figures 2.127–2.129, while the 1H and 13C NMR data of 
compounds 8889 and 90 are summarized in Tables 2.68–2.70, respectively. Other data 








Position 88  89 Position 88  89 
3 3.86 t (3) 3.86 m 3' 3.73 m 4.26 m 
5 2.91 br d (7) 2.91 d (7) 5' 2.69 m 3.35 m 
6 2.47 d (16) 2.41 m 5' 3.12 td  
(14, 2) 
3.62 m 
6 3.29 dd  
(16, 7) 
3.30 m 6' 1.11 br d (14) 1.64 m 
9 7.55 br d (8) 7.55 br d (8) 6' 2.03 td  
(14, 4) 
1.88 td (16, 5) 
10 7.15 br t (8) 7.15 br t (8) 9' 6.88 br d (8) 6.92 d (8) 
11 7.23 br t (8) 7.23 td (8, 1) 10' 6.99 br t (8) 6.77 t (8) 
12 7.34 br d (8) 7.33 br d (8) 11' 6.70 br t (8) 7.04 dt (8, 1) 
14 1.44 dt  
(13, 3) 
1.43 m 12' 6.15 br d (8) 6.17 d (8) 
14 2.42 m 2.41 m 14' 1.68 dt (12, 3) 2.57 br d (14) 
15 1.60 m 1.60 m 14' 2.69 m 2.82 dt (14, 3) 
16 2.09 m 2.08 dt (12, 5) 15' 3.22 br d (3) 3.27 br d (3) 
17 3.73 m 3.75 dd (12, 5) 16' 4.42 d (4)  4.44 d (3.7) 
17 4.00 t (11) 3.96 t (12) 18' 1.55 d (7) 1.62 dd (7, 2) 
18 1.25 s 1.27 s 19' 5.36 q (7) 5.49 q (7) 
20 1.16 dd  
(12, 3) 
1.20 dd (14, 5) 21' 2.92 d (12) 3.30 m 
21 1.60 m 1.64 m 21' 4.19 br d (12) 5.01 br d (13) 
21 2.42 m 2.37 m CO2Me' 3.68 s 3.70 s 
N(1)-Me 3.62 s 3.61 s    
N(4)-Me 2.31 s 2.31 s    














C 88 89 C 88 89 
2 135.8 132.7 2' 92.1 93.1 
3 53.4 53.4 3' 51.7 67.1 
5 54.4 54.3 5' 47.4 64.2 
6 22.8 23.1 6' 31.2 34.5 
7 106.6 106.8 7' 44.1 42.9 
8 126.4 126.5 8' 132.8 133.6 
9 118.3 118.4 9' 120.7 121.5 
10 120.8 119.0 10' 118.1 119.8 
11 118.3 121.1 11' 126.4 127.5 
12 108.7 108.8 12' 109.2 110.2 
13 136.9 137.0 13' 146.9 146.0 
14 32.4 32.6 14' 27.4 21.7 
15 32.3 31.8 15' 31.7 31.4 
16 37.8 37.6 16' 57.7 57.7 
17 65.6 65.6 18' 12.4 12.8 
18 26.5 26.4 19' 118.2 125.0 
19 98.5 99.1 ' 136.1 130.1 
20 36.7 36.5 21' 52.9 67.8 
21 28.4 28.0 CO2Me' 51.6 52.1 
N(1)-Me 29.0 29.1 CO2Me' 171.3 170.3 
N(4)-Me 41.7 41.9    













C NMR Spectroscopic Data for Macrocarpamine (90)
a
 
Position δH δC Position δH δC 
2 ‒ 132.9 2' ‒ 66.7 
3 3.79 br t (3.4) 53.8 3' 2.86 m 54.3 
5 2.97 d (7) 54.9 5' 2.86 m 49.9 
6 2.39 d (16)  22.6 5' 2.86 m  
6 3.20 dd (16, 7)   6' 1.39 m 21.4 
7 ‒ 106.6 6' 1.71 m  
8 ‒ 126.4 7' 2.53 dd (11, 8) 45.6 
9 7.37 br d (7.5) 117.9 8' ‒ 133.6 
10 7. 03 td (7.5, 1) 118.9 9' 6.83 br d (7.5) 123.2 
11 7.15 td (7.5, 1) 120.9 10' 6.44 td (7.5, 1) 117.6 
12 7.29 br d (7.5) 108.8 11' 6.72 td (7.5, 1) 126.6 
13 ‒ 137.1 12' 5.77 br d (7.5) 107.8 
14 1.79 m 32.3 13' ‒ 147.2 
14 1.79 m  14' 1.62 dt (14, 4) 29.3 
15 1.98 m 23.7 14' 2.02 dt (14, 4)  
16 1.84 dt (12, 4) 38.9 15' 3.07 m 32.0 
17 3.88 dd (11, 3)  66.8 16' 4.10 br d (4) 58.1 
17 4.19 t (11)   18' 1.48 dd (7, 2) 12.2 
18 4.50 d (16) 125.5 19' 5.29 qd (7, 2) 118.5 
19 5.37 d (16) 127.3 20' ‒ 135.7 
20 ‒ 115.6 21' 4.25 dt (13, 2) 52.8 
21 6.19 s 144.5 21' 2.86 m  
N(1)-Me 3.61 s 29.1 CO2Me' 3.63 s 51.7 
N(4)-Me 2.25 s 41.8 CO2Me' ‒ 170.5 
















































































































































































































































































































































































































































































































































































































































































































































































































2.2 Alkaloid Variation in A. macrophylla 
 
The present investigation of the stem-bark and leaf of A. macrophylla yielded a total of 
90 alkaloids, which 17 indole (1‒4, 16‒17, 24‒34) and 13 bisindole (71‒75, 77‒82, 86, 
87) alkaloids are new. A total of 20 alkaloids were common in both the stem-bark and 
leaf extracts, comprising seven macroline-type (5‒8, 10, 12‒13), four akuammiline-
type (24, 35, 36, 41), three sarpagine-type (32, 51, 52), one ajmaline-type (54), four 
corynantheine alkaloids (57, 59, 63, 65), and one strychnan alkaloid (67).        
A comparison of the present results with that of an earlier study of the alkaloids 
collected from the different location, showed a significant variation in the alkaloid 
composition between the two samples. The samples of the earlier study were collected 
from the East Coast (Terengganu) while those of the present study were collected from 
the West Coast (Perak) of Penisular Malaysia (Malaya), respectively.  
Firtsly, indole alkaloids which were common to both studies included 10 macroline-
type alkaloids (5‒14), five macroline oxindole alkaloids (19‒23), four akuammiline-
type alkaloids (41, 44‒46), four corynantheine alkaloids (57, 59, 63, 66), and one 
strychnan alkaloid (67). In the case of bisindole alkaloids, a total of 20 (71‒90) were 
found in the present study, of which only two were found in the previous study, viz. 
perhentinine (83) and villalstonine (88).  
Several of the alkaloids obtained in the earlier study, but which were not found in the 
present study were alstohentine (110), alstomicine (109), 6-oxoalstophylline (114), 6-
oxoalstophyllal (115), Macrodasine B (119), N(1)-demethylalstophylline (116), N(1)-
demethylalstophyllal (117), angustimalal (97), 16-hydroxyalstonisine (129), 16-
hydroxyalstonal (130), 16-hydroxy-N(4)-demethylalstophylline oxindole (132), 16-









Conversely, a total of 64 alkaloids (46 indoles and 18 bisindoles) such as the five 
macroline alkaloids (1‒4, 15), three macroline oxindole alkaloids (16‒18), 18 
akuammiline alkaloids (24‒31, 35‒40, 42, 43, 47, 48), 10 sarpagine and ajmaline-type 
alkaloids (32–34, 49‒55), seven corynantheine alkaloids (56, 58, 60–62, 66, 68), one 
strychnan alkaloid (65), one vallesiachotaman alkaloid (69), one carboline alkaloid (70), 
and 18 bisindole alkaloids (71‒82, 84‒87, 89‒90) were obtained in the present study 
but were not detected in the previous study (see Table 2.71). It is therefore apparent 
from the above comparison that the alkaloidal composition varies with the different 
locality, a feature which has been previously noted in our ongoing investigation of the 






















Table 2.71: Comparison of the Alkaloids Obtained from A. macrophylla in the Present 
Investigation (Perak, Malaya) Versus those from an Earlier Study 
(Terengganu, Malaya) 











Macroline Alkaloids     
Alstofolinine (1) (New)    + 
Compound 2 (20,21-Dihydroalstonerine) (New)   +  
Compound 3 (N(1)-Demethylmacrocarpine B) (New)   +  
Macrodasine H (4) (New)   +  
Alstonerine (5)  + + + 
Alstonerinal (6)  + + + 
Alstophylline (7) + + + + 
Alstophyllal (8) + + + + 
Macrocarpine A (9) + + +  
Macrocarpine B (10) + + + + 
Macrocarpine C (11) +  +  
Talcarpine (12) + + + + 
N(4)-Methyl-N(4),21-secotalpinine (13) + + + + 
Macrodasine A (14) +  +  
Macrodasine G (15)     +  
Angustimalal (97) +    
Alstomicine (109)  +   
Alstohentine (110)  +   
6-Oxoalstophylline (114)  +   
6-Oxoalstophyllal (115)  +   
N(1)-Demethylalstophylline (116) +    
N(1)-Demethylalstophyllal (117) +    
Macrodasine B (119) +    
     
Macroline Oxindole Alkaloids     
Compound 16 (11-Methoxyalstonoxine A) (New)    + 
Compound 17 (11-Methoxyalstonoxine B) (New)   +  
Alstonoxine A (18)    + 








Table 2.71, continued 











Alstonisine (20) + +  + 
Alstonal (21) + +  + 
N(4)-Demethylalstophylline oxindole (22) + +  + 
N(4)-Demethylalstophyllal oxindole (23) + +  + 
16-Hydroxyalstonisine (129)  +   
16-Hydroxyalstonal (130)  +   
16-Hydroxy-N(4)-demethylalstophyllal oxindole (131)  +   
16-Hydroxy-N(4)-demethylalstophylline oxindole (132)  +   
     
Akuammiline alkaloids     
Compound 24 (2(S)-Cathafoline) (New)   + + 
Compound 25 (2(S)-10-Methoxycathafoline) (New)    + 
Compound 26 (2(R)-3-Hydroxycathafoline) (New)    + 
Compound 27 (10-Demethoxyvincorine) (New)    + 
Compound 28 (10-Demethoxyvincorine N(4)-oxide) (New)    + 
Compound 29 (11-Methoxyvincorine) (New)    + 
Compound 30 (Vincorine N(4)-oxide) (New)    + 
Compound 31 (11-Demethoxyquaternine) (New)    + 
Cathafoline (35)   + + 
Cathafoline N(4)-oxide (36)   + + 
10-Methoxycathafoline (37)    + 
Strictamine (38)    + 
11-Methoxystrictamine (39)    + 
11-Hydroxystrictamine (40)    + 
Vincorine (41)  + + + 
Norvincorine (42)    + 
Alstonamide (43)    + 
Demethoxyalstonamide (44)  +  + 
Alstomaline (45)  +  + 
Quaternine (46)  +  + 
Picrinine (47)    + 








Table 2.71, continued 











Vincoridine (157)  +   
Volkensine (170)  +   
     
Sarpagine and Ajmaline Alkaloids     
Compound 32 (19,20-Z-Affinisine) (New)   + + 
Compound 33 (Vincamajine N(4)-oxide) (New)    + 
Compound 34 (Vincamajine 17-O-veratrate N(4)-oxide) 
(New) 
   + 
Affinisine (49)   +  
Affinisine oxindole (50)   +  
Normacusine B (51)   + + 
Alstoumerine (52)   + + 
Quebrachidine (53)    + 
Vincamajine (54)   + + 
Vincamajine 17-O-veratrate (55)    + 
     
Corynantheine Alkaloids     
Sitsirikine (56)    + 
16(R),19(E)-Isositsirikine (57) +  + + 
18,19-Dihydroisositsirikine (58)    + 
Pleiocarpamine (59) +  + + 
16-Hydroxymethylpleiocarpamine (60)   +  
Pleiomaltinine (61)   +  
Picramicine (62)   +  
Fluorocarpamine (63) +  + + 
Yohimbine (64)    + 
Talpinine (65)   + + 
10,11-Dimethoxynareline (66)  +  + 
     
Strychnan Alkaloids     
11-Methoxyakuammicine (67) +  + + 








Table 2.71, continued 











Miscellaneous Monoterpene Indole Alkaloids     
Antirhine (69)   +  
1,2,3,4-Tetrahydro-1-oxo--carboline (70)   +  
     
Linearly Fused Bisindoles     
Lumutinine A (71) (New)   +  
Lumutinine B (72) (New)   +  
Lumutinine C (73) (New)   +  
Lumutinine D (74) (New)   +  
Lumutinine E (75) (New)   +  
Macralstonidine (76)   +  
     
Macroline-Macroline Bisindoles     
Lumusidine A (77) (New)   +  
Lumusidine B (78) (New)   +  
Lumusidine C (79) (New)   +  
Lumusidine D (80) (New)   +  
Perhentidine A (81) (New)   +  
Perhentidine B (82) (New)   +  
Perhentinine (83) +  +  
Macralstonine (84)   +  
Anhydromacralstonine (85)   +  
     
Macroline-Pleiocarpamine Bisindoles     
Villalstonidine B (86) (New)   +  
Villalstonidine F (87) (New)   +  
Villalstonine (88) +  +  
Villalstonine N(4)-oxide (89)   +  















Alkaloids are particularly interesting substances because of their multiple 
pharmacological activities. In addition to our systematic chemical investigations, 
alkaloids isolated from the present study were screened for their biological activity, in 
particular for their cytotoxic effects, including their potential in reversing multidrug 
resistance (MDR) in drug-resistant tumor cells. This part of the work was carried out by 




2.3.2 Cytotoxicity and Reversal Multidrug Resistance (MDR) 
 
Cancer represents one of the leading causes of death worldwide. The development of 
new anticancer drugs as well as more effective treatment strategies are crucial in drug 
discovery and clinical therapy. Multidrug resistance (MDR) is one of the significant 
obstacles in cancer chemotherapy. MDR is defined as the ability of cells exposed to a 
single drug to develop resistance to a broad range of structurally and functionally 
unrelated drugs due to enhanced outward transport of drugs mediated by a membrane 
glycoprotein “drug transport pump”.275-277  The cytotoxic drugs that are most frequently 
associated with MDR are hydrophobic, amphipathic natural products, such as Vinca 













The mechanism of MDR is attributed to the over-expression of P-glycoprotein (P-gp) or 
multidrug resistance-associated protein (MRP), which act as transmembrance drug 
efflux pumps, reducing intracellular accumulation of anticancer drugs in the cell.
278,279
 
By introducing a modulator of MDR (also known as a chemosensitizer) together with 
the anticancer drug, this effect can be reversed, which is termed reversal of multidrug 
resistance. When a modulator is present in the growth medium, the sensitivity of the 
resistant cells to the oncolytic can be enhanced by inhibiting the efflux mechanism so 
that cells accumulate a higher intracellular concentration of drug thereby becoming 
more drug-sensitive. Many agents that modulate the function of P-gp have been 





calmodulin antagonists (e.g. trifluoperazine and chlorpromazine), steroidal agents (e.g. 
cortisol and tamoxifen), protein kinase C inhibitors, immunosuppressive drugs (e.g. 




While the first generation agents (e.g. verapamil and cyclosporin) suffered from 
limitations due to unacceptable toxicity, the second generation agents (e.g. valspodar 
and biricodar) were found to possess better tolerability but were limited by displaying 
unpredictable pharmacokinetic interactions, including interactions with other transporter 
proteins.
278
 Third generation agents (e.g. tariquidar and zosuquidar) possess both higher 












The alkaloids obtained from the present study were screened for cytotoxic effects 
against KB cells as well as their potential in reversing multidrug resistance (MDR) in 
drug-resistant KB cells. KB refers to the human oral epidermoid carcinoma cell line. 
The alkaloids were tested at an initial concentration of 25 μg/mL and the IC50 values 
were then determined for the more active compounds and the results are presented in 
Table 2.72. 
 
Compounds 24, 25, 29, 33, 48 and 80 displayed strong activity in reversing MDR in 
vincristine-resistant KB cells, while compounds 16, 26, 31, 38, 80, and 87 displayed 
only moderate activity.  
 
Villalstonine (88) and macrocarpamine (90) showed appreciable cytotoxicity towards 
drug-sensitive and drug-resistant KB cells, while lumutinines A‒E (71‒75), 
macralstonidine (76), lumusidines A–C (77–79), anhydromacralstonine (85), and 
villalstonidine B (86) displayed only moderate activity. 
 
Perhentidines A and B (81 and 82) and perhentinine (83) showed strong cytotoxicity 
toward drug-sensitive and drug-resistant KB cells, while the O-acetyl derivatives of 
these bisindoles (81a‒83a) revealed that acetylation resulted in a reduction of the 
biological activity. Macralstonine (84) was found to be effective in reversing MDR in 
vincristine-resistant KB cells, while the O-acetyl-E-seco-macralstonine (84b) showed 








Table 2.72: Cytotoxic effects of compounds from A. macrophylla against KB cells 
Compound Name IC50, g/mL (M) 
 KB/S KB/VJ300 KB/VJ300 
  VCR (‒) VCR (+) 
Macroline alkaloids    
Alstofolinine (1) >25 >25 >25 
N(4)-Methyl-N(4),21-secotalpinine (13) >25 >25 2.87 (8.48) 
    
Macroline Oxindoles    
Compound 16 (11-Methoxyalstonoxine A) >25 >25 9.25 (25.81) 
Alstonoxine A (18) >25 >25 >25 
Alstonoxine B (19) >25 >25 >25 
    
Akuammiline, sarpagine and ajmaline 
alkaloids 
   
Compound 24 (2(S)-Cathafoline) >25 >25 0.62 (1.83) 
Compound 25 (2(S)-10-Methoxycathafoline) >25 >25 0.31 (0.88) 
Compound 26 (2(R)-3-Hydroxycathafoline) >25 >25 3.74 (10.55) 
Compound 29 (11-Methoxyvincorine) >25 >25 1.32 (3.31) 
Compound 31 (11-Demethoxyquaternine) >25 >25 3.54 (9.26) 
Compound 32 (19,20-Z-Affinisine) >25 >25 0.05 (0.16) 
10-Methoxycathafoline (37) >25 >25 3.11 (8.44) 
Strictamine (38) >25 >25 14.4 (44.67) 
11-Methoxystrictamine (39) >25 >25 0.51 (1.45) 
11-Hydroxystrictamine (40) >25 >25 >25 
Norvincorine (42) >25 >25 >25 
Alstonamide (43) >25 >25 1.06 (2.57) 
Demethoxyalstonamide (44) >25 >25 1.38 (3.61) 
Picrinine (47) >25 >25 1.87 (5.53) 
12-Demethoxytabernulosine (48) >25 >25 1.55 (4.21) 
Normacusine B (51) >25 >25 >25 
Alstoumerine (52) >25 >25 >25 
Quebrachidine (53) >25 >25 6.76 (19.18) 
Vincamajine (54) >25 >25 3.33 (9.09) 
    
Corynantheine alkaloids    
Fluorocarpamine (63) >25 >25 13.87 (40.99) 
10,11-Dimethoxynareline (69) >25 >25 >25 
    
Strychnan alkaloid    








Table 2.72, continued 
Compound Name IC50, g/mL (M) 
 KB/S KB/VJ300 KB/VJ300 
  VCR (‒) VCR (+) 
Linearly fused bisindoles    
Lumutinine A (71) 10.52 (15.63) 10.62 (15.78) 0.21 (0.31) 
Lumutinine B (72) 4.63 (6.88) 5.51 (8.19) 0.10 (0.15) 
Lumutinine C (73) 12.01 (18.17) 13.30 (20.31) 4.61 (6.98) 
Lumutinine D (74) 12.78 (19.82) 18.14 (28.13) 3.93 (6.09) 
Lumutinine E (75) 11.4 (18.07) 11.53 (18.28) 2.74 (4.34) 
Macralstonidine (76) 6.62 (10.27) 4.52 (7.01) 0.13 (0.20) 
    
Macroline-macroline bisindoles    
Lumusidine A (77) 9.59 (13.96) 10.62 (15.46) 0.16 (0.23) 
Lumusidine B (78) 5.51 (7.82) 7.71 (10.94) 0.70 (0.99) 
Lumusidine C (79) 12.63 (17.23) 16.63 (22.69) 1.19 (1.62) 
Lumusidine D (80) >25 >25 5.03 (7.32) 
Perhentidine A (81) 2.91 (4.13) 3.91 (5.55) 2.29 (3.25) 
O-Acetylperhentidine A (81a) 8.57 (11.47) 12.84 (17.19) 0.36 (0.48) 
Perhentidine B (82) 3.35 (4.75) 4.06 (5.76) 0.84 (1.19) 
O-Acetylperhentidine B (82a) 12.83 (17.18) 11.94 (15.99) 0.28 (0.37) 
Perhentinine (83) 3.17 (4.50) 3.94 (5.59) 0.52 (0.74) 
O-Acetylperhentinine (83a) 10.59 (14.18) 11.56 (15.48) 0.30 (0.40) 
Macralstonine (84) >25 >25 1.71 (2.43) 
O-Acetyl-E-seco-macralstonine (84b) 3.02 (4.04) 3.75 (5.02) 0.27 (0.36) 
Anhydromacralstonine (85) 5.65 (8.18) 9.06 (13.11) 0.44 (0.64) 
    
Macroline-pleiocarpamine bisindoles    
Villalstonidine B (86) 4.30 (6.22) 5.01 (7.25) 0.35 (0.51) 
Villalstonidine F (87) >25 >25 5.64 (8.72) 
Villalstonine (88) 2.95 (4.46) 2.64 (3.99) 0.42 (0.64) 
Macrocarpamine (90) 3.32 (5.16) 3.47 (5.40) 0.53 (0.82) 
    







Verapamil >1.0 (> 2.20) >1.0 (> 2.2)  
KB/S – vincristine-sensitive human oral epidermoid carcinoma cell line. 
KB/VJ300 – vincristine-resistant human oral epidermoid carcinoma cell line. 
VCR (+) – with added vincristine, 0.1 g/mL (0.12 M), which did not affect the growth of the 
KB/VJ300 cells.  












3.1 Source and authentication of plant materials 
 
The plant materials (leaf and bark of Alstonia macropylla, K671) were collected from 
Lumut, Perak in Malaysia on September 2004 and were identified by Dr. Richard C. K. 
Chung (Forest Research Institute, Malaysia). The plant materials were screened for their 
alkaloidal constituents before any chemical analysis was carried out. Voucher 





Melting points were determined on Mel-Temp melting point apparatus and were 
uncorrected. Optical rotations were determined on a Jasco P-1020 digital polarimeter. 
UV spectra were obtained on a Shimadzu UV-3101PC spectrophotometer. IR spectra 
were recorded on a Perkin-Elmer 1600 Series or a Perkin-Elmer RX1 FT-IR 
spectrophotometer. ESIMS and HRESIMS were obtained on an Agilent 6530 Q-TOF 
mass spectrometer. HREIMS, and HRLSIMS were obtained at Organic Mass 




C NMR spectra were recorded in CDCl3 using TMS as internal standard on a 
JEOL JNM-LA 400, or JNM-ECA 400 or Bruker Avance III 400 spectrometers, at 400 
and 100 Hz, respectively, or on a Bruker Avance III 600 spectrometers at 600 and 150 








diffraction analysis was carried out on a Bruker SMART APEX II CCD area detector 
system equipped with a graphite monochromator and using Mo K radiation 
(=0.71073 Å), or on an Agilent Technologies SuperNova Dual CCD area detector 
system equipped with mirror monochromator and using Cu K radiation (=1.54184 Å), 
at 100 K. The structure was solved by direct methods (SHELXS-97) and refined with 
full-matrix least-squares on F
2
 (SHELXL-97). (I thank Mr Low Yun Yee for carrying 
out X-ray diffraction analysis). All solvents were distilled prior to use with the 
exception of diethyl ether, which was passed through activated neutral alumina before 
use. All reactions were carried out under N2 in oven-dried glasswares. CH2Cl2 and 
pyridine were distilled from CaH2 under N2.  
 
 
3.3 Chromatographic methods 
 
3.3.1 Column Chromatography 
 
Flash chromatography was performed using Merck silica gel 9385 (230‒400 Mesh 
ASTM). The ratio of silica gel to the sample was approximately 30:1 for crude samples 
and 100:1 for semi-pure fractions. The gel was made into a slurry with chloroform 
before it was packed onto the column and was allowed to equilibrate for at least an hour 
before use. When diethyl ether was used as an eluting solvent, the column was packed 
by the dry packing method. The solvent systems normally used as eluents were 
chloroform with increasing methanol gradient or diethyl ether with increasing ethyl 
acetate gradient. Fractions were monitored by thin layer chromatography (TLC) and 
appropriate fractions were combined and where necessary subjected to further 








3.3.2 Thin Layer Chromatography (TLC) 
 
Thin layer chromatography (TLC) was routinely used to detect and separate the various 
alkaloids. The crude alkaloidal extracts, fractions from chromatography, and isolated 
pure alkaloids were examined by TLC using pre-coated  5 x 10 cm aluminium plates, 
0.25 mm thickness, silica gel 60 F254 (Merck, Darmstadt, G.F.R.). The TLC plates were 
spotted with a piece of fine glass capillary tube and then developed in saturated 
chromatographic tanks with various solvent systems at room temperature. The 
alkaloidal spots were visualized by examination of the TLC plates under UV light (254 
nm), followed by spraying with Dragendorff’s reagent, which formed orange spots. The 
hRf values of the alkaloids are tabulated in Table 3.1. 
 
Table 3.1: The hRf Values of Alkaloids Isolated from Alstonia macrophylla 




Alstofolinine (1)  12 44 21 72 52 
Compound 2 (20,21-Dihydroalstonerine) 4 10 5 62 21 
Compound 3  
(N(1)-Demethylmacrocarpine B) 
0 10 3 28 16 
Macrodasine H (4) 4 13 5 64 30 
Alstonerine (5) 12 38 24 72 48 
Alstonerinal (6) 12 38 24 72 48 
Alstophylline (7) 11 35 20 70 44 
Alstophyllal (8) 11 35 20 70 44 
Macrocarpine A (9) 4 15 9 55 27 
Macrocarpine B (10) 0 10 4 48 21 
Macrocarpine C (11) 7 23 15 71 37 
Talcarpine (12) 11 25 15 68 40 
N(4)-Methyl-N(4),21-secotalpinine (13) 3 10 11 49 26 
Macrodasine A (14) 0 5 0 51 13 
Macrodasine G (15) 0 1 0 45 9 
Compound 16  
(11-Methoxyalstonoxine A) 
2 5 2 58 15 
Compound 17  
(11-Methoxyalstonoxine B) 
0 4 1 34 9 
Alstonoxine A (18) 2 5 2 57 15 
Alstonoxine B (19) 0 6 1 41 11 
Alstonisine (20) 8 40 25 68 50 








Table 3.1: continued 






8 39 20 70 48 
N(4)-Demethylalstophyllal oxindole (23) 8 39 20 70 48 
Compound 24 (2(S)-Cathafoline) 2 2 1 42 4 
Compound 25  
(2(S)-10-Methoxycathafoline) 
0 0 0 34 2 
Compound 26  
(2(R)-3-Hydroxycathafoline)   
9 39 32 65 55 
Compound 27 (10-Demethoxyvincorine) 11 48 45 72 55 
Compound 28  
(10-Demethoxyvincorine N(4)-oxide) 
0 0 0 30 0 
Compound 29 (11-Methoxyvincorine) 9 33 26 69 41 
Compound 30 (Vincorine N(4)-oxide) 0 0 0 35 0 
Compound 31  
(11-Demethoxyquaternine)   
1 7 2 43 13 
Compound 32 (19,20-Z-Affinisine) 2 12 6 48 25 
Compound 33 (Vincamajine N(4)-oxide) 0 0 0 30 0 
Compound 34 (Vincamajine 17-O-
veratrate N(4)-oxide) 
0 0 0 41 0 
Cathafoline (35) 1 2 1 32 4 
Cathafoline N(4)-oxide (36) 0 1 0 20 1 
10-Methoxycathafoline (37) 3 3 2 37 4 
Strictamine (38) 3 4 2 50 9 
11-Methoxystrictamine (39) 1 3 2 49 8 
11-Hydroxystrictamine (40) 2 5 2 36 9 
Vincorine (41)  18 44 40 70 51 
Norvincorine (42) 1 6 2 44 12 
Alstonamide (43) 17 52 29 76 59 
Demethoxyalstonamide (44) 1 6 2 44 12 
Alstomaline (45) 3 7 2 61 16 
Quaternine (46) 4 9 3 61 15 
Picrinine (47) 1 8 4 42 16 
12-Demethoxytabernulosine (48) 3 11 5 62 20 
Affinisine (49) 1 12 5 40 20 
Affinisine oxindole (50) 0 5 1 37 11 
Normacusine B (51) 0 7 2 23 13 
Alstoumerine (52) 0 4 0 38 9 
Quebrachidine (53) 2 11 5 49 21 
Vincamajine (54) 6 26 13 61 35 
Vincamajine 17-O-veratrate (55) 9 30 12 71 38 
Sitsirikine (56) 0 4 1 21 7 
16(R),19(E)-Isositsirikine (57) 0 8 4 41 22 
18,19-Dihydroisositsirikine (58) 2 41 22 49 50 
Pleiocarpamine (59) 2 3 2 43 7 
16-Hydroxymethylpleiocarpamine (60) 0 1 0 28 4 
Pleiomaltinine (61) 0 0 0 52 2 









Table 3.1: continued  




Fluorocarpamine (63) 1 9 5 57 18 
Yohimbine (64) 2 20 9 51 33 
Talpinine (65) 1 9 4 55 23 
10,11-Dimethoxynareline (66) 1 17 3 53 29 
11-Methoxyakuammicine (67) 1 2 1 38 4 
11-Methoxyakuammicine N(4)-oxide 
(68) 
0 0 0 29 0 
Antirhine (69) 0 4 1 21 7 
1,2,3,4-Tetrahydro-1-oxo--carboline 
(70) 
4 13 5 64 30 
Lumutinine A (71) 2 22 6 74 38 
Lumutinine B (72) 2 9 3 69 21 
Lumutinine C (73) 0 1 0 55 8 
Lumutinine D (74) 0 1 0 45 4 
Lumutinine E (75)  0 6 0 44 16 
Macralstonidine (76) 0 10 2 62 20 
Lumusidine A (77) 7 22 7 68 38 
Lumusidine B (78) 0 4 1 32 8 
Lumusidine C (79) 1 10 4 62 24 
Lumusidine D (80) 1 18 7 61 34 
Perhentidine A (81) 0 1 0 41 4 
Perhentidine B (82) 0 1 0 41 5 
Perhentinine (83) 1 4 0 52 10 
Macralstonine (84) 0 5 1 48 11 
Anhydromacralstonine (85) 2 15 4 68 33 
Villalstonidine B (86) 1 3 0 43 6 
Villalstonidine F (87)  0 1 0 34 5 
Villalstonine (88) 0 2 0 56 7 
Villalstonine N(4')-oxide (89) 0 1 0 35 0 





3.3.3 Preparative Centrifugal TLC 
 
Preparative centrifugal TLC was carried out using a round chromatographic plate 
measuring 24 cm in diameter. To prepare the chromatographic plate, the edge of the 
plate is secured with cellophane tape to form a mould. Silica gel (Merck 7749, 50 g) is 








then quickly poured on to the circular glass plate before setting commences. The 
circular glass plate is rotated while the gel is being poured to obtain an even setting. The 
plate is then left to air-dry for about an hour before being dried in an oven at 80 °C for 
about 12 hours. The sample was dissolved in a minimum volume of a suitable solvent 
and loaded at the centre of the plate while the plate is spinning to form a thin band. 
Elution is then carried with the appropriate solvent system. The fractions are collected, 
concentrated by rotary-evaporation, examined by TLC, and combined where 
appropriate. Some of the solvent systems used as eluents were: 
 
1. Chloroform 
2. Chloroform: Hexanes 
3. Chloroform with added 1% of liquid ammonia 
4. Chloroform: Methanol  
5. Diethyl ether  
6. Diethyl ether: Hexanes 
7. Diethyl ether: Methanol 
8. Diethyl ether with added 1% of liquid ammonia 
9. Ethyl acetate 
10. Ethyl acetate: Hexanes 
11. Ethyl acetate: Methanol  













3.4 Spray Reagent (Dragendorff’s Reagent) 
 
Solution A: 0.85 g of bismuth nitrate was dissolved in a mixture of 10 mL glacial acetic 
acid and 40 mL of distilled water. 
Solution B: 8 g of potassium iodide was dissolved in 20 mL of distilled water. 
 
A stock solution was prepared by mixing equal volumes of solutions A and B. 
Dragendorff”s reagent was prepared by mixing 1 mL of stock solution with 2 mL of 
glacial acetic acid and 10 mL of distilled water. Orange spots on the developed TLC 
plates indicate the presence of alkaloids. 
 
 
3.5 Extraction of Alkaloids 
 
The plant materials were dried and ground before extracting with 95% ethanol for 23 
days at room temperature. The ethanol extract was filtered and the residue was then re-
extracted with a fresh portion of distilled ethanol. This procedure was repeated 5 or 6 
times. The combined extract was then concentrated by distillation under reduced 
pressure using a rotary-evaporator to about a tenth of the original volume. The 
concentrated extract was then added slowly into 3 % tartaric acid with constant stirring. 
The acidic solution was then filtered through kieselguhr to remove the non-alkaloidal 
substances. The filtrate was then basified with concentrated ammonia solution to about 
pH 10 with cooling and the liberated alkaloids were extracted exhaustively with 
chloroform. The chloroform extract was then washed with distilled water and dried over 
anhydrous sodium sulfate. Finally, the solvent was removed by evaporation under 








3.6 Isolation of Alkaloids 
 
3.6.1 General Procedure 
 
The crude mixture obtained from the extraction procedure described above was initially 
fractionated by vacuum chromatography over silica gel. The column was eluted with 
chloroform, followed by a stepwise increase of methanol gradient. Based on TLC, the 
many fractions collected were pooled into several major fractions, which were then 
subjected to further fractionation by flash chromatography, vacuum chromatography, 
HPLC, or preparative centrifugal TLC until pure compounds are obtained. 
 
 
3.6.2 Isolation of Alkaloids from the Stem-bark of Alstonia macrophylla 
 
Extraction of 9.0 kg of stem-bark material yielded ca. 57.6 g of crude alkaloidal mixture. 
This mixture was then subjected to chromatography as summarized in the flow diagram 
shown in Figure 3.1 to yield 56 pure alkaloids. 
 
 
3.6.3 Isolation of Alkaloids from the Leaf of Alstonia macrophylla 
 
Extraction of 7 kg of leaf material yielded ca. 45.1 g of crude alkaloidal mixture. This 
mixture was then subjected to chromatography as summarized in the flow diagram 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.7 Compound data 
 
The following alkaloids were isolated from the stem-bark and leaf of A. macrophylla: 
 
Alstofolinine (1): light yellowish oil; [α]D 104 (c 0.36, CHCl3); UV (EtOH) max nm 
(log ) 227 (4.10), 285 (3.43) nm; IR (dry film) max 1769 (lactone) cm
1
; EIMS  m/z 
296 [M]

 (91), 281 (7), 265 (4), 240 (5), 227 (40), 212 (5), 197 (78), 182 (23), 181 (98), 
170 (24), 167 (36), 154 (12), 144 (7), 119 (11); HREIMS m/z 296.1528 (calcd for 
C18H20N2O2, 296.1525); ESIMS m/z 297 [M + H]
+
; HRESIMS m/z 297.1606 (calcd for 
C18H20N2O2 + H, 297.1603); for 
1
H NMR and 
13
C NMR data, see Table 2.2.  HMBC: 
2
J 
H-3 to C-2; H-6, H-6 to C-5; H-6, H-6 to C-7; H-15 to C-14; H-14, H-14, H-16 
to C-15; H-5, H-17, H-17 to C-16; H-16 to C-17. 3J H-6, H-6, H-14, N-1-Me to 
C-2; H-5, H-15, N-4-Me to C-3; H-3, H-15, H-17, N-4-Me to C-5; H-3, H-5, H-9 to C-
7; H-6, H-10, H-12 to C-8; H-11 to C-9; H-12 to C-10; H-9 to C-11; H-10 to C-12; H-
9, H-11, N-1-Me to C-13; H-16 to C-14; H-3, H-5, H-17 to C-15; H-6, H-6, H-14, 
H-14 to C-16; H-5, H-15 to C-17; H-14, H-14, H-17 to C-18. NOESY: H-3/H-14, 
H-14, N-1-Me, N-4-Me; H-5/H-6, H-6, H-17, H-17, N-4-Me; H-6/H-5, H-6; 
H-6/H-5, H-6, H-9; H-9/H-6, H-10; H-10/H-9; H-12/N-1-Me; H-14/H-3; H-
14/H-3, N-1-Me; H-15/H-16; H-16/H-15, H-17, H-17; H-17/H-5, H-16; H-17/H-
5, H-16; N-1-Me/H-3, H-12, H-14; N-4-Me/H-3, H-5. 1D-NOE: H-3/H-14, H-14, 
N-1-Me, N-4-Me; H-5/H-6, H-6, H-16, H-17, H-17, N-4-Me; H-6/H-5, H-6, N-
4-Me; H-9/H-6, H-10; H-16/H-5, H-6, H-15, H-17; H-17/H-5, H-17; H-17/H-5, 









Compound 2 (20,21-Dihydroalstonerine): light yellowish oil; []D 31 (c 0.11, 
CHCl3); UV (EtOH) max (log ) 228 (4.50), 286 (3.79) nm; IR (dry film) max 1710 
cm
1
; EIMS m/z 338 [M]
+
 (100), 307 (8), 295 (11), 264 (10), 251 (6), 238 (8), 223 
(5), 210 (14), 197 (78), 182 (19), 170 (13), 158 (10), 119 (4), 84 (12), 70 (25), 57 





C NMR data, see Table 2.3. NOE: H-14/H-3, H-14', H-15, H-20; H-
17/H-5, H-17'; H-18/H-20, H-21'; H-21/H-20, H-21'; H-21'/H-18, H-21; 
N-1-Me/H-3, H-12; N-4-Me/H-3, H-5, H-6', H-14. 
 
Compound 3 [Macrocarpine D (N(1)-Demethylmacrocarpine B)]: light yellowish 
oil; []D 43 (c 0.89, CHCl3); UV (EtOH) max (log ) 231 (5.16), 286 (4.48) nm; IR 
(dry film) max 3395, 3292  cm
1
; ESIMS m/z 327 [M + H]
+
; HRESIMS m/z 327.2079 
(calcd for C20H26N2O2 + H, 327.2073); for 
1
H NMR and 
13
C NMR data, see Table 2.4, 
respectively. HMBC: 
2
J H-3 to C-2; H-6, H-6' to C-5; H-6, H-6' to C-7; H-10 to 
C-11; H-11 to C-12; H-5 to C-16; H-18 to C-19. 
3
J H-6, H-6', H-14' to C-2; H-3, N-
4-Me to C-3; H-3, N-4-Me to C-5; H-5, H-9 to C-7; H-6, H-10, H-12, NH to C-8; H-
11 to C-9; H-12 to C-10; H-9 to C-11; H-10 to C-12; H-9, H-11 to C-13; H-3, H-5, H-
17, H-21, H-21' to C-15; H-6, H-6' to C-16; H-5 to C-17; H-17, H-17', H-21 to 
C-19; H-18 to C-20. NOE: H-3/N-4-Me; H-5/H-6', H-16, H-17N-4-Me; H-6/H-
6'; H-6'/H-5, H-6, N-4-Me; H-9/H-10; H-14/H-3, H-14', H-15; H-14'/H-3, H-
14, H-19; H-15/H-14, H-20; H-16/H-5, H-6, H-17, H-20; H-17/H-5, H-16, H-
17'; H-17'/H-14', H-17, H-19; H-18/H-19, H-20, H-21'; H-19/H-14', H-17', H-
18, H-20; H-20/H-15, H-16, H-18, H-19, H-21, H-21'; H-21/H-21'; H-21'/H-18, H-20, 









Macrodasine H (4): light yellowish oil; []D 11 (c 0.14, CHCl3); UV (EtOH) max 
(log ) 233 (4.22), 288 (3.55) nm; IR (dry film) max 3423 cm
1
; ESIMS m/z 439 [M + 
H]
+
; HRESIMS m/z 439.2598 (calcd for C26H34N2O4 + H, 439.2591); for 
1
H NMR and 
13
C NMR data, see Table 2.5, respectively; HMBC: 
2
J H-6, H-6 to C-5; H-18 to C-19; 
H-15, H-21, H-21 to C-20; H-21, H-23 to C-22; H-24 to C-23. 3J H-6, H-6, N-1-
Me to C-2; H-5, N-4-Me to C-3; N-4-Me to C-5; H-9 to C-7; H-6, H-10, H-12 to C-8; 
H-11 to C-9; H-12 to C-10; H-9 to C-11; H-10 to C-12; H-9, H-11, N-1-Me to C-13; H-
20 to C-14; H-5, H-21 to C-15; H-5, H-6, H-6, H-14 to C-16; H-5, H-15 to C-17; 
H-17 to C-19; H-18 to C-20. NOESY: H-3/H-14, H-14, N-1-Me, N-4-Me; H-5/H-
6,  H-16, H-17, N-4-Me; H-6/H-5, H-6, H-9; H-6/H-6, H-9, H-16; H-9/H-6, 
H-6, H-10; H-10/H-9, H-11; H-11/H-10, H-12; H-12/H-11, N-1-Me; H-14/H-3, H-
14, H-17; H-14/H-3, H-14, H-15, H-20; H-15/H-14, H-16; H-16/H-5, H-6, H-
15, H-17, H-21; H-17/H-14, H-17, H-18; H-17/H-5, H-16, H-17; H-18/H-17, 
H-23; H-20/H-14, H-21; H-21/H-20, H-21; H-21/H-16, H-21 H-23; H-23/H-
21, H-25a; H-24a/H-24b, H-26a; H-24b/H-24a; H-25a/H-23, H-26b; H-26a/H-25, H-
26b; H-26b/H-25, H-26a; N-1-Me/H-3, H-12; N-4-Me/H-3, H-5.       
 
Alstonerine (5): light yellowish oil; [α]D 127 (c 0.59, CHCl3); UV (EtOH), λmax nm 
(log ε): 230 (4.48), 264 (4.01) and 293 (3.77) nm; ESIMS m/z 337 (MH+, C21H24N2O2 + 
H); for 
1
H NMR and 
13
C NMR data: see Table 2.6 and Table 2.7.  
 
Alstonerinal (6): light yellowish oil; [α]D 32 (c 0.03, CHCl3); UV (EtOH), λmax nm 
(log ε): 228 (4.30), 267 (4.00) and 291 (3.80) nm; ESIMS m/z 337 (MH+, C21H24N2O2 + 
H); for 
1
H NMR and 
13









Alstophylline (7): light yellowish oil; [α]D 101 (c 0.04, CHCl3); UV (EtOH), λmax nm 
(log ε): 203 (4.54), 232 (4.49), 255 (4.10) and 310 (3.73) nm; ESIMS m/z 367 (MH+, 
C22H26N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.6 and Table 2.7. 
 
Alstophyllal (8): light yellowish oil; ESIMS m/z 367 (MH
+





C NMR data, see Table 2.6 and Table 2.7. 
 
Macrocarpine A (9): light yellowish oil; []D +117 (CHCl3, c 0.11); UV (EtOH), max 
nm (log ): 230 (4.15) and 286 (3.46); IR (dry film) max 3400 (OH) cm
-1
; ESIMS m/z 
341 (MH
+
, C21H28N2O2 + H); for 
1
H NMR and 
13
C NMR, see Table 2.8 and Table 2.9. 
 
Macrocarpine B (10): light yellowish oil; [α]D 51 (c 0.34, CHCl3); UV (EtOH), λmax 





, C21H28N2O2 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.8 and 
Table 2.9. 
 
Macrocarpine C (11): light yellowish oil; []D 35 (CHCl3, c 1.55); UV (EtOH), max 





, C23H30N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.8 and 
Table 2.9. 
 
(-)-Talcarpine (12): light yellowish oil; [α]D 26 (c 0.12, CHCl3); UV (EtOH), λmax nm 
(log ε): 209 (3.86), 226 (4.01), 277 (2.65), 285 (2.91) and 294 (2.65) nm; ESIMS m/z 
339 (MH
+
, C21H26N2O2 + H); for 
1
H NMR and 
13









N(4)-Methyl-N(4),21-secotalpinine (13): light yellowish oil; [α]D +19 (c 0.45, CHCl3); 
UV (EtOH), λmax nm (log ε): 205 (3.95), 228 (4.21), 280 (3.00), 285 (3.42) and 300 
(3.12) nm; ESIMS m/z 339 (MH
+
, C21H26N2O2 + H); for 
1
H NMR and 
13
C NMR data, 
see Table 2.10. 
 
Macrodasine A (14): colorless plates from ethanol; mp 149154 °C; []D 36 (c 0.36, 
CHCl3); UV (EtOH) max (log ) 230 (3.88), 287 (3.17) nm; IR (dry film) max 3411 cm
-
1
; ESIMS m/z 455 (MH
+
, C26H34N2O5 + H); for 
1
H NMR and 
13
C NMR data, see Table 
2.11. 
 
Macrodasine G (15): colorless oil; []D  59 (c 0.27, CHCl3); UV (EtOH) max (log ) 
206 (4.50), 229 (4.50), 286 (3.79) nm; IR (dry film) max 3424 cm
-1
; EIMS m/z 454 [M]
+
 
(40), 436 (5), 423 (12), 394 (6), 367 (3), 321 (7), 277 (3), 237 (6), 197 (100), 170 (44), 
144 (10), 128 (7), 98 (5), 70 (13), 55 (5), 44 (20); HREIMS m/z 454.2469 (calcd for 
C26H34N2O5 , 454.2468); for 
1
H NMR and 
13
C NMR data, see Table 2.11. 
 
Compound 16 [Alstonoxine C (11-Methoxyalstonoxine A)]: light yellowish oil; [α]D 
30 (c 0.39, CHCl3); UV (EtOH), λmax nm (log ε): 219 (5.17), 266 (4.33) and 291 (4.24) 
nm; IR (dry film) νmax 3390, 3295, and 1694 cm
-1
; ESIMS m/z 359 [M + H]
+
; 
HRESIMS m/z 359.1979 (calcd for C20H26N2O4 + H, 359.1971); for 
1
H NMR and 
13
C 
NMR data, see Table 2.12. HMBC: 
2
J H(14), H(14') to C(3); H(6) to C(5); H(6), H(6') 
to C(7); H(12) to C(11); H(12) to C(13); H(14'), H(20), H(20') to C(15); H(18), H(20), 
H(20') to C(19); H(15) to C(20). 
3
J H(6), H(6'), N(1)-Me to C(2); H(5) to C(3); H(3), 
H(17), H(17') to C(5); H(5), H(9), H(14) to C(7); H(6), H(10), H(12) to C(8); H(12) to 
C(10); H(9), 11-OMe to C(11); H(10) to C(12); H(9), N(1)-Me to C(13); H(20), H(20') 








to C(17); H(18) to C(20). NOESY: H(3)/H(14), H(14'); H(5)/H(6'), H(16); H(6)/H(6'), 
H(9), H(15), H(16); H(6')/H(5), H(6), H(9); H(9)/H(6), H(6'), H(10), H(15); H(10)/H(9); 
H(14)/H(3), H(14'), H(15), H(20), H(20'); H(14')/H(3), H(14); H(15)/H(6), H(14), 
H(16); H(16)/H(5), H(6), H(15), H(17), H(17'); H(17)/H(16), H(17'), H(20); 
H(17')/H(16), H(17); H(18)/H(20), H(20'); H(20)/H(14), H(17), H(18), H(20'); 
H(20')/H(14), H(18), H(20).  
 
Crystallographic data of Alstonoxine C (16): Colorless block crystals, 
C20H26N2O4.H2O, Mr = 376.44, orthorhombic, space group P212121, a = 7.3753(2) Å, b 
= 12.6375(3) Å, c = 19.5260(4) Å, =  =   = 90, V = 1819.93(8) Å3, T = 100 K, Z  =  
4, Dcalcd = 1.374 gcm
3
, crystal size 0.16 x 0.18 x 0.24 mm
3
, F(000) = 704. The final R1 
value is 0.0383 (wR2 = 0.0898) for 3750 reflections [I>2(I)]. CCDC number: 935820 
   
NaBH4 reduction of alstonoxine C (16). To a mixture of compound 16 (12.4 mg, 0.035 
mmol) in 5 ml of MeOH at 0 
o
C was added NaBH4 (6.5 mg, 0.17 mmol). The solution 
was stirred at 0 
o
C for 1 h. Saturated Na2CO3 (5 ml) solution was added, and the product 
was extracted with CH2Cl2 (3 x 10 ml). The combined organic extract was dried 
(Na2SO4), filtered, and concentrated in vacuo, and the residue was purified by 
centrifugal preparative TLC (SiO2, 1% MeOHCHCl3, NH3-saturated) to afford 17 (5.1 
mg, 41%) and 17a (4.8 mg, 39%). Compound 17a: colorless oil; []25D 33 (c 0.24, 
CHCl3); 
1
H NMR (CDCl3, 400 MHz)  7.69 (1H, d, J = 8.3 Hz), 6.58 (1H, dd, J = 8.3, 
2.2 Hz), 6.45 (1H, d, J = 2.2 Hz), 4.02 (1H, m), 3.99 (1H, m), 3.96 (1H, m), 3.92 (1H, 
m), 3.83 (3H, s), 3.24 (1H, m), 3.17 (3H, s), 2.76 (1H, m), 2.38 (1H, dd, J = 8.4, 2.3 
Hz), 2.06 (1H, d, J = 8.4 Hz), 1.94 (1H, m), 1.77 (1H, m), 1.72 (1H, m), 1.58 (1H, m), 
1.53 (1H, m), 1.29 (1H, d, J = 6 Hz); HRESIMS m/z 327.1718 (calcd for C19H22N2O3 + 








Compound 17 [Alstonoxine D (11-Methoxyalstonoxine B)]: light yellowish oil; []D 
‒16.1 (c 0.23, CHCl3); UV (EtOH), λmax nm (log ε): 224 (4.62), 274 (3.80) and 286 
(3.80) nm; IR (dry film) νmax 3391, 3298, and 1695 cm
-1
; ESIMS m/z 361 [M + H]
+
; 
HRESIMS m/z 361.2125 (calcd for C20H28N2O4 + H, 361.2127); for 
1
H NMR and 
13
C 
NMR data, see Table 2.12. HMBC: 
2
J H(14), H(14') to C(3); H(6), H(6'), H(16) to C(5); 
H(6), H(6') to C(7); H(10), H(12) to C(11); H(12) to C(13); H(14), H(14'), H(20') to 
C(15); H(5), H(17) to C(16); H(18), H(20) to C(19). 
3
J H(6), H(6'), N(1)-Me to C(2); 
H(6'), H(15) to C(3); H(3), H(17), H(17') to C(5); H(14') to C(7); H(6), H(10), H(12) to 
C(8); H(12) to C(10); H(9), 11-OMe to C(11); H(10) to C(12); H(9), H(12), N(1)-Me to 
C(13); H(16), H(20) to C(14); H(3), H(17), H(17'), H(19) to C(15); H(6), H(6'), H(14), 
H(14'), H(20) to C(16); H(18) to C(20). NOESY: H(3)/H(14), H(14'); H(5)/H(6'), H(16); 
H(6)/H(6'), H(9), H(14), H(15), H(16); H(6')/H(5), H(6); H(9)/H(6), H(10), H(15), H(14) 
or H(16); H(10)/H(9), 11-OMe; H(12)/N(1)-Me, 11-OMe; H(14)/H(3), H(6), H(9) or 
H(16), H(14'), H(15), H(20); H(14')/H(3), H(14); H(15)/H(6), H(9), H(14), H(16), 
H(20); H(16)/H(5), H(6), H(9), H(14), H(15), H(17), H(20);  H(17)/H(16), H(17'), 
H(20); H(17')/H(14), H(16), H(17); H(18)/H(19), H(20'); H(19)/H(18), H(20); 
H(20)/H(14), H(15), H(16), H(17), H(19), H(20'); H(20')/H(18), H(20); N(1)-Me/H(12); 
11-OMe/H(10), H(12).  
 
Determination of the C-19 configuration of compound 17 by Horeau’s 
method.
237,238
 To a solution of compound 17 (5 mg, 0.038 mmol) and anhydrous 
pyridine (1 ml), was added, racemic 2-phenylbutyric anhydride (0.1 ml). The resulting 
mixture was stirred for 24 h at rt. Water (3 ml) was then added and the mixture was 
allowed to stand for 30 min. The pH of the solution was adjusted to pH 9 by drop-wise 
addition of NaOH (0.1 M), after which the solution was extracted with CH2Cl2 (3 x 20 








CH2Cl2 (3 x 10 ml). Evaporation of the solvent from the organic phase gave the 
unreacted 2-phenylbutyric acid. The optical rotation of the unreacted 2-phenylbutyric 




Alstonoxine A (18): light yellowish oil; [α]D 34 (c 0.19, CHCl3); UV (EtOH), λmax nm 
(log ε): 216 (3.89), 255 (3.70) and 285 (3.18) nm; IR (dry film) νmax 3390 (OH), 3288 
(NH) and 1694 (broad, multiplet C=O) cm
-1
; ESIMS m/z 329 (MH
+
, C19H24N2O3 + H); 
for 
1
H NMR and 
13
C NMR data, see Table 2.13. 
 
Alstonoxine B (19): light yellowish oil; [α]D 12 (c 0.41, CHCl3); UV (EtOH), λmax nm 
(log ε): 213 (4.15), 255 (3.65) and 286 (3.04) nm; IR (dry film) νmax 3370 (OH), 3288 
(NH) and 1693 (C=O) cm
-1
; ESIMS m/z 331 (MH
+
, C19H26N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.13. 
 
Crystallographic data of Alstonoxine B (19): colorless block crystals, C19H26N2O3, 
Mr = 330.42, monoclinic, space group P21, a = 10.7388(4) Å, b = 10.5321(3) Å, c = 
15.2354(5) Å, =  = 90,  = 92.851(2), V = 1721.02(10) Å3, T = 100 K, Z = 4, Dcalcd 
= 1.275 gcm
3
, crystal size 0.21 x 0.41 x 0.49 mm
3
, F(000) = 712. The final R1 value is 
0.0382 (wR2 = 0.1076) for 7729 reflections [I>2(I)]. CCDC number: 935819 
 
Alstonisine (20): colorless oil; [α]D +191 (c 0.08, CHCl3); UV (EtOH), λmax nm (log ε): 
212 (4.02) and 255 (3.88) nm; ESIMS m/z 339 (MH
+














Alstonal (21): colorless oil; [α]D +256 (c 0.05, CHCl3); UV (EtOH), λmax nm (log ε): 
205 (4.27), 212 (4.27) and 262 (3.92) nm; ESIMS m/z 339 (MH
+
, C20H22N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.14 and Table 2.15. 
 
N(4)-Demethylalstophylline oxindole (22): light yellowish oil; [α]D +119 (c 0.32, 
CHCl3); UV (EtOH), λmax nm (log ε): 213 (4.72), 248 (4.39), and 296 (3.97) nm; 
ESIMS m/z 369 (MH
+
, C21H24N2O4 + H); for 
1
H NMR and 
13
C NMR data, see Table 
2.14 and Table 2.15. 
 
N(4)-Demethylalstophyllal oxindole (23): light yellowish oil; ESIMS m/z 369 (MH
+
, 
C21H24N2O4 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.14 and Table 2.15. 
 
Compound 24 (2(S)-Cathafoline): light yellowish oil; []D 175 (c 0.22, CHCl3) and 
subsequently colorless needles from CH2Cl2-hexane; mp 121‒123 °C; UV (EtOH) max 
(log ) 208 (4.68), 246 (4.38), 308 (4.06)  nm; IR (dry film) max 1737 cm
1
; ESIMS m/z 
339 [M + H]
+





C NMR data, see Table 2.16. HMBC: 
2
J H(3) to C(2); H(6), H(6) to C(5); 
H(5), H(5) to C(6); H(2), H(6), H(16) to C(7); H(10) to C(9); H(11) to C(10); H(10) 
to C(11); H(11) to C(12); H(14a), H(14b), H(16) to C(15); H(19) to C(18); H(18) to 
C(19); H(21a), H(21b) to C(20); H(16) to CO2Me. 
3
J H(6), H(14a), H(16), N1Me to 
C(2); H(5), H(15), H(21a) to C(3); H(3), H(21a), H(21b) to C(5); H(2), H(16) to C(6); 
H(3), H(9), H(5) to C(7); H(2), H(6), H(10), H(12), H(16) to C(8); H(11) to C(9); 
H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11), N1Me to C(13); H(2), H(16) 
to C(14); H(3), H(19), H(21a), H(21b) to C(15); H(2), H(6), H(6) to C(16); H(21a), 








to CO2Me. NOESY: H(2)/H(3), H(6), N1Me; H(3)/H(2), H(14a), H(14b), N1Me; 
H(5)/H(5), H(6); H(5)/H(5), H(6), H(21a); H(6)/H(2), H(5), H(6), H(9); 
H(6)/H(5), H(6); H(9)/H(6), H(10); H(11)/H(10), H(12); H(12)/H(11),  N1Me; 
H(14a)/H(3), H(14b), H(15), H(21b); H(14b)/H(3), H(14a), H(15), H(16); H(15)/H(14a), 
H(14b), H(16), H(18); H(16)/H(14b), H(15); H(18)/H(15), H(19), CO2Me; H(19)/H(18),  
H(21a); H(21a)/H(5), H(19), H(21b); H(21b)/H(14a), H(21a); CO2Me/H(18); 
N1Me/H(2), H(3), H(12). 
 
Compound 25 (2(S)-10-Methoxycathafoline): light yellowish oil; []D 138 (c 0.47, 
CHCl3); UV (EtOH) max (log ) 208 (4.85), 245 (4.60), 307 (4.17) nm; IR (dry film) 
max 1737 cm
1
; ESIMS m/z 369 [M + H]
+
; HRESIMS m/z 369.2172 (calcd for 
C22H28N2O2 + H, 369.2178); for
 1
H NMR and 
13
C NMR data, see Table 2.16. HMBC: 
2
J 
H(3) to C(2); H(6), H(6) to C(5); H(5), H(5) to C(6); H(2), H(6), H(6), H(16) 
to C(7); H(9), H(11) to C(10); H(14b), H(16) to C(15); H(19) to C(18); H(18) to C(19); 
H(21a), H(21b) to C(20); H(16) to CO2Me. 
3
J H(6), H(14a), N1Me to C(2); H(5), 
H(21a) to C(3); H(3), H(21a), H(21b) to C(5); H(2), H(16) to C(6); H(3), H(9), H(5) to 
C(7); H(6), H(12) to C(8); H(11) to C(9); H(12), 10-OMe to C(10); H(9) to C(11); 
H(9), H(11), N1Me to C(13); H(2), H(16) to C(14); H(3), H(19), H(21a), H(21b) to 
C(15); H(2), H(6), H(6) to C(16); H(21a) to C(19); H(14b), H(16), H(18) to C(20); 
H(5), H(5), H(19) to C(21); H(2) to N1Me; CO2Me to CO2Me. 
4
J H(18) to C(21). 
NOESY: H(2)/H(3), H(5), H(6), N1Me; H(3)/H(2), H(14a), H(14b), N1Me; 
H(5)/H(2), H(5), H(6); H(5)/H(5), H(6), H(21a); H(6)/H(2), H(5), H(6), 
H(9); H(6)/H(5), H(6), H(9); H(9)/H(6), H(6), H(16), 10-OMe, CO2Me; 
H(11)/H(12), 10-OMe; H(12)/H(11), N1Me; H(14a)/H(3), H(14b), H(15), H(21b); 








H(14b), H(15); H(18)/H(15), H(19), CO2Me; H(19)/H(18), H(21a); H(21a)/H(5), 
H(19), H(21b); H(21b)/H(14a), H(21a); CO2Me/H(9), H(18); N1Me/H(2), H(3), H(12); 
10-OMe/H(9), H(11). 
 
Compound 26 (2(R)-3-Hydroxycathafoline): light yellowish oil; []D 48 (c 0.24, 
CHCl3); UV (EtOH) max (log ) 202 (4.64), 252 (4.11), 295 (3.69) nm; IR (dry film) 
max 1737 cm
1
; ESIMS m/z 355 [M + H]
+
; HRESIMS m/z 355.2028 (calcd for 
C21H26N2O3 + H, 355.2022); for
 1
H NMR and 
13
C NMR data, see Table 2.17. HMBC: 
2
J 
H(14a), H(14b) to C(3); H(6) to C(5); H(5) to C(6); H(2), H(6), H(6), H(16) to 
C(7); H(10) to C(9); H(9) to C(10); H(10) to C(11); H(11) to C(12); H(16) to C(15); 
H(19) to C(18); H(18) to C(19); H(21a) to C(20); H(16) to CO2Me. 
3
J H(14a), H(14b), 
N(1)-Me to C(2); H(5), H(21a) to C(3); H(21a) to C(5); H(2) to C(6); H(5), H(9) to 
C(7); H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) 
to H(12); H(9), H(11), N(1)-Me to C(13); H(16) to C(14); H(19), H(21a) to C(15); H(2), 
H(6), H(6), H(14b) to C(16); H(21a) to C(19); H(14a), H(18) to C(20); H(5), H(19) 
to C(21); CO2Me to CO2Me. NOESY: H(2)/H(14a); H(5)/H(5), H(21a); 
H(5)/H(5), H(6); H(6)/H(5), H(6); H(6)/H(6), H(9); H(9)/H(6), H(10), 
CO2Me; H(10)/H(9), H(11); H(11)/H(10), H(12); H(12)/H(11), N(1)-Me; H(14a)/H(2), 
H(14b), H(15), H(16); H(14b)/H(14a), H(15), H(21b); H(15)/H(14a), H(14b), H(16), 
H(18); H(16)/H(14a), H(15); H(18)/H(15), H(19); H(19)/H(18), H(21a); H(21a)/H(19), 
H(21b); H(21b)/H(14b), H(21a); CO2Me/H(9); N(1)-Me/H(12). 
  
Compound 27 (10-Demethoxyvincorine): light yellowish oil; []D 127 (c 0.48, 
CHCl3); UV (EtOH) max (log ) 205 (5.21), 256 (4.78), 308 (4.29) nm; IR (dry film) 
max 1736 cm
1
; ESIMS m/z 339 [M + H]
+








C21H26N2O2 + H, 339.2073); for
 1
H NMR and 
13
C NMR data, see Table 2.18. HMBC: 
2
J 
H(3), H(3) to C(2); H(14a/b) to C(3); H(6) to C(5); H(5) to C(6); H(6), H(6), 
H(16) to C(7); H(10) to C(9); H(11) to C(10); H(11) to C(12); H(3), H(3) to C(14); 
H(16) to C(15); H(19) to C(18); H(18) to C(19); H(21a), H(21b) to C(20); H(16) to 
CO2Me. 
3
J H(5), H(14a/b), H(21a), N(1)-Me to C(2); H(15) to C(3); H(21a), H(21b) to 
C(5); H(16) to C(6); H(3), H(5), H(9), H(15), H(21a), H(21b) to C(7); H(6), H(6), 
H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); 
H(9), H(11), N(1)-Me to C(13); H(16) to C(14); H(19), H(21a) to C(15); H(6), H(6), 
H(14a/b) to C(16); H(21a), H(21b) to C(19); H(14a/b), H(16), H(18) to C(20); H(5), 
H(5), H(19) to C(21); CO2Me to CO2Me. NOESY: H(3)/H(3); H(3)/H(3), 21b; 
H(5)/H(5), H(6), H(21a); H(5)/H(5), H(6), H(6); H(6)/H(5), H(6); 
H(6)/H(5), H(5), H(6); H(9)/H(10), H(16); H(10)/H(9), H(11); H(11)/H(10), 
H(12); H(12)/H(11), N(1)-Me; H(14a/b)/H(15), H(16), H(21b); H(15)/H(14a/b), H(16), 
H(18); H(16)/H(9), H(14a/b), H(15); H(18)/H(15), H(19); H(19)/H(18), H(21a); 
H(21a)/H(5), H(19), H(21b); H(21b)/H(3), H(14a/b), H(21a); N(1)Me/H(12).          
 
Compound 28 (10-Demethoxyvincorine N(4)-oxide): light yellowish oil; []D 62 (c 
0.5, CHCl3); UV (EtOH) max (log ) 208 (5.43), 247 (5.19), 299 (4.70) nm; IR (dry 
film) max 1734 cm
1
; ESIMS m/z 355 [M + H]
+
; HRESIMS m/z 355.2019 (calcd for 
C21H26N2O3 + H, 355.2022); for
 1
H NMR and 
13
C NMR data, see Table 2.18. HMBC 
2
J: 
H(3) to C(2); H(6) to C(5); H(6), H(16) to C(7); H(10) to C(9); H(10) to C(11); 
H(3), H(3) to C(14); H(16) to C(15); H(15) to C(16); H(19) to C(18); H(18) to H(19); 
H(15), H(21a), H(21b) to C(20); H(16) to CO2Me. 
3
J: H(5a), H(5b), H(6), H(21a), 
N(1)-Me to C(2); H(15) to C(3); H(21a) to C(5); H(16) to C(6); H(3), H(5a), H(9), 








to C(11); H(10) to C(12); H(9), H(11), N(1)-Me to C(13); H(16) to C(14); H(19), H(21a) 
to C(15); H(6), H(14) to C(16); H(15), H(21a) to C(19); H(16), H(18) to C(20); 
H(5b), H(15), H(19) to C(21); CO2Me to CO2Me. NOESY: H(3)/H(3), H(14), 
H(16), N(1)-Me; H(3)/H(3), H(21b), N(1)-Me; H(5a)/H(5b), H(6), H(6); 
H(5b)/H(5a), H(6); H(6)/H(6), H(5a), H(5b); H(6)/H(5a), H(6), H(19); 
H(9)/H(6), H(10), H(16), CO2Me; H(9), H(11) to C(10); H(10), H(12) to C(11); H(11), 
N(1)-Me to C(12); H(14)/H(14), H(15), H(21b); H(14)/H(3), H(14), H(15), 
H(16); H(15)/H(14), H(14), H(16), H(18); H(16)/H(3), H(9), H(14), H(15); 
H(18)/H(15), H(19), CO2Me; H(19)/H(6), H(18), H(21a); H(21a)/H(19), H(21b); 
H(21b)/H(3), H(14), H(21a); N(1)-Me/H(3), H(3), H(12); CO2Me/H(9), H(18).      
 
Compound 29 (11-Methoxyvincorine): light yellowish oil; []D 86 (c 0.27, CHCl3); 
UV (EtOH) max (log ) 208 (4.16), 256 (3.75), 317 (3.54) nm; IR (dry film) max 1733 
cm
1
; ESIMS m/z 399 [M + H]
+
; HRESIMS m/z 399.2078 (calcd for C23H30N2O4 + H, 
339.2084); for
 1
H NMR and 
13
C NMR data, see Table 2.19. HMBC 
2
J: H(3), H(16) to 
C(2); H(6) to C(5); H(6), H(16) to C(7); H(9) to C(10); H(12) to C(11); H(12) to 
C(13); H(3) to C(14); H(16) to C(15); H(19) to C(18); H(18) to C(19); H(21a), H(21b) 
to C(20); H(16) to CO2Me. 
3
J: H(21a), N(1)-Me to C(2); H(21a), H(21b) to C(5); H(16) 
to C(6); H(5), H(5), H(9) to C(7); H(6), H(12), H(16) to C(8); H(12), 10-OMe to 
C(10); H(9), 11-OMe to C(11); H(9), N(1)-Me to C(13); H(16) to C(14); H(21a) to 
C(15); H(6), H(14) to C(16); H(15), H(21a), H(21b) to C(19); H(16), H(18) to C(20); 
H(5), H(5), H(19) to C(21); CO2Me to CO2Me. NOESY: H(3)/H(3), H(16), N(1)-
Me; H(3)/H(3), N(1)-Me; H(5)/H(5), H(21a); H(5)/H(5), H(6); H(6)/H(5), 
H(6); H(6)/H(6); H(9)/H(16), 10-OMe; H(12)/N(1)-Me, 11-OMe; H(14)/H(15), 








H(19), CO2Me; H(19)/H(18), H(21a); H(21a)/H(5), H(19), H(21b); H(21b)/H(21a); 
CO2Me/H(18); N(1)-Me/H(3), H(3), H(12); 10-OMe/H(9); 11-OMe/H(12).                
 
Compound 30 (Vincorine N(4)-oxide): light yellowish oil; []D 84 (c 0.4, CHCl3); 
UV (EtOH) max (log ) 208 (4.16), 256 (3.75), 317 (3.54)nm; IR (dry film) max 1734 
cm
1
; ESIMS m/z 385 [M + H]
+
; HRESIMS m/z 385.2130 (calcd for C22H28N2O4 + H, 
385.2127); for
 1
H NMR and 
13
C NMR data, see Table 2.19. 
 
Compound 31 (11-Demethoxyquaternine): light yellowish oil; []D 10 (c 0.21, 
CHCl3); UV (EtOH) max (log ) 208 (4.64), 241 (4.35), 307 (3.96) nm; IR (dry film) 
max 1736 cm
1
; ESIMS m/z 383 [M + H]
+
; HRESIMS m/z 383.1978 (calcd for 
C22H26N2O4 + H, 383.1971); for
 1
H NMR and 
13
C NMR data, see Table 2.20. HMBC 
2
J: 
H(3) to C(2); H(6) to C(5); H(5) to C(6); H(6), H(6) to C(7); H(9), H(11) to C(10); 
H(16) to C(15); H(19) to C(18); H(18) to C(19); H(21a) to C(20); H(16) to CO2Me. 
3
J: 
H(5), H(6), N(1)-Me to C(2); H(5), H(21a) to C(3); H(3), H(21a), H(21b) to C(5); 
H(16) to C(6); H(3), H(5), H(9) to C(7); H(6), H(12), H(16) to C(8); H(11) to C(9); 
H(12), 10-OMe to C(10); H(9) to C(11); H(9), H(11), N(1)-Me to C(13); H(3), H(21a), 
H(21b), H(19) to C(15); H(6) to C(16); H(21a) to C(19); H(14a), H(14b), H(16), H(18) 
to C(20); H(19) to C(21); CO2Me to CO2Me. NOESY: H(3)/H(14a), H(14b), N(1)-Me; 
H(5)/H(6), H(6), H(21a); H(6)/H(5), H(6), H(9); H(6)/H(5), H(6); H(9)/H(6), 
CO2Me, 10-OMe; H(11)/H(12), 10-OMe; H(12)/H(11), N(1)-Me; H(14a)/H(3), H(14b), 
H(15), H(16); H(14b)/H(3), H(14a), H(15), H(21b); H(15)/H(14a), H(14b), H(16), 
H(18); H(16)/H(14a), H(15); H(18)/H(15), H(19), CO2Me; H(19)/H(18), H(21a); 
H(21a)/H(5), H(19), H(21b); H(21b)/H(14b), H(21a); N(1)-Me/H(3), H(12); 








Compound 32 (19,20-Z-Affinisine): light yellowish oil; []D  (c 0.45, CHCl3); UV 
(EtOH) max (log ) 209 (5.44), 229 (5.37), 254 (4.92), 284 (4.73) nm; IR (dry film) max 
3395 cm
1
; ESIMS m/z 309 [M + H]
+
; HRESIMS m/z 309.1973 (calcd for C20H24N2O + 
H, 309.1967); for
 1
H NMR and 
13
C NMR data, see Table 2.21. HMBC 
2
J: H(3) to C(2); 
H(6), H(6), H(16) to C(5); H(5) to C(6); H(6), H(6) to C(7); H(9) to C(8); H(3) to 
C(14); H(14b), H(16) to C(15); H(5), H(17) to C(16); H(16) to C(17); H(19) to C(18); 
H(18) to C(19). 
3
J: H(6), H(6), H(14a), H(14b), N(1)-Me to C(2); H(5), H(15), H(21) 
to C(3); H(3), H(17), H(21) to C(5); H(16) to C(6); H(3), H(5), H(9) to C(7); H(6), 
H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); 
H(9), H(11), N(1)-Me to C(13); H(16) to C(14); H(3), H(17), H(19) to C(15); H(6), 
H(6), H(14a), H(14b) to C(16); H(5) to C(17); H(21) to C(19); H(14a), H(14b), H(18) 
to C(20); H(3), H(5), H(19) to C(21). NOESY: H(3)/H(14b), N(1)-Me; H(5)/H(6), 
H(17), H(21); H(6)/H(6), H(9), H(16); H(6)/H(5), H(6); H(9)/H(6), H(10); 
H(10)/H(9); H(12)/N(1)-Me; H(14a)/H(14b), H(15); H(14b)/H(3), H(14a); 
H(15)/H(14a), H(16), H(17), H(19); H(16)/H(6), H(15), H(17); H(17)/H(5), H(15), 
H(16); H(18)/H(19), H(21); H(19)/H(15), H(18); H(21)/H(5), H(18); N(1)-Me/H(3), 
H(12).        
 
Compound 33 (Vincamajine N(4)-oxide): light yellowish oil; [α]D 29 (c 0.04, 
CHCl3); UV (EtOH), λmax nm (log ε): 210 (4.94), 231 (4.70) and 282 (4.30) nm; IR (dry 
film) max 3400 and 1737 cm
1
; ESIMS m/z 383 [M + H]
+
; HRESIMS m/z 383.1980 
(calcd for C22H26N2O4 + H, 383.1971); for 
1
H NMR and 
13
C NMR data, see Table 2.22.  
 
Compound 34 (Vincamajine 17-O-veratrate N(4)-oxide): light yellowish oil; [α]D 








nm; IR (dry film) max 1737 cm
1
; ESIMS m/z 547 [M + H]
+
; HRESIMS m/z 547.2443 
(calcd for C31H34N2O7 + H, 547.2444), for 
1
H NMR and 
13
C NMR data, see Table 2.22. 
 
Cathafoline (35): light yellowish oil; [α]D 35 (c 0.24, CHCl3); UV (EtOH), λmax nm 
(log ε): 208 (3.22), 250 (3.62) and 306 (4.18) nm; ESIMS m/z 399 (MH+, C21H26N2O2 + 
H); for 
1
H NMR and 
13
C NMR data, see Table 2.23 and Table 2.24. 
 
Cathafoline N(4)-oxide (36): light yellowish oil; [α]D 36 (c 0.22, CHCl3); UV (EtOH), 
λmax nm (log ε): 212 (3.98), 250 (3.81) and 294 (3.31) nm; IR (dry film) νmax 3392 (N-
O), 1736 (C=O) cm
-1
; ESIMS m/z 355 (MH
+
, C21H26N2O3 + H); for 
1
H NMR and 
13
C 
NMR data, see Table 2.23 and Table 2.24. 
 
10-Methoxycathafoline (37): light yellowish oil; [α]D ‒57 (c 0.09, CHCl3); UV (EtOH), 
λmax nm (log ε): 204 (4.23), 249 (3.74) and 315 (3.88) nm; IR (dry film) νmax 1736 (C=O) 
cm
-1
; ESIMS m/z 369 (MH
+
, C22H28N2O3 + H); for 
1
H NMR and 
13
C NMR data, see 
Table 2.23 and Table 2.24. 
 
Strictamine (38): light yellowish oil; [α]D +61 (c 0.32, CHCl3); UV (EtOH), λmax nm 
(log ε): 219 (4.07), 264 (3.59), 284 (3.47) and 296 (3.35) nm; ESIMS m/z 323 (MH+, 
C20H22N2O2 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.25 and Table 2.26. 
 
11-Methoxystrictamine (39): light yellowish oil; [α]D +72 (c 0.09, CHCl3); UV 
(EtOH), λmax nm (log ε): 214 (4.15), 250 (3.72), 282 (3.50) and 299 (3.04) nm; ESIMS 
m/z 353 (MH
+
, C21H24N2O3 + H); for 
1
H NMR and 
13










11-Hydroxystrictamine (40): light yellowish oil; [α]D +83 (c 0.68, CHCl3); UV 
(EtOH), λmax nm (log ε): 215 (3.99), 265 (3.48), 280 (3.55) and 296 (3.00) nm; ESIMS 
m/z 339 (MH
+
, C20H22N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.25 and 
Table 2.26. 
 
Vincorine (41): [α]D 47 (c 0.20, CHCl3); UV (EtOH), λmax nm (log ε): 255 (4.00) and 
326 (3.58) nm; ESIMS m/z 369 (MH
+
, C22H28N2O3 + H); for 
1
H NMR and 
13
C NMR 
data, see Table 2.27. 
 
Norvincorine (42): light yellowish oil; []D 162 (c 0.29, CHCl3); UV (EtOH) max 
(log ) 201 (4.46), 241 (3.94), 316 (3.52) nm; IR (dry film) max 1734 cm
1
; ESIMS m/z 
355 (MH
+
, C21H26N2O3 + H); for
 1
H NMR and 
13
C NMR data, see Table 2.27. 
 
Alstonamide (43): light yellowish oil; []D 82 (c 0.63, CHCl3); UV (EtOH) max (log 
) 205 (5.53), 212 (5.51), 266 (5.20), 303 (5.06) nm; IR (dry film) max 1732, 1665 cm
1
; 
ESIMS m/z 413 (MH
+
, C23H28N2O5 + H); for
 1
H NMR and 
13
C NMR data, see Table 
2.28 and Table 2.29. 
 
Demethoxyalstonamide (44): light yellowish oil; [α]D 64 (c 0.12, CHCl3); UV 
(EtOH), λmax nm (log ε): 205 (4.33), 264 (4.01), 291 (3.62) and 361 (3.50) nm; IR (dry 
film) νmax 1733 (C=O, ester) and 1665 (C=O, amide) cm
-1
; ESIMS m/z 383 (MH
+
, 
C22H26N2O4 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.28 and Table 2.29. 
 
Alstomaline (45): light yellowish oil; [α]D 244 (c 0.04, CHCl3); UV (EtOH), λmax nm 










; ESIMS m/z 339 (MH
+
, C20H22N2O3 + H); for 
1
H NMR and 
13
C NMR data, 
see Table 2.28 and Table 2.29. 
 
Quaternine (46): light yellowish oil; [α]D +51 (c 0.20, CHCl3); UV (EtOH), λmax nm 
(log ε): 205 (4.62), 245 (3.91) and 303 (3.71) nm; IR (dry film) νmax 1734 (C=O) cm
-1
; 
ESIMS m/z 413 (MH
+
, C23H28N2O5 + H); for 
1
H NMR and 
13
C NMR data, see Table 
2.30. 
 
Picrinine (47): colorless oil; [α]D 110 (c 0.05, CHCl3); UV (EtOH), λmax nm (log ε): 
220 (3.81), 235 (3.67) and 287 (3.32) nm; ESIMS m/z 339 (MH
+
, C20H22N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.30. 
 
12-Demethoxytabernulosine (48): light yellowish oil; []D 12 (c 0.76, CHCl3); UV 
(EtOH) max (log ) 209 (5.46), 241 (5.14), 305 (4.69) nm; IR (dry film) max 3353, 
1738 cm
1
; ESIMS m/z 369 [M + H]
+
; HRESIMS m/z 369.1819 (calcd for C21H24N2O4 
+ H, 369.1814); for
 1
H NMR and 
13
C NMR data, see Table 2.20. HMBC 
2
J: H(3) to 
C(2); H(14a), H(14b) to C(3); H(6), H(6) to C(5); H(5) to C(6); H(6), H(6), H(16) 
to C(7); H(9), H(11) to C(10); H(14a), H(16) to C(15); H(15) to C(16); H(18) to C(19); 
H(21a), H(21b) to C(20); H(16) to CO2Me. 
3
J: H(5), H(6), H(14b) to C(2); H(15), 
H(21a), H(21b), NH to C(3); H(21a), H(21b) to C(5); H(16) to C(6); H(3), H(5), H(9), 
H(15), NH to C(7); H(6), H(6), H(12), H(16), NH to C(8);  H(11) to C(9); H(12), 10-
OMe to C(10); H(9) to C(11); H(9), H(11) to C(13); H(16) to C(14); H(3), H(19), 
H(21a) to C(15); H(6), H(6), H(14a), H(14b) to C(16); H(19) to C(18); H(21a), 
H(21b) to C(19); H(14a), H(16), H(18) to C(20); H(19) to C(21); CO2Me to CO2Me. 








H(9); H(6)/H(5), H(6); H(9)/H(6), 10-OMe; H(11)/10-OMe; H(12)/NH; 
H(14a)/H(3), H(14b), H(15), H(16); H(14b)/H(3), H(14a), H(15); H(15)/H(14a), H(14b), 
H(16), H(18); H(16)/H(14a), H(15); H(18)/H(15), H(19), CO2Me; H(19)/H(18), H(21a); 
H(21a)/H(5), H(19), H(21b); H(21b)/H(21a); NH/H(3), H(12); CO2Me/H(18); 10-
OMe/H(9), H(11).      
 
Affinisine (49): light yellowish oil; []D  (c 3.75, CHCl3); UV (EtOH) max (log ) 
225 (4.15), 288 (3.98), 302 (3.82) nm; ESIMS m/z 309 (MH
+





C NMR data, see Table 2.32. 
 
Affinisine oxindole (50): light yellowish oil; []D 70 (c 0.063, CHCl3); UV 
(EtOH) max (log ) 211 (4.31), 233 (3.82), 255 (3.87), 290 (3.35) nm; IR (dry film) 
max 3384, 1712 cm
-1
; ESIMS m/z 325 (MH
+
, C20H24N2O2 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.32. 
 
Normacusine B (51): light yellowish oil; [α]D +16 (c 0.26, CHCl3); UV (EtOH), 
λmax nm (log ε): 225 (4.01), 265 (3.48) and 281 (3.41) nm; ESIMS m/z 295 (MH
+
, 
C19H22N2O + H); for 
1
H NMR and 
13
C NMR data, see Table 2.33. 
 
Alstoumerine (52): colorless needles from CHCl3; mp 174176 

C; [α]D 30 (c 0.09, 
CHCl3); UV (EtOH), λmax nm (log ε): 219 (3.89), 234 (3.93), 274 (3.73), 284 (3.77) and 
293 (3.71) nm; ESIMS m/z 325 (MH
+
, C20H24N2O2 + H); for 
1
H NMR and 
13
C NMR 









Quebrachidine (53): light yellowish oil; [α]D +41 (c 0.63, CHCl3); UV (EtOH), λmax 
nm (log ε): 202 (3.82), 245 (4.19) and 288 (3.92) nm; ESIMS m/z 353 (MH+, 
C21H24N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.34 and Table 2.35. 
 
Vincamajine (54): light yellowish oil; [α]D 13 (c 0.03, CHCl3); UV (EtOH), λmax nm 
(log ε): 204 (2.88), 249 (3.29) and 292 (2.90) nm; ESIMS m/z 367 (MH+, C22H26N2O3 + 
H); for 
1
H NMR and 
13
C NMR data, see Table 2.34 and Table 2.35. 
 
Vincamajine 17-O-veratrate (55): light yellowish oil; [α]D 89 (c 1.11, CHCl3); UV 
(EtOH), λmax nm (log ε): 204 (5.50), 213 sh (5.33), 255 (5.04) and 294 (4.81) nm; 
ESIMS m/z 531 (MH
+
, C31H34N2O6 + H); for 
1
H NMR and 
13
C NMR data, see Table 
2.34 and Table 2.35. 
 
Sitsirikine (56): yellowish oil; []D +40 (CHCl3, c 0.14). UV (EtOH), max nm (log ): 
233 (3.91), 272 (3.76), 282 (3.78) and 290 (3.72); IR (dry film) max 3370 (OH) and 
1708 (C=O) cm
-1
; ESIMS m/z 355 (MH
+
, C21H26N2O3 + H); for 
1
H NMR and 
13
C NMR 
data, see Table 2.36 and Table 2.37. 
 
16R, 19E-Isositsirikine (57): yellowish oil; [α]D 21 (c 0.05, CHCl3); UV (EtOH), λmax 
nm (log ε): 225 (4.27), 286 (3.96) and 295 (3.65) nm; ESIMS m/z 355 (MH+, 
C21H26N2O3 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.36 and Table 2.37. 
 
18,19-Dihydroisositsirikine (58): light yellowish oil; []D 86 (c 0.06, CHCl3); UV 
(EtOH) max (log ) 225 (4.13), 280 (3.46) nm; IR (dry film) max  3373, 2877, 1710   
cm
-1
; ESIMS m/z 357 [M + H]
+
; HRESIMS m/z 357.2179 (calcd for C21H28N2O3 + H, 
357.2173); for
 1
H NMR and 
13








Pleiocarpamine (59): light yellowish oil; [α]D +87 (c 0.08, CHCl3); UV (EtOH), λmax 
nm (log ε): 230 (4.32) and 284 (3.85) nm; IR (dry film) max 1758 cm
1
; ESIMS m/z 323 
(MH
+
, C20H22N2O2 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.38 and Table 
2.39. 
 
16-Hydroxymethylpleiocarpamine (60): light yellowish oil; []D +102 (c 0.21, 
CHCl3); UV (EtOH) max (log ) 227 (4.20), 284 (3.71) nm; IR (dry film) max 3352, 
1745 cm
-1




C21H24N2O3 + H); for
 1
H NMR and 
13
C NMR data, 
see Table 2.38 and Table 2.39.  
 
Pleiomaltinine (61): yellowish oil; []D 94 (c 0.48, CHCl3); UV (EtOH) max (log ) 
214 (4.15), 240 (3.86), 284 (3.81) nm; IR (dry film) max 1752, 1650, 1614, 1576 cm
1
; 
EIMS m/z 446 [M]

 (28), 387 [M CO2Me]

 (12), 339 (6), 322 (81), 263 (100), 248 
(23), 232 (35), 218 (19), 180 (72), 135 (34), 108 (19), 96 (8), 71 (8), 43 (8); HREIMS 
m/z 446.1842 (calcd for C26H26N2O5, 446.1842); LSIMS m/z 447 (MH
+
, C26H26N2O5 + 
H); for
 1
H NMR and 
13
C NMR data, see Table 2.38 and Table 2.39. 
 
Picramicine (62): light yellowish oil; []D +109 (c 0.16, CHcCl3); UV (EtOH) max 
(log ) 203 (4.33), 253 (3.78), 292 (3.38) nm; ESIMS m/z 325 (MH+, C20H24N2O2 + H); 
for
 1
H NMR and 
13
C NMR data, see Table 2.40. 
 
Fluorocarpamine (63): light yellowish oil; [α]D +243 (c 1.64, CHCl3); UV (EtOH), 
λmax nm (log ε): 232 (4.15), 260 (3.59) and 289 (3.20) nm; IR (dry film) νmax 1748 and 
1696 (C=O); ESIMS m/z 339 (MH
+
, C20H22N2O3 + H); for 
1
H NMR and 
13
C NMR data, 








Yohimbine (64): light yellowish oil; []D 37 (c 1.24, CHCl3); UV (EtOH) max (log ) 
224 (4.44), 281 (3.83) nm; IR (dry film) max 3362, 2864, 2811, 2760, 1715 cm
-1
; 
ESIMS m/z 355 (MH
+
, C21H26N2O3 + H); for
 1
H NMR and 
13
C NMR data, see Table 
2.41 and Table 2.42. 
 
Talpinine (65): light yellowish oil; []D 4 (c 0.19, CHCl3); UV (EtOH) max (log ) 




ESIMS m/z 325 (MH
+
, 
C20H24N2O2 + H); for
 1
H NMR and 
13
C NMR data, see Table 2.41 and Table 2.42. 
 
10,11-Dimethoxynareline (66): light yellowish oil; [α]D 56 (c 1.57, CHCl3); UV 
(EtOH), λmax nm (log ε): 232 (4.38) and 294 (3.81) nm; IR (dry film) νmax 3201 (OH) 
and 1737 (C=O) cm
-1
; ESIMS m/z 413 (MH
+
, C22H24N2O6 + H); for 
1
H NMR and 
13
C 
NMR, see Table 2.41 and Table 2.42. 
 
11-Methoxyakuammicine (67): light yellowish oil; [α]D 398 (c 0.11, CHCl3); UV 
(EtOH), λmax nm (log ε): 209 (4.05), 223 (4.06), 242 (3.94), 307 (3.88) and 327 (4.01) 
nm; ESIMS m/z 353 (MH
+
, C21H24N2O3 + H); for 
1
H NMR and 
13
C NMR data, see 
Table 2.43. 
 
11-Methoxyakuammicine N(4)-oxide (68): light yellowish oil; []D  (c 0.2, 
CHCl3); UV (EtOH) max (log ) 209 (4.49), 232 (4.27), 253 (4.16), 296 (3.98), and 308 
(4.04) nm; IR (dry film) νmax 3201 (OH) and 1737 (C=O) cm
-1




C21H24N2O4 + H); for 
1
H NMR and 
13









Antirhine (69): colorless oil; []D 40 (c 0.01, CHCl3); UV (EtOH) max (log ) 225 
(4.41), 282 (3.80), 289 (3.68) nm; ESIMS m/z 297 (MH
+





C NMR data, see Table 2.44. 
 
1,2,3,4-Tetrahydro-1-oxo--carboline (70): yellowish oil; []D 56 (c 0.25, CHCl3); 
UV (EtOH) max (log ) 210 (4.98), 231 (5.05), 296 (4.72), 307 (4.74) nm; ESIMS m/z 
187 (MH
+
, C11H10N2O + H); for 
1
H NMR and 
13
C NMR data, see Table 2.44  
 
Lumutinine A (71): light yellowish oil; [α]D +160 (c 0.40, CHCl3); UV (EtOH) max 
nm (log ) 210 (5.61), 233 (5.61), 254 (5.26) shoulder, 283 (4.94) nm; IR (dry film) max 
1617, 1651  cm
1
; ESIMS m/z 673 [M + H]

; HRESIMS m/z 673.3755 (calcd for 
C42H48N4O4 + H, 673.3748); for 
1
H NMR and 
13
C NMR data, see Table 2.45. HMBC: 
2
J H-3 to C-2; H-6 to C-5; H-5 to C-6; H-6 to C-7; H-9 to C-8; H-20 to C-15; H-5 to C-
16; H-18, H-20 to C-19; H-21 to C-20; H-3' to C-2'; H-6' to C-5'; H-5' to C-6'; H-6' to 
C-7'; H-21 to C-10'; H-12' to C-11', H-12' to C-13'; H-5', H-17' to C-16'; H-18' to C-19'; 
H-15', H-21' to C-20'. 
3
J H-6, H-14, N1Me to C-2; H-5, N4Me to C-3; H-3, N4Me to C-5; 
H-5, H-9 to C-7; H-6, H-10, H-12 to C-8; H-11 to C-9; H-12 to C-10; H-9 to C-11; H-
10 to C-12; H-9, H-11, N1Me to C-13; H-20 to C-14; H-3, H-5, H-21 to C-15; H-6, H-
14 to C-16; H-5 to C-17; H-17, H-21 to C-19; H-18 to C-20; H-9' to C-21; H-6', N1Me' 
to C-2'; H-5', N4Me' to C-3'; H-3', H-15', N4Me' to C-5'; H-5', H-9' to C-7'; H-6', H-12' to 
C-8'; H-21 to C-9'; H-12' to C-10', H-9', H-21 to C-11'; H-9', N1Me' to C-13'; H-3', H-5', 
H-17', H-21' to C-15'; H-6', H-14' to C-16'; H-5', H-15', H-21' to C-17'; H-21' to C-19'; 
H-14' to C-20'; H-17' to C-21'. 1D-NOE: H-5/H-6, H-6, H-16, H-17H-17/ H-5, 
H-17H-17/ H-5, H-16, H-17H-18/ H-20, H-21H-5'/ H-6', H-6', H-17', 








H-14, N1Me, N4Me; H-5/ H-16, N4Me; H-6/ H-5; H-9/ H-10; H-12/ H-11, N1Me; H-
15/ H-14; H-17/ H-17, H-14H-17/ H-5, H-16; H-20/ H-18; H-21/ H-18, H-20; 
H-21/ H-14N1Me/ H-14; H-3'/ H-14'a, H-14'b, N1Me', N4Me'; H-5'/ H-16', N4Me'; 
H-6'/ H-16', N4Me'; H-9'/ H-6', H-21H-12'/ N1Me'; H-15'/ H-14', H-16'; H-17'/ H-5', 
H-16'; H-17'/ H-5', H-14', H-16', H-17'H-21'/ H-18'; N1Me'/ H-14' 
 
Lumutinine B (72): Yellowish oil; [α]D ‒11.0 (c 0.48, CHCl3); UV (EtOH) max nm 
(log ) 210 (5.71), 232 (5.64), 255 (5.35), 285 (4.95) nm; IR (dry film) max 1616, 1651 
cm
1
; ESIMS m/z 673 [M + H]

; HRESIMS m/z 673.3751 (calcd for C42H48N4O4 + H, 
673.3748); for 
1
H NMR and 
13
C NMR data, see Table 2.46. HMBC: 
2
J H-3 to C-2; H-
14 to C-3; H-6 to C-7; H-9 to C-8; H-3 to C-14; H-14 to C-15; H-18 to C-19; H-15, H-
21 to C-20; H-3' to C-2'; H-5' to C-3'; H-6' to C-5'; H-6' to H-7'; H-10' to C-11'; H-21 to 
C-12'; H-21' to C-20'. 
3
J H-6, H-14, N1Me to C-2; N4Me to C-3; H-3, H-17, N4Me to C-
5; H-3, H-5, H-9 to C-7; H-6, H-10, H-12 to C-8; H-11 to C-9; H-12 to C-10; H-9 to C-
11; H-10 to C-12; H-9, H-11, N1Me to C-13; H-3, H-16, H-21 to C-15; H-6, H-14 to C-
16; H-17, H-21 to C-19; H-14, H-18 to C-20; H-3 to N4Me; H-6', H-14', N1Me to C-2'; 
N4Me to C-3'; H-3', N4Me to C-5'; H-5', H-9' to C-7'; H-6', H-10' to C-8'; H-9', H-21' to 
C-11', H-10' to C-12'; H-9', N1Me' to C-13'; H-3', H-5', H-15', H-17' to C-15'; H-5', H-6', 
H-17' to C-16'; H-5', H-21' to C-17'; H-18', H-21' to C-19'; H-17' to C-21'; H-5' to N4Me. 
NOE: NOE: H-3/ H-14, H-14, N1Me, N4Me; H-14/ H-14, H-21, H-3; H-17/ H-
17, H-16; H-18/ H-20, H-21H-21/ H-18, H-20, H-21, N1Me'; H-5'/ H-6', H-16', 
H-17', N4Me'; H-6'/ H-5', H-6', N4Me'; H-9'/ H-6', H-6', H-'; H-10'/ H-9'; H-
16'/ H-5', H-6', H-15', H-17'H-17'/ H-17'H-17'/ H-17', H-5', H-16'; H-21'/ H-
18'; N1Me'/ H-3', H-14', H-21, H-21. NOESY: H-3/ H-14, H-14, N1Me, N4Me; 








17/ H-16, H-17; H-17/ H-5; H-20/ H-14, H-14, H-18; H-21/ H-18, H-20; H-
21/ H-14, H-21; H-3'/ H-14, H-14, N4Me'; H-5'/ H-16', N4Me'; H-6'/ H-6', H-
16'; H-9'/ H-10'; H-14'/ H-14'; H-15'/ H-14', H-14', 16'; H-17'/ H-17; H-17'/ 
H-5', H-16'; H-21'/ H-18'; N1Me'/ H-14', H-21, H-21.
 
Lumutinine C (73): light yellowish oil; []D +84 (c 0.32, CHCl3); UV (EtOH) max (log 
): 208 (5.31), 228 (5.33), 284 (4.78) nm; IR (dry film) max 3360 cm
-1
; ESIMS  m/z 661 
[M + H]






C NMR data, see Table 2.47. HMBC: 
2
J H-3 to C-2; H-6 to C-5; H-5 to C-6; H-6 
to C-7; H-9 to C-8; H-20 to C-15; H-5, H-17 to C-16; H-18, H-20 to C-19; H-21 to C-
20; H-20 to C-21; H-3' to C-2'; H-14' to C-3'; H-6' to C-5'; H-5' to C-6'; H-6' to C-7'; H-
21 to C-9'; H-11' to C-10'; H-3' to C-14', H-14' to C-15'; H-5' to C-16'; H-19' to C-18'; 
H-18' to C-19'; H-15', H-19', H-21' to C-20'. 
3
J H-6, H-14, N1Me to C-2; H-5, N4Me to 
C-3; H-3, N4Me to C-5; H-3, H-5, H-9 to C-7; H-6, H-10, H-12 to C-8; H-11 to C-9; H-
12 to C-10; H-9 to C-11; H-10 to C-12; H-9, H-11, N1Me to C-13; H-20 to C-14; H-3, 
H-5, H-21 to C-15; H-6 to C-16; H-5 to C-17; H-17, H-21 to C-19; H-18 to C-20; H-20 
to C-21; H-6', H-14', N1Me' to C-2'; H-15', H-21' to C-3'; H-3', H-15', H-17', H-21' to C-
5'; H-3', H-5' to C-7'; H-21, H-12' to C-8'; H-20, H-11' to C-9'; H-21, H-12' to C-10', H-
11', N1Me' to C-13'; H-17', H-19', H-21' to C-15'; H-6', H-14' to C-16'; H-5' to C-17'; H-
15', H-21' to C-19'; H-14', H-18' to C-20'; H-15', H-19' to C-21'. NOESY: H-3/ N1Me, 
N4Me; H-5/ H-6, N4Me; H-6/ H-5, H-6, N4Me; H-/ H-16; H-9/H-10; H-12/ H-11, 
N1Me; H-14/ H-14, H-15; H-15/ H-14; H-17/ H-17; H-17/ H-5, H-16H-20/ H-
18; H-21/ H-18, H-20, H-21; H-3'/ H-14', N1Me'; H-5'/ H-16'; H-6'/ H-16'; H-12'/ 
H-11', N1Me'; H-14'/ H-14'H-15'/ H-14'H-14'H-16', H-18'; H-17'/ H-16'; H-








Lumutinine D (74): light yellowish oil; []D +209 (c 0.40, CHCl3); UV (EtOH) max 
(log ): 209 (5.40), 231 (5.49), 290 (4.89) nm; IR (dry film) max 3370 cm
-1
; ESIMS  
m/z 645 [M + H]
; HRESIMS m/z 645.3809 (calcd for C41H48N4O3 + H, 645.3799); for
 
1
H NMR and 
13
C NMR data, see Table 2.48. HMBC: 
2
J H-3 to C-2; H-6 to C-5; H-5 to 
C-6; H-6 to C-7; H-9 to C-8; H-3 to C-14; H-5, H-17 to C-16; H-18, H-20 to C-19; H-
21 to C-20; H-3' to C-2'; H-6', H-16' to C-5'; H-5' to C-6'; H-6' to C-7'; H-9' to C-10'; H-
21 to C-11', H-3' to C-14'; H-15', H-17' to C-16'; H-16' to C-17'; H-19' to C-18'; H-18' to 
C-19'. 
3
J H-6, H-14, N1Me to C-2; H-5, N4Me to C-3; H-3, N4Me to C-5; H-3, H-5, H-9 
to C-7; H-6, H-10, H-12 to C-8; H-11 to C-9; H-12 to C-10; H-9 to C-11; H-10 to C-12; 
H-9, H-11, N1Me to C-13; H-20 to C-14; H-3, H-5, H-17, H-21 to C-15; H-6, H-14 to 
C-16; H-5 to C-17; H-17, H-21 to C-19; H-18 to C-20; H-21' to C-21; H-6', H-14', 
N1Me' to C-2'; H-5', H-15' to C-3'; H-3', H-17' to C-5'; H-16' to C-6'; H-3', H-5', H-9' to 
C-7'; H-6', H-12' to C-8'; H-21, H-12' to C-10'; H-20, H-9' to C-11'; H-21 to C-12'; H-9', 
N1Me' to C-13'; H-16' to C-14'; H-17', H-19' to C-15'; H-6', H-14' to C-16'; H-5' to C-17'; 
H-15', H-21' to C-19'; H-14', H-16' to C-20'; H-5', H-19' to C-21'. NOESY: H-3/ H-14, 
H-14, N4Me; H-5/ H-16, N4Me; H-6/ H-6; H-6/ H-5; H-9/ H-6, H-6, H-10; H-
10/ H-11; H-12/ H-11, N1Me; H-14/ H-14, H-15; H-14/ H-3, N1Me; H-15/ H-14; 
H-16/ H-5; H-17/ H-14, H-17H-17/ H-5, H-16; H-20/ H-18; H-21/ H-14, H-
18, H-20, H-21; H-21/ H-14;N1Me/ H-14; H-3'/ H-14', H-21', N1Me'; H-6'/ H-
6'; H-12'/ H-21H-21, N1Me'; H-15'/ H-14H-14; H-17'/ H-5', H-15'; H-19'/ H-
17', H-18'H-21'/ H-18'
 
Lumutinine E (75): light yellowish oil; []D +74  (c 0.14, CHCl3); UV (EtOH) max 
(log ) 229 (3.66), 284 (3.06) nm; IR (dry film) max 3380 cm
1
; EIMS m/z 630 [M]
+
 
(100), 599 [M CH2OH]
+








238 (12), 197 (76), 170 (18), 108 (2), 70 (7); HREIMS m/z 630.3572 (calcd for 
C40H46N4O3, 630.3570); for
 1
H NMR and 
13
C NMR data, see Table 2.49, respectively. 
HMBC: 
2
J H(6), H(6) to C(5); H(6), H(6) to C(7); H(20) to C(15); H(18), H(20) 
to C(19); H(21a), H(21b) to C(20); H(3'), N(1')H to C(2'); H(6'), H(16') to C(5'); 
H(6'), H(6') to C(7'); H(21a), H(21b) to C(9'); H(11') to C(10'); N(1')H to C(13'); 
H(16') to C(17'); H(19') to C(18'); H(18') to C(19'). 
3
J H(6), H(6), N(1)-Me to C(2); 
H(5), N(4)-Me to C(3); H(17), H(17), N(4)-Me to C(5); H(5), H(9) to C(7); H(10), 
H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), 
H(11), N(1)-Me to C(13); H(20) to C(14); H(5), H(21a), H(21b) to C(15); H(6), H(6) 
to C(16); H(5) to C(17); H(17), H(21b) to C(19); H(18) to C(20); H(6') to C(2'); 
H(5'), H(21'a,b) to C(3'); H(3'), H(17'a,b) to C(5'); H(3'), H(5'), N(1')H to C(7'); H(12'), 
N(1')H to C(8'); H(11') to C(9'); H(21a), H(21b), H(12') to C(10'); H(11') to C(13'); 
H(17'a,b), H(19'), H(21'a,b) to C(15'); H(6') to C(16'); H(5') to C(17'); H(16'), H(18') 
to C(20'); H(19') to C(21'). 1D-ROESY: H(3)/N(1)-Me, N(4)-Me; H(5)/H(16), H(17), 
N(4)-Me; H(6)/H(6), H(9), H(16); H(6)/H(5), H(6); H(9)/H(10); H(10)/H(9), 
H(11); H(12)/H(11), N(1)-Me; H(14)/H(3), H(14), H(15), N(1)-Me; H(14)/H(14), 
H(17); H(15)/H(16), H(20); H(17)/H(5H(17 H(17)/H(14), H(17); 18-
Me/H(20), H(11'); H(21a)/H(21b), H(6'); H(21b)/H(21a); N(1)-Me/H(3), H(12); N(4)-
Me/H(3), H(5); H(3')/H(14'a), H(14'b); H(5')/H(21'a,b), H(17'a,b); H(6')/H(6'), H(16'); 
H(6')/H(6'), H(21a); H(11')/H(12'), 18-Me; H(12')/H(11'), N(1')H; H(14'a)/H(14'b), 
H(15'); H(14'b)/H(3'), H(14'a); H(15')/H(14'a, H(16',18'-Me;H(16')/H(15', H(17'a,b); 









Macralstonidine (76): light yellowish oil; []D 96 (c 0.72, CHCl3); UV (EtOH) max 





C NMR data, see Table 2.50.  
 
Lumusidine A (77): light yellowish oil; [α]25D 138 (c 0.24, CHCl3); UV (EtOH) 
max nm (log ) 231 (5.56), 285 (4.90) nm; IR (dry film) max 1618, 1655 cm
1
; 
ESIMS  m/z 687 [M + H]

; HRESIMS m/z 687.3897 (calcd for C43H50N4O4 + H, 
687.3907); for
 1
H NMR and 
13
C NMR data, see Table 2.51. HMBC: 
2
J H(3) to C(2); 
H(14) to C(3); H(6), H(6) to C(5); H(6), H(6) to C(7); H(9) to C(8); H(11) 
to C(10); H(5), H(17) to C(16); H(16) to C(17); H(19) to C(18); H(18) to C(19); 
H(15), H(19), H(21) to C(20); H(3') to C(2'); H(14') to C(3'); H(6') to C(5'); H(5') 
to C(6'); H(6'), H(6') to C(7'); H(9') to C(8'); H(19) to C(10'); H(12') to C(11'); 
H(12') to C(13'); H(5'), H(17') to C(16'); H(15'), H(21') to C(20'). 3J H(6), H(6), 
H(14), H(14), N1Me to C(2); H(5), H(15), N4Me to C(3); H(3) to C(5); H(3), 
H(5), H(9) to C(7); H(6), H(10) to C(8); H(12) to C(10); H(9) to C(11); H(10) to 
C(12); H(9), H(11), N1Me to C(13); H(3), H(5), H(17), H(17), H(19), H(21) to 
C(15); H(6), H(6), H(14) to C(16); H(5), H(15), H(21) to C(17); H(15), H(21), 
H(9') to C(19); H(14), H(14), H(16), H(18) to C(20); H(15), H(17), H(19) to 
C(21); H(3) to N4Me; H(6'), H(6'), H(14'), N1Me' to C(2'); H(5'), N4Me' to C(3'); 
H(3') to C(5'); H(5'), H(9') to C(7'); H(6'), H(12') to C(8'); H(19) to C(9'); H(18), 
H(12') to C(10'); H(19), H(9'), 11'-OMe to C(11'); H(9'), N1Me' to C(13'); H(3'), 
H(5'), H(17'), H(17'), H(21') to C(15'); H(6'), H(6'), H(14') to C(16'); H(5'), 
H(15'), H(21') to C(17'); H(18'), H(21') to C(19'); H(17') to C(21'); H(5') to N4Me'. 
NOESY: H(3)/H(14), H(14), N1Me, N4Me; H(5)/H(16), H(17), N4Me; 








H(10)/H(9), H(11); H(11)/H(10), H(12); H(12)/H(11), N1Me; H(14)/H(3), H(14); 
H(14)/H(3), H(14), H(19), N1Me; H(15)/H(14), H(19); H(16)/H(5), H(6), 
H(17), H(17); H(17)/H(16), H(17); H(17)/H(5), H(16), H(17); H(18)/H(19), 
H(21), H(9'); H(19)/H(14), H(18), H(21), H(9'); H(21)/H(18), H(19), H(9'); 
N1Me/H(3), H(12), H(14); N4Me/H(3), H(5); H(3')/H(14'), H(14'), N1Me', 
N4Me'; H(5')/H(16'), H(17'), N4Me'; H(6')/H(6'), H(9'); H(6')/H(6'), H(9'), 
H(16'); H(9')/H(18), H(19), H(21), H(6'), H(6'); H(12')/11'-OMe, N1Me'; 
H(14')/H(14'), H(18'); H(14')/H(3'), H(14'), H(15'), N1Me'; H(15')/H(14'), 
H(14'), H(16'); H(16')/H(5'), H(6'), H(15'), H(17'); H(17')/H(17'); 
H(17')/H(5'), H(16'), H(17'); H(18')/H(21'); H(21')/H(18'); N1Me'/H(3'), H(12'), 
H(14'); N4Me'/H(3'), H(5'); 11'-OMe/H(12'). 
 
Conversion of Lumusidine A (77) to Its Dimethyl Diiodide Salt 77a: Iodomethane 
(0.5 ml) was added to lumusidine A (77) (6.1 mg, 0.009 mmol), and the mixture 
allowed to stand for 24 h at rt. Excess iodomethane was then removed under reduced 
pressure to furnish a yellowish residue, which on recrystallization from hot MeOH gave 
the corresponding dimethyl diiodide salt 77a (3.8 mg, 43%): light yellowish block 
crystals; >198 °C dec.; ESIMS m/z 358 [M]
2+
 ; HRESIMS m/z 358.2157 [M]
2+
 (calcd 
for C45H56N4O4, 716.4302). 
 
Crystallographic data of lumusidine A dimethyl diiodide salt (77a): light yellowish 
block crystals, C45H56N4O4 2I , Mr = 970.76, monoclinic, space group P21, a = 
15.8916(2) Å, b = 8.92620(10) Å, c = 17.1572(3) Å,   = 90 ,  = 
112.2430 (10), V = 2252.67(5) Å
3
, T = 100 K, Z = 2, Dcalcd = 1.511 gcm , crystal size 
0.10 x 0.12 x 0.18 mm
3








7729 reflections [ ]. The absolute configuration of compound 77a was 
determined on the basis of Flack parameter
284,285
 [x = 0.01(0.03)] and corroborated by 
the Hooft parameter
286,287 
[y = 0.010(0.015)]. CCDC number: 893347 
  
Lumusidine B (78): light yellowish oil; [α]25D 59 (c 0.73, CHCl3); UV (EtOH) max 
nm (log ) 229 (5.48), 285 (4.84) nm; IR (dry film) max 1615, 1652 cm
1
; ESIMS  m/z 
705 [M + H]






C NMR data, see Table 2.52 and Table 2.53. HMBC: 
2
J H(3) to C(2); H(6) 
to C(5); H(5) to C(6); H(6), H(6) to C(7); H(9) to C(8); H(5) to C(16); H(18) to 
C(19); H(19) to C(20); H(3') to C(2'); H(14') to C(3'); H(6') to C(5'); H(6'), H(6') 
to C(7'); H(19), H(9') to C(10'); H(12') to C(11'); H(12') to C(13'); H(5'), H(15'), H(17') 
to C(16'); H(21') to C(20'). 
3
J H(6), H(6), N1Me to C(2); H(5), N4Me to C(3); H(3), 
N4Me to C(5); H(5), H(9) to C(7); H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to 
C(10); H(9) to C(11); H(10) to C(12); H(9), H(11), N1Me to C(13); H(3), H(5), H(17), 
H(21) to C(15); H(6), H(6) to C(16); H(5), H(21) to C(17); H(18) to C(20); H(17) 
to C(21); H(5) to N4Me; H(6'), H(6'), H(14'), N1Me' to C(2'); H(5'), H(15'), N4Me' 
to C(3'); H(3'), N4Me' to C(5'); H(5'), H(9') to C(7'); H(12') to C(8'); H(19) to C(9'); 
H(18), H(20), H(12') to C(10'); H(19), H(9'), 11'-OMe to C(11'); H(9'), N1Me' to C(13'); 
H(3'), H(5'), H(17'), H(17'), H(21') to C(15'); H(6'), H(6'), H(14') to C(16'); H(5') 
to C(17'); H(14'), H(14') to C(20'); H(17') to C(21'); H(5') to N4Me'. NOESY: 
H(3)/H(14), H(14), N1Me, N4Me; H(5)/H(16), H(17); H(6)/H(6), H(9); 
H(6)/H(6), H(9), H(16); H(9)/H(6), H(6), H(10); H(10)/H(9), H(11); H(11)/H(10), 
H(12); H(12)/H(11), N1Me; H(14)/H(3), H(14); H(14)/H(3), H(14), H(19), H(9'); 
H(15)/H(16), H(20), 11'-OMe; H(16)/H(5), H(6), H(15), H(17), H(20); 








OMe; H(19)/H(14), H(18), H(21), H(9'); H(20)/H(15), H(16), H(18), H(21), 11'-OMe; 
H(21)/H(18), H(19), H(20); N1Me/H(3), H(12); N4Me/H(3); H(3')/H(14'), H(14'), 
N1Me', N4Me'; H(5')/H(16'), N4Me'; H(6')/H(6'), H(9'), H(16'), H(17'); 
H(6')/H(6'), H(9'); H(9')/H(6'), H(6'), H(14'),  H(18), H(19); H(12')/11'-OMe, 
N1Me'; H(14')/H(3'), H(14'), H(17'); H(14')/H(3'), H(14'), H(15'), N1Me'; 
H(15')/H(14'), H(16'); H(16')/H(6'), H(15'), H(17'); H(17')/H(14'), H(17'); 
H(17')/H(6'), H(16'), H(17'); H(18')/H(21'); H(21')/H(18'); N1Me'/H(3'), H(12'), 
H(14'); N4Me'/H(3'), H(5'); 11'-OMe/H(15), H(18), H(20), H(12').    
 
Acetylation of lumusidine B (78): To a solution of lumusidine B (78) (4.2 mg, 0.006 
mmol), pyridine (1.45 μl, 0.018 mmol), and CH2Cl2 (2 ml) was added Ac2O (0.9 μl, 
0.009 mmol), and the mixture was stirred at rt. The progress of the reaction was 
monitored with TLC and stopped at ca. 95% completion by addition of 5% Na2CO3 
solution (2 ml). The organic layer was washed with water, dried with Na2SO4, 
concentrated in vacuo, and the residue was puriﬁed via centrifugal preparative TLC 
(SiO2, 100:5 CHCl3 /MeOH, NH3-saturated) to give 2.5 mg (56%) of O-acetyl 
derivative 78a:  light yellowish oil; []25D 56 ( c 0.09, CHCl3); UV (EtOH) max (log ) 





H NMR and 
13
C NMR data, see Table 2.52 and Table 2.53, 
respectively; ESIMS m/z 747 [M + H]
+
; HRESIMS m/z 747.4123 (calcd for C45H54N4O4 
+ H, 747.4122). 
 
Conversion of Lumusidine B (78) to Its Dimethyl Diiodode Salt 78b: Iodomethane 
(0.5 ml) was added to lumusidine B (78) (5.4 mg, 0.008 mmol), and the mixture 








pressure to furnish a yellowish residue, which on recrystallization from hot MeOH gave 
the corresponding dimethyl diiodide salt 78b (4.2 mg, 53%): light yellowish block 
crystals; mp 230−234 °C; ESIMS m/z 367 [M]2+; HRESIMS m/z 367.2207 [M]2+ (calcd 
for C45H58N4O5, 734.4407). 
 





, Mr = 988.77, monoclinic, space group C2, a = 
28.5993(5) Å, b = 11.4265(2) Å, c = 18.3052(4) Å,  =  = 90o,  = 127.1400o (10), 
V = 4768.59(16) Å
3
, T = 100 K, Z = 4, Dcalcd = 1.404 gcm
-3
, crystal size 0.07 x 0.21 
x 0.42 mm
3
, F(000) = 540. The final R1 value is 0.0703 (wR2 = 0.1874) for 8792 
reflections [I>2(I)]. The absolute configuration of compound 78b was determined 
on the basis of Flack parameter
284,285
 [x = 0.01(0.03)] and corroborated by the Hooft 
parameter
286,287
 [y = 0.052(0.011)]. CCDC number: 893348 
 
Lumusidine C (79): light yellowish oil; [α]25D 16 (c 0.21, CHCl3); UV (EtOH) max 
nm (log ) 231 (5.66), 283 (5.01) nm; IR (dry film) max 1619, 1653 cm
1
; ESIMS  m/z 
733 [M + H]






C NMR data, see Table 2.54; HMBC: 
2
J H(6) to C(5); H(6), H(6) to 
C(7); H(9) to C(8); H(5) to C(16); H(18) to C(19); H(21a), H(21b) to C(20); OCH2CH3 
to OCH2CH3; H(3') to C(2'); H(6'), H(6') to C(5'); H(6'), H(6') to C(7'); H(9') to 
C(8'); H(21a), H(21b) to C(10'); H(12') to C(11'); H(12') to C(13'); H(17') to C(16'); 
H(18') to C(19'); H(21') to C(20'). 
3
J H(6), H(6), N1Me to C(2); H(5), N4Me to C(3); 
H(3), N4Me to C(5); H(5), H(9) to C(7);  H(10), H(12) to C(8); H(11) to C(9); H(12) to 
C(10); H(9) to C(11); H(10) to C(12); H(9), H(11), N1Me to C(13); H(5), H(21a), 








H(21a), OCH2CH3 to C(19); H(18) to C(20); H(6'), H(6'), H(14'), N1Me' to C(2'); 
H(5'), N4Me' to C(3'); H(3'), N4Me' to C(5'); H(5'), H(9') to C(7'); H(12') to C(8'); 
H(21a), H(21b) to C(9'); H(12') to C(10'); H(21a), H(21b), H(9'), 11'-OMe to C(11'); 
H(9'), N1Me' to C(13'); H(3'), H(5'), H(17'), H(17'), H(21') to C(15'); H(6'), H(6') 
to C(16'); H(5'), H(21') to C(17'); H(21') to C(19'); H(15'), H(17') to C(21'); H(5') to 
N4Me'. NOESY: H(3)/H(14), H(14), N1Me, N4Me; H(5)/H(6), H(16), H(17), 
N4Me; H(6)/ H(6), H(9); H(6)/H(5), H(6), H(9), H(16); H(9)/H(6), H(6), H(10); 
H(10)/H(9), H(11); H(11)/H(10), H(12); H(12)/H(11), N1Me; H(14)/H(3), H(14); 
H(14)/H(3), H(14), H(15),  H(18), H(20), N1Me; H(15)/H(14), H(16), H(21a), H(9'); 
H(16)/H(15), H(17), H(21a); H(17)/H(17); H(17)/H(5), H(16), H(17); 
H(18)/H(14), H(20), H(21b), OCH2CH3;  H(20)/H(14), H(18), H(21b), H(9'); 
H(21a)/H(15), H(16), H(21b), H(9'); H(21b)/H(18), H(20), H(21a), H(9'); N1Me/H(3), 
H(14), H(12); N4Me/H(3), H(5); OCH2CH3/H(18), OCH2CH3; H(3')/H(14'), H(14'), 
N1Me', N4Me'; H(5')/H(6'), H(16'), H(17'), N4Me'; H(6')/H(6'), H(9'); H(6')/H(5'), 
H(6'), H(16'), H(9'); H(9')/H(6'), H(6'), H(20), H(21a), H(21b); H(12')/11'-OMe, 
N1Me'; H(14')/H(3'), H(14'), H(17'); H(14')/H(3'), H(14'), H(15'), N1Me'; 
H(15')/H(14'), H(16'); H(16')/H(5'), H(6'), H(15'), H(17'); H(17')/H(5'), H(14'), 
H(17'); H(17')/ H(16'), H(17'); H(18')/H(21'); H(21')/H(18'); N1Me'/H(3'), H(12'), 
H(14'); N4Me'/H(3'), H(5'); 11'-OMe/H(12'). 
 
Lumusidine D (80): light yellowish oil; [α]25D 161 (c 0.38, CHCl3); UV (EtOH) max 
nm (log ) 233 (5.86), 283 (5.17) nm; IR (dry film) max 1618, 1654 cm
1
; ESIMS  m/z 
687 [M + H]






C NMR data, see Table 2.55; HMBC: 
2
J H(6) to C(5); H(6), H(6) to 








H(3') to C(2'); H(6') to C(5'); H(6'), H(6') to C(7'); H(9') to C(8'); H(11') to C(10'); 
H(21)/H(12'); H(5'), H(17') to C(16'); H(15'), H(21') to C(20'). 3J H(6), H(6), 
H(14), H(14), N1Me to C(2); H(5) to C(3); N4Me to C(5); H(5), H(9) to C(7); H(6), 
H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); 
H(9), H(11), N1Me to C(13); H(5), H(17), H(17), H(21) to C(15); H(6) to C(16); 
H(5) to C(17); H(17), H(21) to C(19); H(18) to C(20); H(3), H(5) to N4Me; H(6'), 
H(6'), H(14'), H(14'), N1Me' to C(2'); H(5') to C(3'); H(3'), N4Me' to C(5'); H(5'), 
H(9') to C(7');  H(6'), H(10') to C(8'); H(21), H(9'), 11'-OMe to C(11'); H(10') to C(12'); 
H(21), H(9'), N1Me' to C(13'); H(16') to C(14'); H(3'), H(5'), H(17'), H(17'), H(21') to 
C(15'); H(6'),  H(14') to C(16'); H(5'), H(21') to C(17'); H(17') to C(21'); H(3'), H(5') 
to N4Me'. NOESY: H(3)/H(14), H(14), N1Me, N4Me; H(5)/H(6), H(16), H(17), 
N4Me; H(6)/ H(6), H(9); H(6)/H(5), H(6), H(9), H(16); H(9)/H(6), H(6), H(10); 
H(10)/H(9), H(11); H(11)/H(10); H(12)/N1Me; H(14)/H(3), H(14), H(17); 
H(14)/H(3), H(14), H(15), N1Me; H(15)/H(14); H(16)/H(5), H(6), H(17); 
H(17)/H(14), H(16), H(17); H(17)/H(5), H(17); H(18)/H(21); H(21)/H(18); 
N1Me/H(3), H(14), H(12); N4Me/H(3); H(3')/H(14'), H(14'), N4Me'; H(5')/H(6'), 
H(16'), H(17'), N4Me'; H(6')/H(6'), H(9'); H(6')/H(5'), H(6'), H(16'), H(9'); 
H(9')/H(6'), H(6'), H(10); H(10')/H(9'), 11'-OMe; H(14')/H(3'), H(14'); 
H(14')/H(3'), H(14'), H(15'); H(15')/H(14'), H(16'); H(16')/H(5'), H(6'), H(15'); 
H(17')/H(17'); H(17')/H(5'), H(17'); H(18')/H(21'); H(21')/H(18'); N4Me'/H(3'); 
11'-OMe/H(10'). 
 
Crystallographic data of lumusidine D (80): colorless needles, C43H50N4O4, Mr = 
686.87, orthorhombic, space group P212121, a = 9.8437(14) Å, b = 14.164(2) Å, c = 
25.802(4) Å,  = =  = 90o, T = 100 K, Z = 4, Dcalcd = 1.268 gcm
-3








0.07 x 0.21 x 0.32 mm
3
, F(000) = 1472.0. The final R1 value is 0.0694 (wR2 = 
0.1483) for 4209 reflections [I>2(I)]. CCDC number: 893349 
 
Perhentidine A (81): light yellowish oil; []D 78 (c 0.34, CHCl3); UV (EtOH) max 
(log ) 231 (4.69), 285 (4.87) nm; IR (dry film) max 3380, 1702, 1652, 1618 cm
1
; 
EIMS m/z 686 [M H2O]
+
 (100), 617 (4), 547 (10), 486 (33), 454 (5), 379 (12), 343 (9), 
307 (13), 250 (13), 197 (67), 170 (17), 149 (8), 43 (9); HRLSIMS m/z 705.4020 [M + 
H]
+ 
(calcd for C43H52N4O5 + H, 705.4016); for 
1
H NMR and 
13
C NMR data, see Table 
2.56 and Table 2.57, respectively. HMBC: 
2
J H(3) to C(2); H(6), H(6) to C(5); H(6), 
H(6) to C(7); H(5) to C(16); H(18), H(20) to C(19); H(15), H(21a) to C(20); H(3') to 
C(2'); H(6') to C(5'); H(6'), H(6') to C(7'); H(9') to C(8'); H(10') to C(11'); H(21a), 
H(21b) to C(12'); H(5'), H(17'), H(17') to C(16'); H(18') to C(19'); H(21') to C(20'). 
3
J H(6), H(6), H(14), N(1)-Me to C(2); H(5), N(4)-Me to C(3); H(17a), N(4)-Me to 
C(5); H(5), H(9) to C(7); H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); 
H(9) to C(11); H(10) to C(12); H(9), N(1)-Me to C(13); H(20) to C(14); H(3), H(5), 
H(17a) to C(15); H(6), H(6) to C(16); H(5) to C(17); H(21b) to C(19); H(18) to 
C(20); H(3'), N(4)-Me' to C(5'); H(5'), H(17'), H(21') to C(15'); H(6'), H(6'), 
H(14'), N(1)-Me' to C(2'); H(5'), N(4)-Me' to C(3'); H(5'), H(9') to C(7'); H(10') to 
C(8'); H(9'), H(21a), H(21b), 11-OMe' to C(11'); H(10') to C(12'); H(21a), H(9'), N(1)-
Me' to C(13'); H(3') to C(15'); H(6'), H(6') to C(16'); H(5'), H(21') to C(17'); H(17') 
to C(21'). 
4
J H(18') to C(21'). NOESY: H(3)/H(14), H(14), N(1)-Me, N(4)-Me; 
H(5)/H(6)6), H(16), H(17), N(4)-Me; H(6)/H(5), H(6), H(9), N(4)-Me; 
H(6)/H(5), H(6), H(9), H(15), H(16); H(9)/H(6)6), H(10); H(10)/H(9), H(11); 
H(11)/H(10), H(12); H(12)/H(11), N(1)-Me; H(14)/H(3), H(20) [or H(21b)], H(14), 








H(16)/H(5), H(6) H(15), H(17); H(17)/H(5), H(16), H(20) [or H(21b)]; 
H(18)/H(14)17), H(20) [or H(21b)],  11'-OMe, N(1')-Me; H(20)/H(14), H(17), 
H(18), H(21b); H(21a)/H(15), H(20) [or H(21b)], N(1')-Me; H(21b)/H(14), H(14), 
H(15), H(21a), N(1')-Me; N(1)-Me/H(3), H(12), H(14)N(4)-Me/H(3), H(5), 
H(6)3'14')14')')-Me, ')-Me5')/H(6'), H(6')16'), 
H(17'), H(17'), N(4')-Me; H(6')/H(5'), H(6') H(9'), N(4')-Me; H(6')/H(5'), 
H(6') H(9'), H(16'), H(17')9'6'), H(6'), H(10'); H(10')/H(9'), 11'-OMe; 
H(14')/H(3'), H(14', H(17'); H(14')/H(3'), H(14')15'), N(1')-Me; 
H(15')/H(14'), H(16'); H(16')/H(5'), H(6'), H(15'), H(17'), H(17)17'5'), 
H(16'), H(17')14'); H(17')/H(5'), H(6'), H(16'), H(17'), H(18'); H(18')/H(17'), 
H(21'); H(21')/H(18'); N1'-Me/H(3'), H(14')21a), H(18), H(20) [or H(21b)]; N(4')-
Me/H(3'), H(5'), H(6'); 11'-OMe/H(10'), H(18).    
          
Acetylation of perhentidine A (81): To a stirred solution of 81 (18.3 mg, 0.026 mmol), 
in CH2Cl2 (2 mL) and pyridine (6.3 l, 0.079 mmol) was added dropwise acetic 
anhydride (3.7 l, 0.039 mmol), and the mixture was stirred at room temperature for 2 
h. The mixture was quenched with 10% Na2CO3 (5 mL) and extracted with CH2Cl2 (3 
10 mL). The combined organic layers were dried (Na2SO4), the solvent evaporated in 
vacuo, and the residue purified by preparative centrifugal TLC (SiO2, C(N)) to give 9.1 
mg (47%) of the diacetate derivative 81a as a light yellowish oil; []25D 111 (c 0.45, 
CHCl3); UV (EtOH) max (log ) 230 (4.99), 285 (4.30) nm; IR (dry film) max 1732, 
1703, 1652, 1620 cm
-1
; ESIMS m/z 747 [M + H]
+
; HRESIMS m/z 747.4122 (calcd for 
C45H54N4O6 + H, 747.4119); for
 1
H NMR and 
13
C NMR data, see Table 2.56 and Table 
2.57, respectively. NOESY: H(3)/H(14), N(1)-Me, N(4)-Me; H(5)/H(6), H(16), 








H(16); H(9)/H(6)6), H(10); H(10)/H(9), H(11); H(11)/H(10), H(12); 
H(12)/H(11), N(1)-Me; H(14)/H(3), H(20), H(21b), N(1)-Me, H(17); H(15)/H(6), 
H(16), H(21a); H(16)/H(5), H(6) H(15), H(17); H(17a)/H(16) [or H(14)], H(17b), 
H(18), H(20); H(17b)/H(5), H(14) [or H(16)], H(17a); H(18)/H(17a), H(20); 
H(20)/H(14), H(17a), H(18), H(21b); H(21a)/H(15), H(21b), N(1')-Me; H(21b)/H(14), 
H(20), H(21a); N(1)-Me/H(3), H(12), H(14); N(4)-Me/H(3), H(5), 
H(6)(3')(14')(14')(')-Me, (')-Me; H(5')/H(6'), H(6')(16'), 
H(17'), H(17'), N(4')-Me; H(6')/H(5'), H(6') H(9'); H(6')/H(5'), H(6') H(9'), 
H(16'); H(9')/H(6'), H(6'), H(10'); H(10')/ H(9'), 11'-OMe; H(14')/H(3'), H(14'), 
H(17')(14')(3'), H(14')(15'), N(1')-Me; H(15')/H(14'), H(16'); H(16')/H(5'), 
H(6'), H(15'), H(17'); H(17')/H(5'), H(17')14'); H(17')/H(5'), H(16'), 
H(17'); H(18')/H(21'); H(21')/H(18'); N(1')-Me/H(3'), H(14')21a); N(4')-Me/H(3'), 
H(5'); 11'-OMe/H(10').   
 
Perhentidine B (82): light yellowish oil; [α]25D 38 (c 0.52, CHCl3); UV (EtOH) 
max nm (log ) 234 (4.49), 286 (3.81) nm; IR (dry film) max 3392 (OH), 1707, 
1653, 1618 cm
1
; ESIMS m/z 705 [M + H]

; HRESIMS m/z 705.3993 (calcd for 
C43H52N4O5 + H, 705.4013); for
 1
H NMR and 
13
C NMR data, see Table 2.58 and 
Table 2.59. HMBC: 
2
J H(6), H(6) to C(5); H(6), H(6) to C(7); H(17b) to 
C(16); H(5) to C(17); H(18) to C(19); H(21b) to C(20); H(3') to C(2'); H(6'), 
H(6') to C(7'); H(10') to C(11'); H(21a), H(21b) to C(12'); H(17') to C(16'); H(18') 
to C(19'); H(21') to C(20'); 
3
J: H(6), H(6), N(1)-Me to C(2); H(5), N(4)-Me to 
C(3); H(17b), N(4)-Me to C(5); H(5), H(9) to C(7); H(6)10), H(12) to C(8); 
H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11), N(1)-








C(19); H(18) to C(20); H(6'), H(6'), H(14'), N(1')-Me to C(2'); H(5'), N(4')-Me 
to C(3'); H(3'), N(4')-Me to C(5'); H(5'), H(9') to C(7'); H(6'), H(10') to C(8'); 
H(9'), H(21a), H(21b), 11'-OMe to C(11'); H(10') to C(12'); H(9'), H(21a), H(21b), 
N(1')-Me to C(13'); H(3'), H(5'), H(17'),H(17'), H(21') to (15'); H(5'), H(6'), 
H(6') to C(16'); H(5'), H(21') to C(17'). NOESY: H(3)/H(14), H(14), N(1)-Me, 
N(4)-Me; H(5)/H(6) H(17a), N(4)-Me; H(6)/H(5), H(6), H(9), N(4)-Me; 
H(6)/H(5), H(6), H(9), H(16); H(9)/H(6)6), H(10); H(10)/H(9), H(11); 
H(11)/H(10), H(12); H(12)/H(11), N(1)-Me; H(14)/H(3), H(14), H(20); 
H(14)/H(3), H(14), H(15), N(1)-Me; H(15)/H(6), H(14) H(21a); H(16)/H(5), 
H(6)17a), H(17b), H(21b); H(17a)/H(5), H(16), H(17b), H(20), H(21b);  
H(17b)/H(16), H(17a), H(20), H(21b), 11'-OMe; H(18)/H(20), 11'-OMe; H(20)/ 
H(14), H(17a), H(17b), H(18), H(21b); H(21a)/H(15), H(21b), N(1')-Me (signals 
overlapped with H(20)); H(21b)/H(16), H(17b), H(20), H(21a); N(1)-Me/H(3), 
H(12), H(14); N(4)-Me/H(3), H(5), H(6); H(3')/H(14')14')')-
Me')-Me; H(5')/H(6')6'), H(16), H(17'), H(17'), N(4')-Me; 
H(6')/H(5'), H(6') H(9'), ')-Me; H(6')/H(5'), H(6') H(9'), H(15'), H(16'); 
H(9')/H(6'), H(6'), H(10'); H(10')/H(9'), 11'-OMe; H(14')/H(3'), H(14'), 
H(17')14')3'), H(14')')-Me; H(15')/H(6')14'), H(16'); 
H(16')/H(5'), H(6'), H(15'), H(17'); H(17')/H(5'), H(14') H(17'); 
H(17')/H(5'), H(16'), H(17'); H(18')/H(21'); H(21')/H(18'); N(1')-Me/H(3'), 
H(14'), H(21a); N(4')-Me/H(3'), H(5'), H(6); 11'-OMe/H(10'), H(17b).                                              
 
Acetylation of perhentidine B (82): To a stirred solution of 82 (18.8 mg, 0.027 
mmol), in CH2Cl2 (2 mL) and pyridine (6.4 l, 0.081 mmol) was added dropwise 








temperature for 2 h. The mixture was quenched with 10% Na2CO3 (5 mL) and 
extracted with CH2Cl2 (3 10 mL). The combined organic layers were dried 
(Na2SO4), the solvent evaporated in vacuo, and the residue purified by preparative 
centrifugal TLC (SiO2, C(N)) to give 8.5 mg (43%) of the diacetate derivative 82a 
as a light yellowish oil; []25D 42 (c 0.43, CHCl3); UV (EtOH) max (log ) 230 
(5.01), 288 (4.32) nm; IR (dry film) max 1734, 1709, 1654, 1619 cm
-1
; ESIMS m/z 
747 [M H]+; HRESIMS m/z 747.4109 (calcd for C45H54N4O6 + H, 747.4119); for
 
1
H NMR and 
13
C NMR data, see Table 2.58 and Table 2.59, respectively. NOESY: 
H(3)/H(14), H(14), N(1)-Me, N(4)-Me; H(5)/H(6) H(17), N(4)-Me; 
H(6)/H(9), H(6), N(4)-Me; H(6)/H(5), H(6), H(9), H(15), H(16); 
H(9)/H(6)6), H(10); H(10)/H(9), H(11); H(11)/H(10), H(12); H(12)/H(11), 
N(1)-Me; H(14)/H(3), H(14), H(17), H(20); H(14)/H(3), H(14), H(15), N(1)-
Me; H(15)/H(6), H(14) H(21a); H(16)/H(5), H(6)17), H(21b); H(17)/H(5), 
H(16), H(20), H(21b), 11'-OMe; H(18)/H(5), H(16), H(20), H(21b), 11'-OMe; 
H(20)/H(14), H(17), H(18) [or H(14)]; H(21a)/H(15), H(21b), N(1')-Me; H(21b)/ 
H(16), H(17), H(21a); N(1)-Me/H(3), H(12), H(14); N(4)-Me/H(3), H(5), H(6); 
H(3')/H(14')14')')-Me, ')-Me; H(5')/H(6')6'), H(16), H(17'), 
H(17'), N(4')-Me; H(6')/H(5'), H(6') H(9'), ')-Me; H(6')/H(5'), H(6') 
H(9'), H(15'), H(16'); H(9')/H(6'), H(6'), H(10'); H(10')/H(9'), 11'-OMe; 
H(14')/H(3'), H(14'), H(17'); H(14')/H(3'), H(14')')-Me; 
H(15')/H(6')14'), H(16'); H(16')/H(5'), H(6'), H(15'), H(17') H(17'); 
H(17')/H(5'), H(14') H(17'); H(17')/H(5'), H(16'), H(17'); H(18')/H(21'); 
H(21')/H(18'); N(1')-Me/H(3'), H(14'), H(21a); N(4')-Me/H(3'), H(5'), H(6); 11'-









Perhentinine (83): light yellowish oil; []D 61 (c 1.19, CHCl3); UV (EtOH) max 




ESIMS m/z 705 (MH
+
, C43H52N4O5 + H); for
 1
H NMR and 
13
C NMR data, see Table 
2.60 and Table 2.61. 
 
Acetylation of perhentinine (83): Reaction of 83 (15.1 mg, 0.021 mmol) with acetic 
anhydride (3 l, 0.032 mmol) in pyridine (5 l, 0.063 mmol) and CH2Cl2 (2 ml) gave 
83a (8.2 mg, 52%): light yellowish oil; []25D 103 (c 0.35, CHCl3); UV (EtOH) max 




ESIMS m/z 747 [M + H]
+
; HRESIMS m/z 747.4123 (calcd for C45H54N4O6 + H, 
747.4119); for 
1
H NMR and 
13
C NMR data, see Table 2.60 and Table 2.61, respectively. 
 
Conversion of Perhentinine (83) to its Dimethyl Diiodide Salt 83b. Iodomethane (0.5 
ml, 8 mmol) was added to perhentinine (83) (16 mg, 0.02 mmol) and the mixture 
allowed to stand for 24 h at rt. Excess iodomethane was then removed under reduced 
pressure to furnish a yellowish residue which on recrystallization from hot MeOH gave 
the corresponding dimethyl diiodide salt 83b (14 mg, 62%): light yellowish block 
crystals; mp 228-230
 o
C; []25D 55 (c 0.05, MeOH); UV (EtOH) max (log ) 221 
(5.83), 295 (4.97) nm; ESIMS m/z 367 [M]
2+
; HRESIMS m/z 367.2207 [M]
2+
 (calcd for 
C45H58N4O5, 734.4396). 
 





= 988.77, orthorhombic, space group P212121, a = 14.5059(2) Å, b = 14.8002(2) Å, c = 
22.4594(3) Å, V = 4821.81(11) Å
3
, T = 100 K, Z = 4, Dcalcd = 1.307 gcm , crystal size 
0.16 x 0.19 x 0.21 mm
3
, F(000) = 1920. The final R1 value is 0.0634 (wR2 = 0.1921) for 








basis of Flack parameter [x = 0.04(0.03)] and corroborated by the Hooft parameter [y = 
0.022(0.07)]. CCDC number: 865674 
 







C); []25D +22 (c 0.5, CHCl3){lit.
172
 []25D +22 (c 2.0, 
CHCl3)}; UV (EtOH) max (log ) 233 (5.44), 288 (4.81) nm; for 
1
H NMR and 
13
C 
NMR data, see Table 2.62 and Table 2.63, respectively.  
 
O-Acetyl-E-seco-macralstonine (84a): Reaction of 84 (16.8 mg, 0.024 mmol) with 
acetic anhydride (3.4 l, 0.036 mmol) in pyridine (5.8 l, 0.071 mmol) and CH2Cl2 (2 
ml) gave 84a (11 mg, 62%): light yellowish oil; []25D 34 (c 1.1, CHCl3); UV (EtOH) 




ESIMS m/z 747 [M + H]
+
; HRESIMS m/z 747.4119 (calcd for C45H54N4O6 + H, 
747.4119); for 
1
H NMR and 
13
C NMR data, see Table 2.64. 
 
Crystallographic data of macralstonine (84): C43H52N4O5, Mr = 704.89, monoclinic, 
space group C2, a = 11.73280(10) Å, b = 13.07670(10) Å, c = 19.2454(2) Å, =  = 
90,  = 108.475(3), V = 3632.9(7) Å3, T = 100 K, Z = 4, Dcalcd = 1.289 gcm
3
, crystal 
size 0.02 x 0.10 x 0.20 mm
3
, F(000) = 1512. The final R1 value is 0.0720 (wR2 = 
0.1869) for 6280 reflections [I>2(I)]. The absolute configuration of compound 84 was 
determined based on the Flack parameter [x = 0.1(0.4)] in conjunction with the Hooft 
parameter [y = 0.30(0.14)] obtained from a statistical analysis of the Bijvoet pairs. 









Anhydromacralstonine (85): light yellowish oil; []D 86 (c 0.18, CHCl3); UV (EtOH) 
max (log ) 230 (4.66), 294 (3.94) nm; IR (dry film) max 1651 cm
1
; HREIMS m/z 
686.3816 [M]
+
 (calcd for C43H50N4O4, 686.3832); for 
1
H NMR and 
13
C NMR data, see 
Table 2.65. 
 
Villalstonidine B (86): light yellowish oil; []D 101 (c 0.58, CHCl3); UV (EtOH) max 
(log ) 230 (4.58), 246 (4.17) (shoulder), 287 (3.98) nm; IR (dry film) max 3388, 1747 
cm
1
; EIMS m/z 690 [M]
+
 (16), 659 [M CH2OH]
+
 (27), 583 (8), 368 (38), 321 (36), 
248 (23), 197 (63), 170 (29), 135 (100), 70 (17); HREIMS m/z 690.3781 (calcd for 
C42H50N4O5, 690.3781); for
 1
H NMR and 
13
C NMR data, see Table 2.66 and Table 2.67. 
HMBC: 
2
J H(3) to C(2); H(6), H(6) to C(5); H(5) to C(6); H(6), H(6) to C(7); 
H(14), H(14), H(20) to C(15); H(5) to C(16); H(18) to C(19); H(21) to C(20); H(20) 
to C(21); H(14'b) to C(3'); H(6'a), H(21), H(21) to C(7'); H(10') to C(9'); H(9') to 
C(10'); H(14'b) to C(15'); H(19') to C(18'); H(18') to C(19'); H(21'a), H(21'b) to C(20'). 
3
J H(6), H(6), H(14), N(1)-Me to C(2); H(5), N(4)-Me to C(3); N(4)-Me to C(5); 
H(5), H(9) to C(7); H(6), H(10), H(12) to C(8); H(11) to C(9); H(12) to C(10); H(9) to 
C(11); H(10) to C(12); H(9), H(11), N(1)-Me to C(13); H(20) to C(14); H(3), H(5), 
H(17), H(21) to C(15); H(5), H(6), H(6) to C(16); H(5), H(15) to C(17); H(15), 
H(17), H(21) to C(19); H(18) to C(20); H(6'a), H(6'b) to C(21); H(6'a), H(14'a) to 
C(2'); H(5'), H(15'), H(21'a) to C(3'); H(5'), H(9') to C(7'); H(21), H(10'), H(12') to 
C(8'); H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); H(10') to C(12'); H(9'), H(11') to 
C(13'); H(3'), H(22'a), H(22'b), H(19') to C(15'); H(21'a), H(15') to C(19'); H(18') to 
C(20'); H(3'), H(5'), H(5'), H(19') to C(21'). NOESY: H(3)/N(1)-Me, N(4)-Me; 
H(5)/N(4)-Me; H(6)/H(6 (6)/H(6, N(4)-Me H(12)/N(1)-Me; H(14)/H(3), 








H(17)/H(17); H(17)/H(17), H(18); H(18)/H(17); H(20)/H(18); 
H(21)/H(21), H(9'); H(21)/H(21); N(1)-Me/H(3, H(12 N(4)-Me/H(3, H(5 
H(3')/H(14'bH(5')/H(5'); H(5')/H(3'), H(5'); H(6'a)/H(6'b); H(6'b)/H(6'a); 
H(12')/H(11'); H(14'a)/H(3'), H(14'b); H(14'b)/H(3'), H(14'a), H(15'); H(15')/H(18'); 
H(22'a)/H(15'), H(22'b); H(22'b)/H(12'), H(22'a); H(18')/H(15', H(19' H(19')/H(18', 
H(21'a21'aH('), H(21'b); H(21'b)/H(21'a). NOE: H(12')/H(11' H(22'b) 
H(15')/H(14'a, H(14'b H(22'a, H(22'b, H(18'H(22'a)/H(12'), H(15'), H(22'b);  
H(22'b)/H(12'), H(22'a); CO2Me'/H(12'), H(18'). 
 
Villalstonidine F (87): light yellowish oil; [α]25D 40 (c 0.10, CHCl3); UV (EtOH) max 
nm (log ) 230 (5.80), 251 (5.83), 288 (5.90), 294 (5.91) nm; IR (dry film) max 3400, 
1753 cm
1
; ESIMS  m/z 647 [M + H]

; HRESIMS m/z 647.3603 (calcd for C40H46N4O4 
+ H, 647.3594); for 
1
H NMR and 
13
C NMR data, see Table 2.66 and Table 2.67. HMBC: 
2
J NH to C(2); H(6), H(6) to C(5); H(6), H(6) to C(7); NH to C(13); H(5) to C(16); 
H(18) to C(19); H(19') to C(18'); H(18') to C(19'); H(19') to C(20'). 
3
J H(6), H(6) to 
C(2); H(5), N4Me to C(3); N4Me to C(5); H(5), NH to C(7); H(10), H(12), NH to C(8); 
H(11) to C(9); H(12) to C(10); H(9) to C(11); H(10) to C(12); H(9), H(11) to C(13); 
H(5) to C(15); H(6), H(6) to C(16); H(5) to C(17); H(21) to C(19); H(18) to C(20); 
H(3), H(5) to N4Me; H(21a), H(6') to C(2'); H(9') to C(7'); H(21b), H(10'), H(12') to 
C(8'); H(11') to C(9'); H(12') to C(10'); H(9') to C(11'); H(11') to C(12'); H(9'), H(11') to 
C(13'); H(18') to C(20'); H(19') to C(21'); CO2Me' to CO2Me. NOESY: H(3)/H(14), 
H(14), NH, N4Me; H(5)/H(6), H(16), H(17), N4Me; H(6)/H(5), H(6); 
H(6)/H(6), H(9), H(16); H(9)/H(6), H(10); H(10)/H(9), H(11); H(11)/H(10), H(12); 
H(12)/H(11), NH; H(14)/H(3), H(14), H(17); H(14)/H(3), H(14), H(20), H(21b), 








H(18)/H(17); H(20)/H(14); H(21a)/H(9'); NH/H(3), H(14), H(12); N4Me/H(3), 
H(5); H(5')/H(5'), H(6'); H(5')/H(5'); H(6')/H(5'), H(6'), H(9'); H(6')/H(6'); 
H(9')/H(21a), H(6'), H(10'); H(10')/H(9'), H(11'); H(11')/H(10'), H(12'); H(12')/H(11'), 
H(16'), CO2Me'; H(14')/H(14'), H(15'), H(16'); H(14')/H(14'), H(15'); 
H(15')/H(14'), H(14'), H(16'), H(18'); H(16')/H(12'), H(14'), H(15'); H(18')/H(15'), 
H(19'); H(19')/H(18'), H(21'); H(21')/H(19'), H(21'); H(21')/H(21'); 
CO2Me'/H(12'). 
 
Villalstonine (88): light yellowish oil; []D 56 (c 0.25, CHCl3); UV (EtOH) max (log 
) 230 (5.80), 251 (5.83), 286 (5.90), 294 (5.91) nm; ESIMS m/z 661 (MH+, 
C41H48N4O4 + H); for 
1
H NMR and 
13
C NMR data, see Table 2.68 and Table 2.69, 
respectively.  
 
Villalstonine N(4')-oxide (89): light yellowish oil; []D 43 (c 0.40, CHCl3); UV 
(EtOH) max (log ) 203 (4.25), 229 (4.13), 286 (3.54) nm; EIMS m/z 660 (MO
+
, 
C41H48N4O5 O); for 
1
H NMR and 
13
C NMR data, see Table 2.68 and Table 2.69. 
 
Macrocarpamine (90): light yellowish oil; []D 10 (c 0.44, CHCl3); UV (EtOH) max 
(log ) 207 (4.14), 231 (4.25), 255 (4.10), 290 (3.55) nm; IR (dry film) max 1757 cm
1
; 




H NMR and 
13












3.8 Cytotoxicity Assays 
 
Cytotoxicity assays were carried out on KB (human oral epidermoid carcinoma cell 
line), or Jurkat (human T-cell-leukemia cell line) cells. The cells were maintained in 
culture flasks in Eagle’s MEM, supplemented with 10% fetal calf serum and kanamycin 
(60 µg/mL). The KB or Jurkat cells (1.5×10
5
/mL) were seeded in 0.2 mL of culture 
medium/well in 96-well plates (Corning Glass Works). The cells were treated in 
triplicate with graded concentrations of 5 µL test samples and were then incubated in a 
5% carbon dioxide atmosphere at 37 °C for 72 h. The MTT assay was used to measure 
the cytotoxicity effect.
288
 The activity was shown as the IC50 value, which was the 
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